18639629	11423	Pavlov VA	Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.	Brain, behavior, and immunity	2009	75
22246100	11423	Shaltiel G	Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target.	Brain structure and function	2013	42
23236169	11423	Sailaja BS	Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
23401542	11423	Mineur YS	Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
24096295	11423	Karvat G	Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism.	Neuropsychopharmacology 	2014	24
7870173	11441	Picciotto MR	Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain.	Nature	1995	156
9364063	11441	Orr-Urtreger A	Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.	The Journal of neuroscience 	1997	117
12589374	11441	Lambe EK	Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex.	Neuropsychopharmacology 	2003	85
12716925	11441	Wooltorton JR	Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.	The Journal of neuroscience 	2003	121
15056277	11441	Shytle RD	Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors.	Journal of neurochemistry	2004	99
15155845	11441	Salminen O	Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.	Molecular pharmacology	2004	178
15649582	11441	Gotti C	Neuronal nicotinic receptors: from structure to pathology.	Progress in neurobiology	2004	172
16001069	11441	Maskos U	Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors.	Nature	2005	180
16697744	11441	van Westerloo DJ	The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice.	Gastroenterology	2006	91
16772172	11441	Mameli-Engvall M	Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors.	Neuron	2006	90
17408579	11441	Couey JJ	Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex.	Neuron	2007	79
18033235	11441	Exley R	Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.	Neuropsychopharmacology 	2008	103
19020025	11441	Pons S	Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration.	The Journal of neuroscience 	2008	138
19116908	11441	van Maanen MA	Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice.	Arthritis and rheumatism	2009	62
19176801	11441	Liu Q	A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.	The Journal of neuroscience 	2009	48
19228980	11441	Grady SR	Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.	The Journal of neuroscience 	2009	73
19587288	11441	Dziewczapolski G	Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2009	54
19812319	11441	Xiao C	Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway.	The Journal of neuroscience 	2009	45
19846875	11441	Nizri E	Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.	Journal of immunology	2009	48
20203199	11441	Threlfell S	Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.	The Journal of neuroscience 	2010	60
20203212	11441	Parikh V	Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.	The Journal of neuroscience 	2010	50
20592195	11441	Campbell NR	Endogenous signaling through alpha7-containing nicotinic receptors promotes maturation and integration of adult-born neurons in the hippocampus.	The Journal of neuroscience 	2010	40
20660270	11441	Drenan RM	Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.	The Journal of neuroscience 	2010	56
20668200	11441	Hendrickson LM	Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.	The Journal of neuroscience 	2010	50
21289604	11441	Zhao-Shea R	Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.	Neuropsychopharmacology 	2011	43
21836018	11441	Guillem K	Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention.	Science	2011	54
22222765	11441	Liu L	Nicotine persistently activates ventral tegmental area dopaminergic neurons via nicotinic acetylcholine receptors containing α4 and α6 subunits.	Molecular pharmacology	2012	38
22396410	11441	Exley R	Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum.	The Journal of neuroscience 	2012	31
22649244	11441	Lozada AF	Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors.	The Journal of neuroscience 	2012	39
23247824	11441	Leslie FM	Nicotinic receptors in addiction pathways.	Molecular pharmacology	2013	26
23881354	11441	Ji H	Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis.	Mucosal immunology	2014	26
23929694	11441	Matteoli G	A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen.	Gut	2014	40
25476971	11441	Antolin-Fontes B	The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.	Neuropharmacology	2015	16
24487620	11516	Krashes MJ	An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger.	Nature	2014	93
9311920	11604	Ollmann MM	Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.	Science	1997	298
9844012	11604	Broberger C	The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice.	Proceedings of the National Academy of Sciences of the United States of America	1998	137
15761497	11604	Xu AW	PI3K integrates the action of insulin and leptin on hypothalamic neurons.	The Journal of clinical investigation	2005	128
16254186	11604	Luquet S	NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates.	Science	2005	285
16296893	11604	Xu AW	Effects of hypothalamic neurodegeneration on energy balance.	PLoS biology	2005	66
19160495	11604	Tong Q	Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance.	Nature neuroscience	2008	176
19563755	11604	Wu Q	Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation.	Cell	2009	136
21209617	11604	Aponte Y	AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training.	Nature neuroscience	2011	249
21364278	11604	Krashes MJ	Rapid, reversible activation of AgRP neurons drives feeding behavior in mice.	The Journal of clinical investigation	2011	265
21873987	11604	Diano S	Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity.	Nature medicine	2011	71
22232663	11604	Wu Q	Ablation of neurons expressing agouti-related protein, but not melanin concentrating hormone, in leptin-deficient mice restores metabolic functions and fertility.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
22325203	11604	Liu T	Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone.	Neuron	2012	77
22419158	11604	Wu Q	Deciphering a neuronal circuit that mediates appetite.	Nature	2012	92
22682251	11604	Ren H	FoxO1 target Gpr17 activates AgRP neurons to regulate food intake.	Cell	2012	54
22729177	11604	Dietrich MO	AgRP neurons regulate development of dopamine neuronal plasticity and nonfood-associated behaviors.	Nature neuroscience	2012	35
22801496	11604	Atasoy D	Deconstruction of a neural circuit for hunger.	Nature	2012	194
24074868	11604	Dietrich MO	Mitochondrial dynamics controlled by mitofusins regulate Agrp neuronal activity and diet-induced obesity.	Cell	2013	52
24462248	11604	Vogt MC	Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding.	Cell	2014	47
24567905	11604	Wang Q	Arcuate AgRP neurons mediate orexigenic and glucoregulatory actions of ghrelin.	Molecular metabolism	2014	42
25600267	11604	Ghamari-Langroudi M	G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons.	Nature	2015	28
25703096	11604	Chen Y	Sensory detection of food rapidly modulates arcuate feeding circuits.	Cell	2015	60
25748653	11604	Dietrich MO	Hypothalamic Agrp neurons drive stereotypic behaviors beyond feeding.	Cell	2015	18
25915020	11604	Betley JN	Neurons for hunger and thirst transmit a negative-valence teaching signal.	Nature	2015	66
25915476	11604	Garfield AS	A neural basis for melanocortin-4 receptor-regulated appetite.	Nature neuroscience	2015	43
26329458	11604	Henry FE	Cell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to weight-loss.	eLife	2015	22
27015310	11604	Steculorum SM	AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue.	Cell	2016	14
27019015	11604	Padilla SL	Agouti-related peptide neural circuits mediate adaptive behaviors in the starved state.	Nature neuroscience	2016	11
12504922	11651	De Sarno P	Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.	Neuropharmacology	2002	131
14981233	11651	Schubert M	Role for neuronal insulin resistance in neurodegenerative diseases.	Proceedings of the National Academy of Sciences of the United States of America	2004	139
15033922	11651	Ho L	Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.	FASEB journal 	2004	144
15254091	11651	Hou L	Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.	The Journal of neuroscience 	2004	168
15713641	11651	Easton RM	Role for Akt3/protein kinase Bgamma in attainment of normal brain size.	Molecular and cellular biology	2005	183
15836427	11651	Hippenmeyer S	A developmental switch in the response of DRG neurons to ETS transcription factor signaling.	PLoS biology	2005	298
16051150	11651	Beaulieu JM	An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior.	Cell	2005	294
16453021	11651	Anitha M	GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway.	The Journal of clinical investigation	2006	73
16738242	11651	Wang L	Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration.	The Journal of neuroscience 	2006	95
16877357	11651	Adhami F	Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy.	The American journal of pathology	2006	87
16923958	11651	Dummler B	Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies.	Molecular and cellular biology	2006	80
18367451	11651	Garza JC	Leptin increases adult hippocampal neurogenesis in vivo and in vitro.	The Journal of biological chemistry	2008	69
18371380	11651	Hegedus B	Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.	Cell stem cell	2007	67
18614687	11651	Flores AI	Constitutively active Akt induces enhanced myelination in the CNS.	The Journal of neuroscience 	2008	110
18639865	11651	Krishnan V	AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.	Biological psychiatry	2008	60
18794877	11651	Endersby R	PTEN signaling in brain: neuropathology and tumorigenesis.	Oncogene	2008	65
19474313	11651	Narayanan SP	Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.	The Journal of neuroscience 	2009	101
20335475	11651	Fan L	Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippocampal extracellular signal-regulated kinase and phosphatidylinositol 3-kinase activation.	The Journal of neuroscience 	2010	49
20615072	11651	Cheng Z	Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.	Antioxidants and redox signaling	2011	52
20926677	11651	Schmid CL	Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.	The Journal of neuroscience 	2010	42
21460223	11651	Jimenez S	Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.	The Journal of biological chemistry	2011	37
22322096	11651	Stokes MP	PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.	Molecular and cellular proteomics 	2012	31
22446186	11651	Selvaraj S	Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.	The Journal of clinical investigation	2012	32
22689977	11651	Jo H	Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death.	Proceedings of the National Academy of Sciences of the United States of America	2012	36
23775075	11651	Schmid CL	Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons.	The Journal of biological chemistry	2013	27
23926267	11651	Zhu Z	Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance.	The Journal of neuroscience 	2013	35
24670654	11651	Liu P	Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.	Nature	2014	64
24686304	11651	Arnold SE	High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice.	Neurobiology of disease	2014	27
25037225	11651	Zeldich E	The neuroprotective effect of Klotho is mediated via regulation of members of the redox system.	The Journal of biological chemistry	2014	31
25788687	11651	Sun J	Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.	The Journal of neuroscience 	2015	16
25913858	11651	Mukai J	Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia.	Neuron	2015	16
10611368	11816	Bales KR	Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	1999	96
10694577	11816	Holtzman DM	Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2000	191
11120756	11816	Shibata M	Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.	The Journal of clinical investigation	2000	266
12939405	11816	Harris FM	Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	95
15014128	11816	Brecht WJ	Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.	The Journal of neuroscience 	2004	98
15087308	11816	Meir KS	Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.	Arteriosclerosis, thrombosis, and vascular biology	2004	87
15195085	11816	Koistinaho M	Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.	Nature medicine	2004	138
15788759	11816	Lim GP	A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.	The Journal of neuroscience 	2005	124
16687490	11816	Xu Q	Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus.	The Journal of neuroscience 	2006	89
17942401	11816	Cao D	Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.	The Journal of biological chemistry	2007	83
18155324	11816	Vitek MP	APOE genotype-specific differences in the innate immune response.	Neurobiology of aging	2009	79
18549781	11816	Jiang Q	ApoE promotes the proteolytic degradation of Abeta.	Neuron	2008	240
18987181	11816	Riddell DR	Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.	The Journal of neuroscience 	2008	87
19033669	11816	Deane R	apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.	The Journal of clinical investigation	2008	176
19474305	11816	Bales KR	Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice.	The Journal of neuroscience 	2009	87
19560099	11816	Nichol K	Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice.	Alzheimer's and dementia 	2009	54
19577821	11816	Sullivan PM	Reduced levels of human apoE4 protein in an animal model of cognitive impairment.	Neurobiology of aging	2011	37
19951691	11816	Li G	GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.	Cell stem cell	2009	57
19955384	11816	Dumanis SB	ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.	The Journal of neuroscience 	2009	63
20005821	11816	Kim J	Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.	Neuron	2009	76
21118811	11816	Chen HK	Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease.	The Journal of biological chemistry	2011	36
21356305	11816	Drake C	Brain inflammation is induced by co-morbidities and risk factors for stroke.	Brain, behavior, and immunity	2011	53
21471207	11816	Nishitsuji K	Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.	The Journal of biological chemistry	2011	46
21715678	11816	Castellano JM	Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.	Science translational medicine	2011	229
22159114	11816	Kim J	Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis.	The Journal of neuroscience 	2011	59
22323736	11816	Cramer PE	ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.	Science	2012	271
22622580	11816	Bell RD	Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.	Nature	2012	216
22763456	11816	Dutta P	Myocardial infarction accelerates atherosclerosis.	Nature	2012	163
22836247	11816	Mandrekar-Colucci S	Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.	The Journal of neuroscience 	2012	81
22848551	11816	Hawkes CA	Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele.	PloS one	2012	40
23293020	11816	Tai LM	Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.	The Journal of biological chemistry	2013	33
23620513	11816	Verghese PB	ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions.	Proceedings of the National Academy of Sciences of the United States of America	2013	82
23704552	11816	Fitz NF	Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".	Science	2013	55
23704553	11816	Price AR	Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".	Science	2013	46
23704554	11816	Tesseur I	Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".	Science	2013	45
23704555	11816	Veeraraghavalu K	Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".	Science	2013	45
23999527	11816	Hammer C	Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.	Molecular psychiatry	2014	54
24948358	11816	Rodriguez GA	Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.	Journal of neuroinflammation	2014	22
25381879	11816	Butovsky O	Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.	Annals of neurology	2015	33
25675483	11816	Han BH	Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.	Proceedings of the National Academy of Sciences of the United States of America	2015	24
25757756	11816	Halliday MR	Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2016	35
26152694	11816	Lane-Donovan C	Reelin protects against amyloid β toxicity in vivo.	Science signaling	2015	20
26686669	11816	Cacciottolo M	The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.	Neurobiology of aging	2016	11
7845465	11820	Games D	Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.	Nature	1995	309
8816718	11820	Paresce DM	Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.	Neuron	1996	135
9037091	11820	Johnson-Wood K	Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1997	170
9117892	11820	Borchelt DR	A vector for expressing foreign genes in the brains and hearts of transgenic mice.	Genetic analysis 	1996	119
9291938	11820	Irizarry MC	APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.	Journal of neuropathology and experimental neurology	1997	130
9354339	11820	Borchelt DR	Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.	Neuron	1997	224
9371838	11820	Sturchler-Pierrat C	Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.	Proceedings of the National Academy of Sciences of the United States of America	1997	259
9422548	11820	Frautschy SA	Microglial response to amyloid plaques in APPsw transgenic mice.	The American journal of pathology	1998	120
9427614	11820	Holcomb L	Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.	Nature medicine	1998	259
10037741	11820	Moechars D	Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.	The Journal of biological chemistry	1999	135
10077666	11820	Hsia AY	Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.	Proceedings of the National Academy of Sciences of the United States of America	1999	271
10408445	11820	Schenk D	Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.	Nature	1999	574
10804202	11820	Kane MD	Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.	The Journal of neuroscience 	2000	97
11140684	11820	Chen G	A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.	Nature	2000	135
11140685	11820	Janus C	A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.	Nature	2000	300
11140686	11820	Morgan D	A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.	Nature	2000	335
11160418	11820	Kawarabayashi T	Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.	The Journal of neuroscience 	2001	299
11438712	11820	DeMattos RB	Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	272
11520987	11820	Lewis J	Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.	Science	2001	280
11700559	11820	Weggen S	A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.	Nature	2001	294
11880504	11820	Kruman II	Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease.	The Journal of neuroscience 	2002	86
12612547	11820	Wyss-Coray T	Adult mouse astrocytes degrade amyloid-beta in vitro and in situ.	Nature medicine	2003	195
12695498	11820	Anandatheerthavarada HK	Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.	The Journal of cell biology	2003	115
12732730	11820	Miller BC	Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	81
12736345	11820	Wilcock DM	Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.	The Journal of neuroscience 	2003	86
12925731	11820	Gong Y	Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.	Proceedings of the National Academy of Sciences of the United States of America	2003	237
12930788	11820	Yan Q	Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.	The Journal of neuroscience 	2003	117
14523085	11820	Cirrito JR	In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.	The Journal of neuroscience 	2003	161
14985348	11820	Davis J	Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor.	The Journal of biological chemistry	2004	113
15115763	11820	Reddy PH	Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.	Human molecular genetics	2004	78
15174014	11820	Trinchese F	Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.	Annals of neurology	2004	77
15311281	11820	Herzig MC	Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.	Nature neuroscience	2004	102
15475691	11820	Moolman DL	Dendrite and dendritic spine alterations in Alzheimer models.	Journal of neurocytology	2004	74
15578094	11820	Gong B	Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.	The Journal of clinical investigation	2004	108
15766532	11820	Lazarov O	Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.	Cell	2005	177
15862213	11820	Song SK	Demyelination increases radial diffusivity in corpus callosum of mouse brain.	NeuroImage	2005	417
15917461	11820	Jankowsky JL	Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2005	94
16136043	11820	Singer O	Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.	Nature neuroscience	2005	109
16141783	11820	Morgan D	Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics.	Journal of neuropathology and experimental neurology	2005	65
16210396	11820	Caspersen C	Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.	FASEB journal 	2005	195
16237174	11820	Chin J	Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease.	The Journal of neuroscience 	2005	105
16239972	11820	Cirrito JR	P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.	The Journal of clinical investigation	2005	144
16282321	11820	Oddo S	Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.	The Journal of biological chemistry	2006	116
16291932	11820	Klunk WE	Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.	The Journal of neuroscience 	2005	85
16298135	11820	Kim JH	Detecting axon damage in spinal cord from a mouse model of multiple sclerosis.	Neurobiology of disease	2006	68
16344143	11820	Wearne SL	New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple scales.	Neuroscience	2005	102
16354928	11820	Laird FM	BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.	The Journal of neuroscience 	2005	165
16365303	11820	Yue X	Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.	Proceedings of the National Academy of Sciences of the United States of America	2005	80
16469784	11820	Townsend M	Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.	The Journal of physiology	2006	174
16551656	11820	Manczak M	Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.	Human molecular genetics	2006	253
16641106	11820	Galvan V	Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664.	Proceedings of the National Academy of Sciences of the United States of America	2006	97
16767098	11820	McLaurin J	Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.	Nature medicine	2006	81
16806094	11820	Wolf SA	Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.	Biological psychiatry	2006	67
16815330	11820	Salehi A	Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.	Neuron	2006	161
16864778	11820	Butovsky O	Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.	Proceedings of the National Academy of Sciences of the United States of America	2006	85
16943563	11820	Green KN	Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2006	126
16984903	11820	Tahara K	Role of toll-like receptor signalling in Abeta uptake and clearance.	Brain 	2006	123
17021169	11820	Oakley H	Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.	The Journal of neuroscience 	2006	418
17029828	11820	Garcia-Alloza M	Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.	Neurobiology of disease	2006	146
17056594	11820	Oddo S	Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles.	The Journal of biological chemistry	2006	104
17116235	11820	Lambert MP	Monoclonal antibodies that target pathological assemblies of Abeta.	Journal of neurochemistry	2007	104
17197420	11820	Shen J	The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2007	134
17368446	11820	Mac Donald CL	Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury.	Experimental neurology	2007	85
17544172	11820	Tseng BP	Abeta inhibits the proteasome and enhances amyloid and tau accumulation.	Neurobiology of aging	2008	76
17549256	11820	Shaftel SS	Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.	The Journal of clinical investigation	2007	115
17551515	11820	LaFerla FM	Intracellular amyloid-beta in Alzheimer's disease.	Nature reviews. Neuroscience	2007	386
17634375	11820	Ring S	The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice.	The Journal of neuroscience 	2007	115
17784957	11820	Munoz L	A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.	Journal of neuroinflammation	2007	61
17965777	11820	Wang J	Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.	The Journal of clinical investigation	2007	63
18155846	11820	Lesné S	Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function.	Neuroscience	2008	51
18218341	11820	Reddy PH	Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.	Trends in molecular medicine	2008	170
18410513	11820	Thirumangalakudi L	High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.	Journal of neurochemistry	2008	62
18480253	11820	Muhammad A	Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation.	Proceedings of the National Academy of Sciences of the United States of America	2008	70
18486110	11820	Hirata-Fukae C	Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.	Brain research	2008	63
18497889	11820	Pickford F	The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.	The Journal of clinical investigation	2008	253
18562603	11820	Maier M	Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2008	83
18759972	11820	Lee JW	Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation.	Journal of neuroinflammation	2008	79
19151372	11820	Boissonneault V	Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.	Brain 	2009	72
19225519	11820	Nikolaev A	APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.	Nature	2009	345
19275634	11820	Deane R	Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.	CNS and neurological disorders drug targets	2009	101
19621015	11820	Toledo EM	Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.	Molecular psychiatry	2010	62
19625522	11820	Peng S	Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.	The Journal of neuroscience 	2009	46
19805389	11820	Smith DL	Reversal of long-term dendritic spine alterations in Alzheimer disease models.	Proceedings of the National Academy of Sciences of the United States of America	2009	70
19837693	11820	Ghosal K	Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
19854267	11820	Butterfield DA	In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.	Free radical biology and medicine	2010	47
20071513	11820	Wesson DW	Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.	The Journal of neuroscience 	2010	66
20164348	11820	Wu HY	Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.	The Journal of neuroscience 	2010	127
20308787	11820	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	61
20371804	11820	Tomiyama T	A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.	The Journal of neuroscience 	2010	113
20434528	11820	Dawson HN	Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.	Neuroscience	2010	49
20451588	11820	Lee KJ	Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines.	Neuroscience	2010	41
20463404	11820	Dragicevic N	Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.	Journal of Alzheimer's disease 	2010	47
20471717	11820	Lee HJ	Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.	Neurobiology of aging	2012	41
20632020	11820	Boche D	Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.	Acta neuropathologica	2010	41
20846376	11820	Lee DC	LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.	Journal of neuroinflammation	2010	65
21040845	11820	Harris JA	Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.	Neuron	2010	89
21307267	11820	Yao J	Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2011	39
21436112	11820	Fodero-Tavoletti MT	18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.	Brain 	2011	63
21472769	11820	Puzzo D	Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory.	Annals of neurology	2011	59
21488093	11820	Umeda T	Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo.	Journal of neuroscience research	2011	53
21747957	11820	Yao J	2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.	PloS one	2011	36
21873260	11820	Calkins MJ	Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.	Human molecular genetics	2011	100
21994365	11820	Langer F	Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition.	The Journal of neuroscience 	2011	66
22037588	11820	Reddy PH	Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.	Biochimica et biophysica acta	2012	62
22046307	11820	Westmark CJ	Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice.	PloS one	2011	42
22047170	11820	Zhao J	The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.	Journal of neuroinflammation	2011	51
22170863	11820	Tamayev R	β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia.	EMBO molecular medicine	2012	43
22492996	11820	Mao P	Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.	Human molecular genetics	2012	35
22539346	11820	Xiao Q	Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.	The Journal of biological chemistry	2012	35
22584394	11820	Biscaro B	Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease.	Neuro-degenerative diseases	2012	30
22747753	11820	Krstic D	Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice.	Journal of neuroinflammation	2012	58
22884903	11820	Tyan SH	Amyloid precursor protein (APP) regulates synaptic structure and function.	Molecular and cellular neurosciences	2012	34
22915123	11820	Oulès B	Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.	The Journal of neuroscience 	2012	37
23038755	11820	Kraft AW	Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice.	FASEB journal 	2013	54
23365075	11820	Browne TC	IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.	Journal of immunology	2013	28
23820808	11820	Kandalepas PC	The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques.	Acta neuropathologica	2013	50
23959870	11820	Singh I	Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
23973293	11820	McClean PL	Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.	Neuropharmacology	2014	31
24305823	11820	Kanekiyo T	Neuronal clearance of amyloid-β by endocytic receptor LRP1.	The Journal of neuroscience 	2013	43
24501359	11820	Vargas JY	In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model.	The Journal of neuroscience 	2014	24
24623762	11820	Born HA	Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease.	The Journal of neuroscience 	2014	29
24646365	11820	Vassar R	Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects.	Journal of neurochemistry	2014	54
24899710	11820	Fowler SW	Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2014	24
25253696	11820	Maloney JA	Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.	The Journal of biological chemistry	2014	26
25853174	11820	Pooler AM	Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.	Acta neuropathologica communications	2015	16
26549211	11820	Zhang Z	Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.	Nature communications	2015	15
10655103	11829	Manley GT	Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.	Nature medicine	2000	276
12578959	11829	Amiry-Moghaddam M	An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain.	Proceedings of the National Academy of Sciences of the United States of America	2003	95
14597704	11829	Amiry-Moghaddam M	Delayed K+ clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of alpha-syntrophin-null mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	85
15208268	11829	Papadopoulos MC	Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema.	FASEB journal 	2004	149
15695511	11829	Papadopoulos MC	Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis.	The Journal of biological chemistry	2005	71
16303850	11829	Saadoun S	Involvement of aquaporin-4 in astroglial cell migration and glial scar formation.	Journal of cell science	2005	115
16470808	11829	Binder DK	Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin-4 water channels.	Glia	2006	99
16564496	11829	Verkman AS	Three distinct roles of aquaporin-4 in brain function revealed by knockout mice.	Biochimica et biophysica acta	2006	74
17135365	11829	Auguste KI	Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury.	FASEB journal 	2007	66
19345723	11829	Saadoun S	AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology.	Neuroscience	2009	45
21257712	11829	Li L	Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation.	FASEB journal 	2011	42
21262839	11829	Benfenati V	An aquaporin-4/transient receptor potential vanilloid 4 (AQP4/TRPV4) complex is essential for cell-volume control in astrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2011	54
21298100	11829	Li SY	Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury.	PloS one	2011	37
21525279	11829	Skucas VA	Impairment of select forms of spatial memory and neurotrophin-dependent synaptic plasticity by deletion of glial aquaporin-4.	The Journal of neuroscience 	2011	36
21990350	11829	Haj-Yasein NN	Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet.	Proceedings of the National Academy of Sciences of the United States of America	2011	52
22069219	11829	Zhang H	Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.	Annals of neurology	2011	49
22271321	11829	Tradtrantip L	Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.	Annals of neurology	2012	61
22374891	11829	Saadoun S	Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.	Annals of neurology	2012	51
22378467	11829	Binder DK	Aquaporin-4 and epilepsy.	Glia	2012	33
22419561	11829	Haj-Yasein NN	Aquaporin-4 regulates extracellular space volume dynamics during high-frequency synaptic stimulation: a gene deletion study in mouse hippocampus.	Glia	2012	33
22526022	11829	Ratelade J	Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.	Acta neuropathologica	2012	34
23055279	11829	Tradtrantip L	Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.	Annals of neurology	2013	26
23443171	11829	Ren Z	'Hit &amp;amp; Run' model of closed-skull traumatic brain injury (TBI) reveals complex patterns of post-traumatic AQP4 dysregulation.	Journal of cerebral blood flow and metabolism 	2013	38
23563310	11829	Zhang H	Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.	The Journal of clinical investigation	2013	32
24583950	11829	Yao Y	Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity.	Nature communications	2014	21
25204284	11829	Kress BT	Impairment of paravascular clearance pathways in the aging brain.	Annals of neurology	2014	76
27481936	11829	Lundgaard I	Glymphatic clearance controls state-dependent changes in brain lactate concentration.	Journal of cerebral blood flow and metabolism 	2017	6
9989497	11865	Jin X	A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock.	Cell	1999	152
10807566	11865	Shearman LP	Interacting molecular loops in the mammalian circadian clock.	Science	2000	249
11163178	11865	Bunger MK	Mop3 is an essential component of the master circadian pacemaker in mammals.	Cell	2000	345
11303101	11865	Yagita K	Molecular mechanisms of the biological clock in cultured fibroblasts.	Science	2001	108
15634777	11865	Morton AJ	Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.	The Journal of neuroscience 	2005	85
16093318	11865	Shimba S	Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2005	116
16675400	11865	Debruyne JP	A clock shock: mouse CLOCK is not required for circadian oscillator function.	Neuron	2006	126
17124323	11865	McDearmon EL	Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice.	Science	2006	75
18497298	11865	Fuller PM	Differential rescue of light- and food-entrainable circadian rhythms.	Science	2008	77
19091946	11865	Son GH	Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production.	Proceedings of the National Academy of Sciences of the United States of America	2008	55
20519775	11865	Kondratova AA	Circadian clock proteins control adaptation to novel environment and memory formation.	Aging	2010	42
20539819	11865	Lee S	Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice.	PloS one	2010	54
20562852	11865	Marcheva B	Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes.	Nature	2010	318
20967239	11865	Ko CH	Emergence of noise-induced oscillations in the central circadian pacemaker.	PLoS biology	2010	67
23142819	11865	Paschos GK	Obesity in mice with adipocyte-specific deletion of clock component Arntl.	Nature medicine	2012	94
24270424	11865	Musiek ES	Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration.	The Journal of clinical investigation	2013	59
25741730	11865	Mieda M	Cellular clocks in AVP neurons of the SCN are critical for interneuronal coupling regulating circadian behavior rhythm.	Neuron	2015	23
9367153	11921	Ben-Arie N	Math1 is essential for genesis of cerebellar granule neurons.	Nature	1997	152
10364557	11921	Bermingham NA	Math1: an essential gene for the generation of inner ear hair cells.	Science	1999	286
10683172	11921	Helms AW	Autoregulation and multiple enhancers control Math1 expression in the developing nervous system.	Development	2000	116
10816314	11921	Zheng JL	Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears.	Nature neuroscience	2000	186
11425898	11921	Zine A	Hes1 and Hes5 activities are required for the normal development of the hair cells in the mammalian inner ear.	The Journal of neuroscience 	2001	95
12915300	11921	Lumpkin EA	Math1-driven GFP expression in the developing nervous system of transgenic mice.	Gene expression patterns 	2003	135
15543141	11921	Woods C	Math1 regulates development of the sensory epithelium in the mammalian cochlea.	Nature neuroscience	2004	135
15846349	11921	Kiernan AE	Sox2 is required for sensory organ development in the mammalian inner ear.	Nature	2005	179
16145671	11921	Matei V	Smaller inner ear sensory epithelia in Neurog 1 null mice are related to earlier hair cell cycle exit.	Developmental dynamics 	2005	142
16202707	11921	Wang VY	Math1 expression redefines the rhombic lip derivatives and reveals novel lineages within the brainstem and cerebellum.	Neuron	2005	123
18039969	11921	Raft S	Cross-regulation of Ngn1 and Math1 coordinates the production of neurons and sensory hair cells during inner ear development.	Development	2007	83
18347090	11921	Zhao H	Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development.	Genes and development	2008	52
18754012	11921	Gubbels SP	Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer.	Nature	2008	91
19185848	11921	Read TA	Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.	Cancer cell	2009	95
19541997	11921	Maricich SM	Merkel cells are essential for light-touch responses.	Science	2009	79
19668217	11921	Aldinger KA	FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation.	Nature genetics	2009	54
19782676	11921	Morrison KM	Mammalian Merkel cells are descended from the epidermal lineage.	Developmental biology	2009	55
19914183	11921	Rose MF	Math1 is essential for the development of hindbrain neurons critical for perinatal breathing.	Neuron	2009	48
21146598	11921	Pan N	Conditional deletion of Atoh1 using Pax2-Cre results in viable mice without differentiated cochlear hair cells that have lost most of the organ of Corti.	Hearing research	2011	45
21360794	11921	Weston MD	MicroRNA-183 family expression in hair cell development and requirement of microRNAs for hair cell maintenance and survival.	Developmental dynamics 	2011	39
21653840	11921	Jeon SJ	Notch signaling alters sensory or neuronal cell fate specification of inner ear stem cells.	The Journal of neuroscience 	2011	40
22279587	11921	Pan N	A novel Atoh1 "self-terminating" mouse model reveals the necessity of proper Atoh1 level and duration for hair cell differentiation and viability.	PloS one	2012	39
22340499	11921	Ahmed M	Eya1-Six1 interaction is sufficient to induce hair cell fate in the cochlea by activating Atoh1 expression in cooperation with Sox2.	Developmental cell	2012	58
22573682	11921	Liu Z	Age-dependent in vivo conversion of mouse cochlear pillar and Deiters' cells to immature hair cells by Atoh1 ectopic expression.	The Journal of neuroscience 	2012	59
23318633	11921	Driver EC	The Atoh1-lineage gives rise to hair cells and supporting cells within the mammalian cochlea.	Developmental biology	2013	31
23614009	11921	Duncan JS	Continued expression of GATA3 is necessary for cochlear neurosensory development.	PloS one	2013	26
23673358	11921	Bardot ES	Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells.	The EMBO journal	2013	35
23761906	11921	Cai T	Conditional deletion of Atoh1 reveals distinct critical periods for survival and function of hair cells in the organ of Corti.	The Journal of neuroscience 	2013	30
24806673	11921	Shi F	β-Catenin is required for hair-cell differentiation in the cochlea.	The Journal of neuroscience 	2014	21
25855195	11921	Cai T	Characterization of the transcriptome of nascent hair cells and identification of direct targets of the Atoh1 transcription factor.	The Journal of neuroscience 	2015	23
26224861	11921	Kuo BR	In Vivo Cochlear Hair Cell Generation and Survival by Coactivation of β-Catenin and Atoh1.	The Journal of neuroscience 	2015	16
9102301	11924	de la Pompa JL	Conservation of the Notch signalling pathway in mammalian neurogenesis.	Development	1997	130
9806930	11924	Brown NL	Math5 encodes a murine basic helix-loop-helix transcription factor expressed during early stages of retinal neurogenesis.	Development	1998	101
11825874	11924	Parras CM	Divergent functions of the proneural genes Mash1 and Ngn2 in the specification of neuronal subtype identity.	Genes and development	2002	82
16202708	11924	Hand R	Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex.	Neuron	2005	112
16705040	11924	Nguyen L	p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex.	Genes and development	2006	133
17596284	11924	Ferri AL	Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner.	Development	2007	82
18075251	11924	Pontious A	Role of intermediate progenitor cells in cerebral cortex development.	Developmental neuroscience	2008	116
19521500	11924	Sansom SN	The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis.	PLoS genetics	2009	101
19881504	11924	Brill MS	Adult generation of glutamatergic olfactory bulb interneurons.	Nature neuroscience	2009	96
8816704	12028	Deckwerth TL	BAX is required for neuronal death after trophic factor deprivation and during development.	Neuron	1996	144
9454852	12028	White FA	Widespread elimination of naturally occurring neuronal death in Bax-deficient mice.	The Journal of neuroscience 	1998	108
10719890	12028	Patel TD	Development of sensory neurons in the absence of NGF/TrkA signaling in vivo.	Neuron	2000	98
15081359	12028	Yang X	Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway.	Developmental biology	2004	95
15342910	12028	Forger NG	Deletion of Bax eliminates sex differences in the mouse forebrain.	Proceedings of the National Academy of Sciences of the United States of America	2004	70
15574493	12028	Weiner JA	Gamma protocadherins are required for synaptic development in the spinal cord.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
16928866	12028	Gould TW	Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.	The Journal of neuroscience 	2006	106
17435755	12028	Nagai M	Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.	Nature neuroscience	2007	347
18158332	12028	Howell GR	Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma.	The Journal of cell biology	2007	185
18288109	12028	Chao JR	Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.	Nature	2008	64
18295378	12028	Hauptmann S	Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.	Neurobiology of aging	2009	86
18948087	12028	Yi JH	PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.	Brain research	2008	50
19029044	12028	Lefebvre JL	gamma-Protocadherins regulate neuronal survival but are dispensable for circuit formation in retina.	Development	2008	64
20007710	12028	Zhang Y	The mitochondrial pathway of anesthetic isoflurane-induced apoptosis.	The Journal of biological chemistry	2010	59
21127253	12028	Ren D	BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program.	Science	2010	161
21415464	12028	Khanna A	Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice.	Aging	2011	40
22460798	12028	Johnson BN	The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax.	Proceedings of the National Academy of Sciences of the United States of America	2012	37
23041929	12028	Southwell DG	Intrinsically determined cell death of developing cortical interneurons.	Nature	2012	45
25833129	12028	Hill AS	Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors.	Neuropsychopharmacology 	2015	35
25976060	12028	Wang H	MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim.	Brain pathology	2016	11
7568031	12064	Korte M	Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.	Proceedings of the National Academy of Sciences of the United States of America	1995	270
7852993	12064	Barbacid M	The Trk family of neurotrophin receptors.	Journal of neurobiology	1994	145
8137432	12064	Jones KR	Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development.	Cell	1994	151
8139657	12064	Ernfors P	Mice lacking brain-derived neurotrophic factor develop with sensory deficits.	Nature	1994	163
8663990	12064	Patterson SL	Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice.	Neuron	1996	259
9349818	12064	Altar CA	Anterograde transport of brain-derived neurotrophic factor and its role in the brain.	Nature	1997	189
10366630	12064	Pozzo-Miller LD	Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice.	The Journal of neuroscience 	1999	101
10499792	12064	Huang ZJ	BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex.	Cell	1999	309
10611369	12064	Lyons WE	Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.	Proceedings of the National Academy of Sciences of the United States of America	1999	161
10679428	12064	Berardi N	Critical periods during sensory development.	Current opinion in neurobiology	2000	94
10716929	12064	Kernie SG	BDNF regulates eating behavior and locomotor activity in mice.	The EMBO journal	2000	165
10725920	12064	Jovanovic JN	Synapsins as mediators of BDNF-enhanced neurotransmitter release.	Nature neuroscience	2000	131
11135642	12064	Tucker KL	Neurotrophins are required for nerve growth during development.	Nature neuroscience	2001	132
11333982	12064	Guillin O	BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.	Nature	2001	94
11487640	12064	Fariñas I	Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression.	The Journal of neuroscience 	2001	102
11872844	12064	Kovalchuk Y	Postsynaptic Induction of BDNF-Mediated Long-Term Potentiation.	Science	2002	90
11905999	12064	Lee J	Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice.	Journal of neurochemistry	2002	84
12354284	12064	Lee J	Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.	Journal of neurochemistry	2002	191
12473684	12064	Rivera C	BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion.	The Journal of cell biology	2002	114
12514234	12064	Saarelainen T	Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.	The Journal of neuroscience 	2003	157
12588797	12064	Gines S	Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice.	Human molecular genetics	2003	76
12589027	12064	Duan W	Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	108
12796784	12064	Xu B	Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor.	Nature neuroscience	2003	196
12890780	12064	Gorski JA	Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites.	The Journal of neuroscience 	2003	126
14593183	12064	Chen WG	Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.	Science	2003	380
14999077	12064	Spires TL	Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.	The Journal of neuroscience 	2004	72
15066262	12064	Saura CA	Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration.	Neuron	2004	192
15115821	12064	Baquet ZC	Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.	The Journal of neuroscience 	2004	104
15133062	12064	Sudo N	Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice.	The Journal of physiology	2004	211
15233915	12064	He XP	Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model.	Neuron	2004	89
15249684	12064	Monteggia LM	Essential role of brain-derived neurotrophic factor in adult hippocampal function.	Proceedings of the National Academy of Sciences of the United States of America	2004	170
15342740	12064	Canals JM	Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.	The Journal of neuroscience 	2004	81
15486301	12064	Pang PT	Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity.	Science	2004	255
15647480	12064	Hashimoto T	Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.	The Journal of neuroscience 	2005	108
15689544	12064	Sairanen M	Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus.	The Journal of neuroscience 	2005	172
15745951	12064	Kerns RT	Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice.	The Journal of neuroscience 	2005	106
15987954	12064	Ridder S	Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.	The Journal of neuroscience 	2005	74
16202713	12064	Barco A	Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture.	Neuron	2005	74
16221865	12064	Bolger TA	Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death.	The Journal of neuroscience 	2005	65
16306394	12064	Bull ND	The adult mouse hippocampal progenitor is neurogenic but not a stem cell.	The Journal of neuroscience 	2005	74
16415867	12064	Ziv Y	Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood.	Nature neuroscience	2006	252
16446138	12064	Chang Q	The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.	Neuron	2006	185
16469931	12064	Berton O	Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress.	Science	2006	457
16501568	12064	Tsankova NM	Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.	Nature neuroscience	2006	428
16613552	12064	Sokoloff P	The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.	CNS and neurological disorders drug targets	2006	72
16697351	12064	Monteggia LM	Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.	Biological psychiatry	2007	136
16924103	12064	Govindarajan A	Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects.	Proceedings of the National Academy of Sciences of the United States of America	2006	78
16938843	12064	Ziv Y	Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury.	Proceedings of the National Academy of Sciences of the United States of America	2006	62
16945350	12064	Schroeder FA	Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse.	Biological psychiatry	2007	102
17023662	12064	Chen ZY	Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior.	Science	2006	340
17040481	12064	Rossi C	Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment.	The European journal of neuroscience	2006	118
17057708	12064	Ozdinler PH	IGF-I specifically enhances axon outgrowth of corticospinal motor neurons.	Nature neuroscience	2006	103
17149751	12064	Aid T	Mouse and rat BDNF gene structure and expression revisited.	Journal of neuroscience research	2007	246
17264839	12064	Heldt SA	Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories.	Molecular psychiatry	2007	147
17379385	12064	Zuccato C	Role of brain-derived neurotrophic factor in Huntington's disease.	Progress in neurobiology	2007	107
17387691	12064	Ethell IM	Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets.	Journal of neuroscience research	2007	111
17442827	12064	Lynch G	Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease.	The Journal of neuroscience 	2007	55
17618281	12064	Graham DL	Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse.	Nature neuroscience	2007	162
17959817	12064	Strand AD	Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.	The Journal of neuroscience 	2007	71
18077569	12064	Lipsky RH	Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity.	Annals of the New York Academy of Sciences	2007	68
18086127	12064	Gharami K	Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice.	Journal of neurochemistry	2008	59
18160634	12064	Unger TJ	Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity.	The Journal of neuroscience 	2007	102
18204444	12064	Matsumoto T	Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF.	Nature neuroscience	2008	96
18322085	12064	Bath KG	Variant brain-derived neurotrophic factor (Val66Met) alters adult olfactory bulb neurogenesis and spontaneous olfactory discrimination.	The Journal of neuroscience 	2008	57
18382462	12064	Singh KK	Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration.	Nature neuroscience	2008	79
18541795	12064	Kassis I	Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.	Archives of neurology	2008	74
18614020	12064	An JJ	Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons.	Cell	2008	189
18990365	12064	Graham DL	Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward.	Biological psychiatry	2009	54
19038219	12064	Hong EJ	A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition.	Neuron	2008	127
19136973	12064	Yang J	Neuronal release of proBDNF.	Nature neuroscience	2009	110
19264961	12064	Simmons DA	Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
19280661	12064	Stranahan AM	Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.	Hippocampus	2009	104
19293383	12064	Sakata K	Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
19293698	12064	Head BP	Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system.	Anesthesiology	2009	67
19299695	12064	Wolf SA	CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis.	Journal of immunology	2009	68
19339601	12064	Yu H	Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory.	The Journal of neuroscience 	2009	51
19448629	12064	Dean C	Synaptotagmin-IV modulates synaptic function and long-term potentiation by regulating BDNF release.	Nature neuroscience	2009	60
19452518	12064	Fuss J	Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis.	Hippocampus	2010	47
19540623	12064	Poon WW	β-Amyloid impairs axonal BDNF retrograde trafficking.	Neurobiology of aging	2011	42
19633196	12064	Blurton-Jones M	Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	164
19773812	12064	Norman GJ	Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury.	Molecular psychiatry	2010	41
20004026	12064	Pistell PJ	Cognitive impairment following high fat diet consumption is associated with brain inflammation.	Journal of neuroimmunology	2010	91
20075215	12064	Soliman F	A genetic variant BDNF polymorphism alters extinction learning in both mouse and human.	Science	2010	184
20095008	12064	Magariños AM	Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons.	Hippocampus	2011	59
20130183	12064	Rauskolb S	Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth.	The Journal of neuroscience 	2010	85
20133801	12064	Choi DC	Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear.	Proceedings of the National Academy of Sciences of the United States of America	2010	68
20133810	12064	Jang SW	A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone.	Proceedings of the National Academy of Sciences of the United States of America	2010	130
20164338	12064	Cordeira JW	Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system.	The Journal of neuroscience 	2010	42
20172507	12064	Lonetti G	Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice.	Biological psychiatry	2010	52
20219647	12064	Berchtold NC	Exercise and time-dependent benefits to learning and memory.	Neuroscience	2010	66
20232397	12064	Kuzumaki N	Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene induced by an enriched environment.	Hippocampus	2011	43
20407211	12064	Massa SM	Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.	The Journal of clinical investigation	2010	71
20434997	12064	Fritsch B	Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning.	Neuron	2010	238
20445049	12064	Ubhi K	Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.	The Journal of neuroscience 	2010	46
20592198	12064	Bianchi P	Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.	The Journal of neuroscience 	2010	43
20592208	12064	Ninan I	The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus.	The Journal of neuroscience 	2010	45
20600016	12064	Bercik P	Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice.	Gastroenterology	2010	70
20603014	12064	Cao L	Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.	Cell	2010	67
20604989	12064	Klein AB	Blood BDNF concentrations reflect brain-tissue BDNF levels across species.	The international journal of neuropsychopharmacology	2011	69
20670674	12064	Park HR	A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor.	Neuroscience letters	2010	44
20686454	12064	Schmidt HD	Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.	Neuropsychopharmacology 	2010	84
20850189	12064	Milnerwood AJ	Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease.	Trends in neurosciences	2010	77
20955337	12064	Frielingsdorf H	Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder.	Annals of the New York Academy of Sciences	2010	43
21048129	12064	Xie Y	BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.	The Journal of neuroscience 	2010	61
21054680	12064	Neufeld KM	Reduced anxiety-like behavior and central neurochemical change in germ-free mice.	Neurogastroenterology and motility 	2011	141
21123312	12064	Andero R	Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning.	The American journal of psychiatry	2011	64
21176785	12064	Beers DR	Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.	Brain, behavior, and immunity	2011	37
21228172	12064	Hongpaisan J	PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.	The Journal of neuroscience 	2011	42
21389231	12064	Clarkson AN	AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke.	The Journal of neuroscience 	2011	55
21414397	12064	Yang T	The molecular basis of making spiral ganglion neurons and connecting them to hair cells of the organ of Corti.	Hearing research	2011	37
21423756	12064	Lopatina T	Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo.	PloS one	2011	42
21677641	12064	Autry AE	NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.	Nature	2011	316
21683077	12064	Bercik P	The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice.	Gastroenterology	2011	161
21878528	12064	Kobilo T	Running is the neurogenic and neurotrophic stimulus in environmental enrichment.	Learning and memory	2011	63
21900882	12064	Devi L	7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.	Neuropsychopharmacology 	2012	56
21907139	12064	Cao L	White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis.	Cell metabolism	2011	90
21949705	12064	Dinel AL	Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome.	PloS one	2011	35
22036038	12064	Liu RJ	Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.	Biological psychiatry	2012	76
22057192	12064	Graybeal C	Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF.	Nature neuroscience	2011	42
22152994	12064	Thöne J	Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.	The American journal of pathology	2012	30
22194582	12064	Karpova NN	Fear erasure in mice requires synergy between antidepressant drugs and extinction training.	Science	2011	83
22252978	12064	Marlatt MW	Running throughout middle-age improves memory function, hippocampal neurogenesis, and BDNF levels in female C57BL/6J mice.	Developmental neurobiology	2012	56
22332955	12064	Marconi S	Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush.	Tissue engineering. Part A	2012	37
22365548	12064	Kondo M	Motor protein KIF1A is essential for hippocampal synaptogenesis and learning enhancement in an enriched environment.	Neuron	2012	32
22396415	12064	Pattwell SS	The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex.	The Journal of neuroscience 	2012	37
22412021	12064	Dieni S	BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons.	The Journal of cell biology	2012	63
22426422	12064	Liao GY	Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin.	Nature medicine	2012	46
22442074	12064	Yu H	Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants.	The Journal of neuroscience 	2012	62
22492055	12064	Wilhelm JC	Cooperative roles of BDNF expression in neurons and Schwann cells are modulated by exercise to facilitate nerve regeneration.	The Journal of neuroscience 	2012	32
22508336	12064	Sharma S	Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry.	International journal of obesity	2013	47
22735487	12064	Liao B	Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.	Experimental neurology	2012	73
22771460	12064	Fass DM	Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.	Neuropharmacology	2013	31
22840395	12064	Zhou B	Snapin recruits dynein to BDNF-TrkB signaling endosomes for retrograde axonal transport and is essential for dendrite growth of cortical neurons.	Cell reports	2012	31
22910688	12064	Branchi I	Early interactions with mother and peers independently build adult social skills and shape BDNF and oxytocin receptor brain levels.	Psychoneuroendocrinology	2013	25
23044468	12064	Hashimoto K	Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression.	Progress in neurobiology	2013	34
23055503	12064	Waterhouse EG	BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission.	The Journal of neuroscience 	2012	47
23128924	12064	Tripp A	Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder.	The American journal of psychiatry	2012	46
23229740	12064	Sharma S	Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal.	International journal of obesity	2013	32
23446639	12064	Jiang M	Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.	Human molecular genetics	2013	26
23511700	12064	Walker AK	NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.	Neuropsychopharmacology 	2013	55
23597512	12064	Li W	BDNF deregulation in Rett syndrome.	Neuropharmacology	2014	26
23615664	12064	Intlekofer KA	Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism.	Neuropsychopharmacology 	2013	29
23651226	12064	Gourley SL	The orbitofrontal cortex regulates outcome-based decision-making via the lateral striatum.	The European journal of neuroscience	2013	25
23804093	12064	Chatterjee S	A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice.	The Journal of neuroscience 	2013	26
23843530	12064	Orefice LL	Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines.	The Journal of neuroscience 	2013	25
24035762	12064	Ouyang Q	Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development.	Neuron	2013	31
24056302	12064	Niu W	In vivo reprogramming of astrocytes to neuroblasts in the adult brain.	Nature cell biology	2013	91
24120943	12064	Wrann CD	Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway.	Cell metabolism	2013	67
24201284	12064	Bloodgood BL	The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition.	Nature	2013	52
24360280	12064	Parkhurst CN	Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.	Cell	2013	209
24509083	12064	Qiu H	ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.	The Journal of clinical investigation	2014	50
24614170	12064	Castello NA	7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss.	PloS one	2014	22
24746813	12064	Yang J	proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus.	Cell reports	2014	29
24920623	12064	Fulmer CG	Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.	The Journal of neuroscience 	2014	29
25196192	12064	Xuan W	Low-level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis.	Journal of biophotonics	2015	20
25329343	12064	Wan G	Neurotrophin-3 regulates ribbon synapse density in the cochlea and induces synapse regeneration after acoustic trauma.	eLife	2014	32
25385582	12064	Kundakovic M	DNA methylation of BDNF as a biomarker of early-life adversity.	Proceedings of the National Academy of Sciences of the United States of America	2015	40
25600109	12064	Lin LC	Somatostatin, neuronal vulnerability and behavioral emotionality.	Molecular psychiatry	2015	19
25609615	12064	Genheden M	BDNF stimulation of protein synthesis in cortical neurons requires the MAP kinase-interacting kinase MNK1.	The Journal of neuroscience 	2015	15
25628381	12064	Zhang JC	Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.	The international journal of neuropsychopharmacology	2014	30
25866195	12064	Desbonnet L	Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour.	Brain, behavior, and immunity	2015	44
26019015	12064	Kamat PK	Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.	Molecular neurobiology	2016	11
26337614	12064	Zhang JC	Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.	Psychopharmacology	2015	19
26519901	12064	Björkholm C	BDNF - a key transducer of antidepressant effects.	Neuropharmacology	2016	18
26595656	12064	Joo JY	Stimulus-specific combinatorial functionality of neuronal c-fos enhancers.	Nature neuroscience	2016	15
26786312	12064	Zimmermann KS	Connections of the Mouse Orbitofrontal Cortex and Regulation of Goal-Directed Action Selection by Brain-Derived Neurotrophic Factor.	Biological psychiatry	2017	8
26854229	12064	Martínez G	Regulation of Memory Formation by the Transcription Factor XBP1.	Cell reports	2016	15
26976569	12064	Ren Q	Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.	Proceedings of the National Academy of Sciences of the United States of America	2016	15
8929530	12286	Fletcher CF	Absence epilepsy in tottering mutant mice is associated with calcium channel defects.	Cell	1996	119
10611370	12286	Jun K	Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit.	Proceedings of the National Academy of Sciences of the United States of America	1999	103
15003170	12286	van den Maagdenberg AM	A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression.	Neuron	2004	111
16611813	12286	DeFazio RA	Separate populations of receptor cells and presynaptic cells in mouse taste buds.	The Journal of neuroscience 	2006	93
19005038	12286	Catterall WA	Inherited neuronal ion channelopathies: new windows on complex neurological diseases.	The Journal of neuroscience 	2008	72
19285472	12286	Tottene A	Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice.	Neuron	2009	79
20186955	12286	van den Maagdenberg AM	High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice.	Annals of neurology	2010	43
10594647	12307	Marsicano G	Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.	The European journal of neuroscience	1999	159
10888735	12307	Haverkamp S	Immunocytochemical analysis of the mouse retina.	The Journal of comparative neurology	2000	200
11306623	12307	Porter JT	Diverse types of interneurons generate thalamus-evoked feedforward inhibition in the mouse barrel cortex.	The Journal of neuroscience 	2001	98
11597605	12307	Abrahamson EE	Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections.	Brain research	2001	153
11850457	12307	Neuhoff H	I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.	The Journal of neuroscience 	2002	104
12691666	12307	Blatow M	Ca2+ buffer saturation underlies paired pulse facilitation in calbindin-D28k-containing terminals.	Neuron	2003	76
12881482	12307	Palop JJ	Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits.	Proceedings of the National Academy of Sciences of the United States of America	2003	115
17197085	12307	Selby L	Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein.	Neuroscience letters	2007	62
19295151	12307	Minkeviciene R	Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.	The Journal of neuroscience 	2009	118
20221886	12307	Van De Werd HJ	Cytoarchitectonic and chemoarchitectonic characterization of the prefrontal cortical areas in the mouse.	Brain structure and function	2010	56
14574680	12308	Tamamaki N	Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse.	The Journal of comparative neurology	2003	383
14689473	12308	Ghosh KK	Types of bipolar cells in the mouse retina.	The Journal of comparative neurology	2004	144
15115742	12308	López-Bendito G	Preferential origin and layer destination of GAD65-GFP cortical interneurons.	Cerebral cortex	2004	84
16394266	12308	Niculescu MD	Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains.	FASEB journal 	2006	103
17183554	12308	Tran PB	Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain.	The Journal of comparative neurology	2007	89
18855018	12308	Qu ZD	Immunohistochemical analysis of neuron types in the mouse small intestine.	Cell and tissue research	2008	57
19129386	12308	Xu X	Laminar specificity of functional input to distinct types of inhibitory cortical neurons.	The Journal of neuroscience 	2009	94
21460837	12308	De Marco García NV	Neuronal activity is required for the development of specific cortical interneuron subtypes.	Nature	2011	68
21795545	12308	Tricoire L	A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity.	The Journal of neuroscience 	2011	92
23140664	12308	Cabungcal JH	Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine.	Biological psychiatry	2013	44
11415931	12310	Hong KU	Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion.	American journal of respiratory cell and molecular biology	2001	133
12123694	12310	Mach DB	Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.	Neuroscience	2002	103
16446142	12310	Kramer I	A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification.	Neuron	2006	77
16553616	12310	Beltramo M	CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.	The European journal of neuroscience	2006	77
17113352	12310	Price TJ	Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse.	The journal of pain 	2007	76
20032263	12310	Schnegelsberg B	Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.	American journal of physiology. Regulatory, integrative and comparative physiology	2010	54
25788675	12310	Carter ME	Parabrachial calcitonin gene-related peptide neurons mediate conditioned taste aversion.	The Journal of neuroscience 	2015	18
27301688	12310	Roman CW	Genetically and functionally defined NTS to PBN brain circuits mediating anorexia.	Nature communications	2016	11
1321493	12322	Silva AJ	Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice.	Science	1992	198
1378648	12322	Silva AJ	Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice.	Science	1992	214
11357133	12322	Frankland PW	Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory.	Nature	2001	87
12031405	12322	Fox K	Anatomical pathways and molecular mechanisms for plasticity in the barrel cortex.	Neuroscience	2002	81
12684449	12322	Weeber EJ	Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome.	The Journal of neuroscience 	2003	78
15131309	12322	Frankland PW	The involvement of the anterior cingulate cortex in remote contextual fear memory.	Science	2004	199
15133516	12322	Wang H	Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP.	Nature neuroscience	2004	70
18803808	12322	Yamasaki N	Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders.	Molecular brain	2008	94
22926190	12322	Dutton SB	Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility.	Neurobiology of disease	2013	36
25579851	12322	Salling MC	Moderate Alcohol Drinking and the Amygdala Proteome: Identification and Validation of Calcium/Calmodulin Dependent Kinase II and AMPA Receptor Activity as Novel Molecular Mechanisms of the Positive Reinforcing Effects of Alcohol.	Biological psychiatry	2016	12
8980237	12346	Tsien JZ	Subregion- and cell type-restricted gene knockout in mouse brain.	Cell	1996	286
9054501	12346	Abel T	Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory.	Cell	1997	251
9108112	12346	Schauwecker PE	Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches.	Proceedings of the National Academy of Sciences of the United States of America	1997	114
9185557	12346	Lu YM	Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.	The Journal of neuroscience 	1997	124
9844008	12346	Barad M	Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory.	Proceedings of the National Academy of Sciences of the United States of America	1998	109
10195221	12346	Chapman PF	Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.	Nature neuroscience	1999	181
10196567	12346	Impey S	Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning.	Nature neuroscience	1998	109
10557337	12346	van Praag H	Running enhances neurogenesis, learning, and long-term potentiation in mice.	Proceedings of the National Academy of Sciences of the United States of America	1999	506
10611641	12346	Albensi BC	Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity.	Synapse	2000	90
10777798	12346	Oliva AA Jr	Novel hippocampal interneuronal subtypes identified using transgenic mice that express green fluorescent protein in GABAergic interneurons.	The Journal of neuroscience 	2000	197
10823894	12346	Krucker T	Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus.	Proceedings of the National Academy of Sciences of the United States of America	2000	95
11733061	12346	Zeng H	Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory.	Cell	2001	136
11746377	12346	Rockenstein E	Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).	Journal of neuroscience research	2001	89
12040087	12346	Nakazawa K	Requirement for hippocampal CA3 NMDA receptors in associative memory recall.	Science	2002	233
12097508	12346	Collinson N	Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.	The Journal of neuroscience 	2002	124
12235359	12346	Bartos M	Fast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks.	Proceedings of the National Academy of Sciences of the United States of America	2002	142
12388586	12346	Cabin DE	Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein.	The Journal of neuroscience 	2002	217
12451117	12346	Stackman RW	Small conductance Ca2+-activated K+ channels modulate synaptic plasticity and memory encoding.	The Journal of neuroscience 	2002	85
12535953	12346	Buzsáki G	Hippocampal network patterns of activity in the mouse.	Neuroscience	2003	102
12718863	12346	Nakazawa K	Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience.	Neuron	2003	133
12907806	12346	Seidenbecher T	Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval.	Science	2003	168
14766964	12346	Li C	Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	96
14993607	12346	Caraiscos VB	Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors.	Proceedings of the National Academy of Sciences of the United States of America	2004	163
15515178	12346	Belichenko PV	Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.	The Journal of comparative neurology	2004	91
15716631	12346	Hall ED	Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury.	Journal of neurotrauma	2005	99
16291936	12346	Ramsden M	Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).	The Journal of neuroscience 	2005	152
16603318	12346	Cristino L	Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.	Neuroscience	2006	97
16651626	12346	Spires TL	Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy.	The American journal of pathology	2006	111
16928182	12346	Saatman KE	Differential behavioral and histopathological responses to graded cortical impact injury in mice.	Journal of neurotrauma	2006	63
17224406	12346	Bloodgood BL	Nonlinear regulation of unitary synaptic signals by CaV(2.3) voltage-sensitive calcium channels located in dendritic spines.	Neuron	2007	113
17227847	12346	Crozier RA	Deprivation-induced synaptic depression by distinct mechanisms in different layers of mouse visual cortex.	Proceedings of the National Academy of Sciences of the United States of America	2007	60
17241269	12346	Hooper C	Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.	The European journal of neuroscience	2007	70
17351635	12346	Shen H	Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at puberty.	Nature neuroscience	2007	84
17384643	12346	Dodt HU	Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain.	Nature methods	2007	186
17521573	12346	Fiacco TA	Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity.	Neuron	2007	100
17951027	12346	Chen J	Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system.	Brain, behavior, and immunity	2008	121
18184796	12346	Ronesi JA	Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation.	The Journal of neuroscience 	2008	100
18218862	12346	Nakashiba T	Transgenic inhibition of synaptic transmission reveals role of CA3 output in hippocampal learning.	Science	2008	148
18650312	12346	Royeck M	Role of axonal NaV1.6 sodium channels in action potential initiation of CA1 pyramidal neurons.	Journal of neurophysiology	2008	61
18784294	12346	Avignone E	Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling.	The Journal of neuroscience 	2008	54
19026746	12346	Kimura R	Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.	Neurobiology of disease	2009	53
19204281	12346	Wulff P	Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons.	Proceedings of the National Academy of Sciences of the United States of America	2009	106
19363490	12346	George MS	HCN hyperpolarization-activated cation channels inhibit EPSPs by interactions with M-type K(+) channels.	Nature neuroscience	2009	62
19523516	12346	Serenó L	A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.	Neurobiology of disease	2009	66
19555647	12346	Nakashiba T	Hippocampal CA3 output is crucial for ripple-associated reactivation and consolidation of memory.	Neuron	2009	72
19561297	12346	Dong HW	Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1.	Proceedings of the National Academy of Sciences of the United States of America	2009	65
19641109	12346	Chakroborty S	Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.	The Journal of neuroscience 	2009	60
19666749	12346	Pan B	Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzod1,3dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.	The Journal of pharmacology and experimental therapeutics	2009	68
19730425	12346	Hwang LL	Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice.	Obesity	2010	51
20133798	12346	Clarke JR	Plastic modifications induced by object recognition memory processing.	Proceedings of the National Academy of Sciences of the United States of America	2010	41
20299596	12346	Shen H	A critical role for alpha4betadelta GABAA receptors in shaping learning deficits at puberty in mice.	Science	2010	75
20418874	12346	Ortinski PI	Selective induction of astrocytic gliosis generates deficits in neuronal inhibition.	Nature neuroscience	2010	116
20619937	12346	Jawhar S	Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.	Neurobiology of aging	2012	65
21069780	12346	Ricobaraza A	Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease.	Hippocampus	2012	47
21240263	12346	Barretto RP	Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy.	Nature medicine	2011	60
21437933	12346	Stowe AM	Repetitive hypoxia extends endogenous neurovascular protection for stroke.	Annals of neurology	2011	38
21727897	12346	Fonken LK	Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology.	Molecular psychiatry	2011	42
21738775	12346	Lesting J	Patterns of coupled theta activity in amygdala-hippocampal-prefrontal cortical circuits during fear extinction.	PloS one	2011	57
21821124	12346	Ginsberg SD	Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.	Neurobiology of disease	2012	37
21825022	12346	Panzanelli P	Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells.	The Journal of physiology	2011	40
22246433	12346	Lovett-Barron M	Regulation of neuronal input transformations by tunable dendritic inhibition.	Nature neuroscience	2012	103
22293457	12346	Vinet J	Neuroprotective function for ramified microglia in hippocampal excitotoxicity.	Journal of neuroinflammation	2012	54
22347811	12346	Navarrete M	Astrocytes mediate in vivo cholinergic-induced synaptic plasticity.	PLoS biology	2012	85
22485176	12346	Zhang QG	Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury.	PloS one	2012	49
22532069	12346	Van der Jeugd A	Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.	Acta neuropathologica	2012	35
22553014	12346	Smith CC	CNS dopamine transmission mediated by noradrenergic innervation.	The Journal of neuroscience 	2012	33
22592800	12346	Busche MA	Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2012	70
22699914	12346	Chakroborty S	Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice.	The Journal of neuroscience 	2012	32
22900595	12346	Mouzon B	Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes.	Journal of neurotrauma	2012	34
23172108	12346	Cui Z	Hypothalamic and other connections with dorsal CA2 area of the mouse hippocampus.	The Journal of comparative neurology	2013	28
23235828	12346	Granger AJ	LTP requires a reserve pool of glutamate receptors independent of subunit type.	Nature	2013	76
23254376	12346	Pop AS	Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant.	Psychopharmacology	2014	22
23256159	12346	Chen G	How vision and movement combine in the hippocampal place code.	Proceedings of the National Academy of Sciences of the United States of America	2013	57
23283174	12346	Volk LJ	PKM-ζ is not required for hippocampal synaptic plasticity, learning and memory.	Nature	2013	96
23396101	12346	Ziv Y	Long-term dynamics of CA1 hippocampal place codes.	Nature neuroscience	2013	125
23407965	12346	Gourley SL	Corticosteroid-induced neural remodeling predicts behavioral vulnerability and resilience.	The Journal of neuroscience 	2013	40
23426681	12346	Rosenberg D	Neuronal D-serine and glycine release via the Asc-1 transporter regulates NMDA receptor-dependent synaptic activity.	The Journal of neuroscience 	2013	40
23538967	12346	Deng W	Selection of distinct populations of dentate granule cells in response to inputs as a mechanism for pattern separation in mice.	eLife	2013	35
23560052	12346	Wright AL	Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.	PloS one	2013	35
23888038	12346	Ramirez S	Creating a false memory in the hippocampus.	Science	2013	110
23912949	12346	Kaifosh P	Septo-hippocampal GABAergic signaling across multiple modalities in awake mice.	Nature neuroscience	2013	29
24005292	12346	Peng Z	A reorganized GABAergic circuit in a model of epilepsy: evidence from optogenetic labeling and stimulation of somatostatin interneurons.	The Journal of neuroscience 	2013	27
24336151	12346	Kohara K	Cell type-specific genetic and optogenetic tools reveal hippocampal CA2 circuits.	Nature neuroscience	2014	62
24407853	12346	Takács VT	Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus.	Brain structure and function	2015	18
24462101	12346	Cabral HO	Oscillatory dynamics and place field maps reflect hippocampal ensemble processing of sequence and place memory under NMDA receptor control.	Neuron	2014	26
24476943	12346	Zhong P	Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.	Neuropsychopharmacology 	2014	20
24525710	12346	Zhu H	Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory.	Neuropsychopharmacology 	2014	23
24558155	12346	Lovett-Barron M	Dendritic inhibition in the hippocampus supports fear learning.	Science	2014	75
24560703	12346	Grienberger C	NMDA receptor-dependent multidendrite Ca(2+) spikes required for hippocampal burst firing in vivo.	Neuron	2014	39
24572357	12346	Hitti FL	The hippocampal CA2 region is essential for social memory.	Nature	2014	59
24656815	12346	Sun Y	Cell-type-specific circuit connectivity of hippocampal CA1 revealed through Cre-dependent rabies tracing.	Cell reports	2014	24
24657968	12346	Tønnesen J	Spine neck plasticity regulates compartmentalization of synapses.	Nature neuroscience	2014	67
24863146	12346	Pagani JH	Role of the vasopressin 1b receptor in rodent aggressive behavior and synaptic plasticity in hippocampal area CA2.	Molecular psychiatry	2015	20
25073927	12346	Siegle JH	Enhancement of encoding and retrieval functions through theta phase-specific manipulation of hippocampus.	eLife	2014	32
25220759	12346	Peeraer E	Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.	Neurobiology of disease	2015	17
25363782	12346	Sheffield ME	Calcium transient prevalence across the dendritic arbour predicts place field properties.	Nature	2015	29
25456500	12346	Šišková Z	Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer's disease.	Neuron	2014	25
25524838	12346	MacKenzie G	Chronic stress shifts the GABA reversal potential in the hippocampus and increases seizure susceptibility.	Epilepsy research	2015	16
26098371	12346	Attardo A	Impermanence of dendritic spines in live adult CA1 hippocampus.	Nature	2015	30
26157003	12346	Lee SH	Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.	The Journal of neuroscience 	2015	18
26167906	12346	Bittner KC	Conjunctive input processing drives feature selectivity in hippocampal CA1 neurons.	Nature neuroscience	2015	27
26436451	12346	Rajasethupathy P	Projections from neocortex mediate top-down control of memory retrieval.	Nature	2015	35
26740658	12346	Nguyen Chi V	Hippocampal Respiration-Driven Rhythm Distinct from Theta Oscillations in Awake Mice.	The Journal of neuroscience 	2016	10
27217145	12346	Jiang M	Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism.	Molecular psychiatry	2017	6
27251287	12346	Cai DJ	A shared neural ensemble links distinct contextual memories encoded close in time.	Nature	2016	25
15852011	12350	Ngo-Anh TJ	SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines.	Nature neuroscience	2005	151
16399667	12350	Zhao C	Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus.	The Journal of neuroscience 	2006	345
16436593	12350	Gruart A	Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice.	The Journal of neuroscience 	2006	107
18622400	12350	Toni N	Neurons born in the adult dentate gyrus form functional synapses with target cells.	Nature neuroscience	2008	208
19261885	12350	Besser L	Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus.	The Journal of neuroscience 	2009	52
19421325	12350	Garthe A	Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies.	PloS one	2009	138
20404165	12350	Kobayashi K	Reversal of hippocampal neuronal maturation by serotonergic antidepressants.	Proceedings of the National Academy of Sciences of the United States of America	2010	52
23143513	12350	Gu Y	Optical controlling reveals time-dependent roles for adult-born dentate granule cells.	Nature neuroscience	2012	84
23303931	12350	Wilke SA	Deconstructing complexity: serial block-face electron microscopic analysis of the hippocampal mossy fiber synapse.	The Journal of neuroscience 	2013	30
24991962	12350	Denny CA	Hippocampal memory traces are differentially modulated by experience, time, and adult neurogenesis.	Neuron	2014	55
25143618	12350	Schlingloff D	Mechanisms of sharp wave initiation and ripple generation.	The Journal of neuroscience 	2014	25
25209930	12350	Calfa G	Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice.	Hippocampus	2015	23
25392490	12350	Ellender TJ	Excitatory effects of parvalbumin-expressing interneurons maintain hippocampal epileptiform activity via synchronous afterdischarges.	The Journal of neuroscience 	2014	28
25534024	12350	Boluda S	Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.	Acta neuropathologica	2015	19
25673833	12350	Waters EM	G-protein-coupled estrogen receptor 1 is anatomically positioned to modulate synaptic plasticity in the mouse hippocampus.	The Journal of neuroscience 	2015	20
26904943	12350	Broussard JI	Dopamine Regulates Aversive Contextual Learning and Associated In Vivo Synaptic Plasticity in the Hippocampus.	Cell reports	2016	10
8934524	12367	Kuida K	Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice.	Nature	1996	278
9708735	12367	Kuida K	Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.	Cell	1998	264
14980203	12367	Marín-Teva JL	Microglia promote the death of developing Purkinje cells.	Neuron	2004	146
15207349	12367	Xu W	Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea.	Neuroscience	2004	91
15326158	12367	Martin PM	Death of retinal neurons in streptozotocin-induced diabetic mice.	Investigative ophthalmology and visual science	2004	120
15494404	12367	Gardian G	Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.	The Journal of biological chemistry	2005	119
16249509	12367	Feit-Leichman RA	Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.	Investigative ophthalmology and visual science	2005	75
17192305	12367	Samuel MA	Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis.	Journal of virology	2007	69
17346857	12367	Bianchi SL	Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics.	Neurobiology of aging	2008	73
18187572	12367	Koike M	Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury.	The American journal of pathology	2008	118
18434510	12367	Davis TH	Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus.	The Journal of neuroscience 	2008	168
18493258	12367	You Z	Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice.	Journal of cerebral blood flow and metabolism 	2008	78
19095836	12367	Loepke AW	The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory.	Anesthesia and analgesia	2009	55
20460993	12367	Lu Y	Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice.	Anesthesiology	2010	45
20510932	12367	Li Z	Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization.	Cell	2010	149
21151119	12367	D'Amelio M	Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease.	Nature neuroscience	2011	124
21293251	12367	Istaphanous GK	Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice.	Anesthesiology	2011	61
21562285	12367	Kim-Han JS	The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons.	The Journal of neuroscience 	2011	36
21956042	12367	Kodama M	Neonatal desflurane exposure induces more robust neuroapoptosis than do isoflurane and sevoflurane and impairs working memory.	Anesthesiology	2011	36
22368036	12367	Zhang Y	Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory.	Annals of neurology	2012	64
23223278	12367	Simon DJ	A caspase cascade regulating developmental axon degeneration.	The Journal of neuroscience 	2012	51
23314109	12367	Zheng H	Sevoflurane anesthesia in pregnant mice induces neurotoxicity in fetal and offspring mice.	Anesthesiology	2013	27
23316765	12367	Eimer WA	Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.	Molecular neurodegeneration	2013	36
23396011	12367	Subbanna S	G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain.	Neurobiology of disease	2013	26
23776240	12367	Talantova M	Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.	Proceedings of the National Academy of Sciences of the United States of America	2013	90
24478350	12367	Ertürk A	Local pruning of dendrites and spines by caspase-3-dependent and proteasome-limited mechanisms.	The Journal of neuroscience 	2014	30
8855328	12568	Ohshima T	Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.	Proceedings of the National Academy of Sciences of the United States of America	1996	197
10604473	12568	Bibb JA	Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.	Nature	1999	133
11268215	12568	Bibb JA	Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.	Nature	2001	122
12765608	12568	Noble W	Cdk5 is a key factor in tau aggregation and tangle formation in vivo.	Neuron	2003	105
12941275	12568	Xie Z	Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration.	Cell	2003	91
14642273	12568	Cruz JC	Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.	Neuron	2003	137
15676027	12568	Uchida Y	Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.	Genes to cells 	2005	87
16192374	12568	Kitazawa M	Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.	The Journal of neuroscience 	2005	162
16337919	12568	Fischer A	Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory.	Neuron	2005	78
16341208	12568	Kawauchi T	Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration.	Nature cell biology	2006	87
16803897	12568	Plattner F	The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.	The Journal of biological chemistry	2006	81
17035538	12568	Cruz JC	p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.	The Journal of neuroscience 	2006	66
17143272	12568	Fu WY	Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism.	Nature neuroscience	2007	96
17529984	12568	Hawasli AH	Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation.	Nature neuroscience	2007	114
19020030	12568	Ma XM	Kalirin-7 is required for synaptic structure and function.	The Journal of neuroscience 	2008	65
20962218	12568	Piedrahita D	Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice.	The Journal of neuroscience 	2010	46
21944720	12568	Odajima J	Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation.	Developmental cell	2011	39
22095718	12568	Kitazawa M	Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.	Journal of immunology	2011	59
23064382	12568	Lai KO	TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory.	Nature neuroscience	2012	37
24239383	12568	Adler BL	Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.	Neurobiology of aging	2014	23
27557711	12568	Doktor TK	RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns.	Nucleic acids research	2017	7
1467557	12647	Cashman NR	Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons.	Developmental dynamics 	1992	159
8558238	12647	Gritti A	Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor.	The Journal of neuroscience 	1996	118
21544206	12647	Higley MJ	Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum.	PloS one	2011	46
23785154	12647	Kolisnyk B	ChAT-ChR2-EYFP mice have enhanced motor endurance but show deficits in attention and several additional cognitive domains.	The Journal of neuroscience 	2013	34
10508865	12741	Morita K	Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells.	The Journal of cell biology	1999	152
12743111	12741	Nitta T	Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice.	The Journal of cell biology	2003	328
14576355	12741	Stamatovic SM	Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase.	Journal of cell science	2003	107
15689955	12741	Stamatovic SM	Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.	Journal of cerebral blood flow and metabolism 	2005	114
18187566	12741	Yamamoto M	Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells.	The American journal of pathology	2008	65
18344992	12741	Zhong Z	ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.	Nature neuroscience	2008	99
18799677	12741	McColl BW	Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.	The Journal of neuroscience 	2008	97
21857898	12741	Feng S	Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.	PloS one	2011	42
24522913	12741	Chai Q	Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.	Journal of virology	2014	22
25411471	12741	Braniste V	The gut microbiota influences blood-brain barrier permeability in mice.	Science translational medicine	2014	98
10993920	12772	Fife BT	CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.	The Journal of experimental medicine	2000	124
11015448	12772	Izikson L	Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.	The Journal of experimental medicine	2000	132
12808141	12772	Abbadie C	Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2.	Proceedings of the National Academy of Sciences of the United States of America	2003	151
16554469	12772	Belmadani A	Chemokines regulate the migration of neural progenitors to sites of neuroinflammation.	The Journal of neuroscience 	2006	93
17191078	12772	Yan YP	Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia.	Journal of cerebral blood flow and metabolism 	2007	71
17332467	12772	Dimitrijevic OB	Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice.	Stroke	2007	84
17351623	12772	El Khoury J	Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.	Nature medicine	2007	260
17989304	12772	Zhang J	Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain.	The Journal of neuroscience 	2007	113
18835047	12772	El Khoury J	Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.	Trends in pharmacological sciences	2008	62
19228962	12772	D'Mello C	Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation.	The Journal of neuroscience 	2009	127
19553445	12772	Jung H	Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain.	The Journal of neuroscience 	2009	53
20354174	12772	Yao H	Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration.	Blood	2010	54
21060874	12772	Saederup N	Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice.	PloS one	2010	143
21508244	12772	Naert G	CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.	The Journal of neuroscience 	2011	49
21813677	12772	Mildner A	Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease.	The Journal of neuroscience 	2011	84
22079990	12772	Mizutani M	The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.	Journal of immunology	2012	88
22190370	12772	Terrando N	Resolving postoperative neuroinflammation and cognitive decline.	Annals of neurology	2011	74
22863620	12772	Butovsky O	Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.	The Journal of clinical investigation	2012	97
23071306	12772	Varvel NH	Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells.	Proceedings of the National Academy of Sciences of the United States of America	2012	56
23185004	12772	Miller RE	CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis.	Proceedings of the National Academy of Sciences of the United States of America	2012	44
23243025	12772	Belarbi K	CCR2 deficiency prevents neuronal dysfunction and cognitive impairments induced by cranial irradiation.	Cancer research	2013	26
23922372	12772	Ngo LY	Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis.	The Journal of infectious diseases	2014	33
23966702	12772	Wohleb ES	Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior.	The Journal of neuroscience 	2013	85
24142887	12772	Sennlaub F	CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice.	EMBO molecular medicine	2013	46
24623768	12772	Hammond MD	CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage.	The Journal of neuroscience 	2014	30
24695541	12772	Morganti JM	Cranial irradiation alters the brain's microenvironment and permits CCR2+ macrophage infiltration.	PloS one	2014	21
24806994	12772	Hsieh CL	CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.	Journal of neurotrauma	2014	22
24966389	12772	Fenn AM	IL-4 signaling drives a unique arginase+/IL-1β+ microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury.	The Journal of neuroscience 	2014	43
25589768	12772	Morganti JM	CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury.	The Journal of neuroscience 	2015	31
25779633	12772	Lampron A	Inefficient clearance of myelin debris by microglia impairs remyelinating processes.	The Journal of experimental medicine	2015	27
27444755	12772	Sager HB	Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.	Circulation research	2016	18
12590258	12799	Lappe-Siefke C	Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination.	Nature genetics	2003	240
19421151	12799	Lindberg N	Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.	Oncogene	2009	63
20504959	12799	Budde H	Control of oligodendroglial cell number by the miR-17-92 cluster.	Development	2010	45
24671992	12799	Wahl SE	Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination.	The Journal of neuroscience 	2014	35
10318961	12801	Zimmer A	Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	1999	227
10588688	12801	Hanus L	HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.	Proceedings of the National Academy of Sciences of the United States of America	1999	99
10998107	12801	Hájos N	Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.	The European journal of neuroscience	2000	131
11298451	12801	Di Marzo V	Leptin-regulated endocannabinoids are involved in maintaining food intake.	Nature	2001	255
11516401	12801	Wilson RI	Presynaptic specificity of endocannabinoid signaling in the hippocampus.	Neuron	2001	138
11586361	12801	Panikashvili D	An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.	Nature	2001	125
11734603	12801	Varma N	Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus.	The Journal of neuroscience 	2001	116
12019305	12801	Ohno-Shosaku T	Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.	The Journal of neuroscience 	2002	93
12060781	12801	Robbe D	Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens.	Proceedings of the National Academy of Sciences of the United States of America	2002	147
12152079	12801	Marsicano G	The endogenous cannabinoid system controls extinction of aversive memories.	Nature	2002	365
12399252	12801	Ravinet Trillou C	Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.	American journal of physiology. Regulatory, integrative and comparative physiology	2003	100
12538878	12801	Wang L	Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	88
12897210	12801	Cota D	The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.	The Journal of clinical investigation	2003	178
12917492	12801	Ibrahim MM	Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.	Proceedings of the National Academy of Sciences of the United States of America	2003	108
14770190	12801	Ravinet Trillou C	CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.	International journal of obesity and related metabolic disorders 	2004	95
15331569	12801	Patel S	Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.	Endocrinology	2004	95
15637635	12801	Chhatwal JP	Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear.	Neuropsychopharmacology 	2005	97
15864349	12801	Osei-Hyiaman D	Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.	The Journal of clinical investigation	2005	225
16037095	12801	Aguado T	The endocannabinoid system drives neural progenitor proliferation.	FASEB journal 	2005	73
16179366	12801	Straiker A	Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.	The Journal of physiology	2005	73
16301180	12801	Safo PK	Endocannabinoids control the induction of cerebellar LTD.	Neuron	2005	74
16452678	12801	Aguado T	The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells.	The Journal of neuroscience 	2006	61
16540577	12801	Kawamura Y	The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.	The Journal of neuroscience 	2006	135
16672646	12801	Yoshida T	Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.	The Journal of neuroscience 	2006	106
16723537	12801	Domenici MR	Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.	The Journal of neuroscience 	2006	61
16834756	12801	Piomelli D	Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).	CNS drug reviews	2006	91
16908411	12801	Monory K	The endocannabinoid system controls key epileptogenic circuits in the hippocampus.	Neuron	2006	156
17558404	12801	Agarwal N	Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.	Nature neuroscience	2007	138
17684555	12801	Lafourcade M	Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.	PloS one	2007	79
17927447	12801	Monory K	Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.	PLoS biology	2007	65
17994113	12801	Guindon J	Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.	British journal of pharmacology	2008	85
18562209	12801	Goncalves MB	A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner.	Molecular and cellular neurosciences	2008	54
18602217	12801	Costa B	The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.	Pain	2008	53
19648913	12801	Puighermanal E	Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.	Nature neuroscience	2009	75
20139974	12801	Bellocchio L	Bimodal control of stimulated food intake by the endocannabinoid system.	Nature neuroscience	2010	49
20435001	12801	Jiang B	The maturation of GABAergic transmission in visual cortex requires endocannabinoid-mediated LTD of inhibitory inputs during a critical period.	Neuron	2010	44
21050275	12801	Wu CS	Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections.	The European journal of neuroscience	2010	45
21278728	12801	Lafourcade M	Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions.	Nature neuroscience	2011	51
21785434	12801	Xi ZX	Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice.	Nature neuroscience	2011	90
22266354	12801	Brents LK	Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.	Biochemical pharmacology	2012	35
22328089	12801	Pouladi MA	Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.	Human molecular genetics	2012	38
22385967	12801	Han J	Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.	Cell	2012	64
22388959	12801	Bénard G	Mitochondrial CB₁ receptors regulate neuronal energy metabolism.	Nature neuroscience	2012	61
23150578	12801	Pamplona FA	Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.	Proceedings of the National Academy of Sciences of the United States of America	2012	36
23848221	12801	Ignatowska-Jankowska BM	In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.	British journal of pharmacology	2014	27
23959891	12801	DePoy L	Chronic alcohol produces neuroadaptations to prime dorsal striatal learning.	Proceedings of the National Academy of Sciences of the United States of America	2013	57
24509429	12801	Soria-Gómez E	The endocannabinoid system controls food intake via olfactory processes.	Nature neuroscience	2014	31
24853387	12801	Deng L	Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.	Biological psychiatry	2015	23
25368177	12801	Zhang HY	Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	31
25485758	12801	Dudok B	Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling.	Nature neuroscience	2015	32
25707796	12801	Koch M	Hypothalamic POMC neurons promote cannabinoid-induced feeding.	Nature	2015	38
12042814	12803	Linker RA	CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.	Nature medicine	2002	83
16474388	12803	Pun S	Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF.	Nature neuroscience	2006	157
17853440	12803	Kokoeva MV	Evidence for constitutive neural cell proliferation in the adult murine hypothalamus.	The Journal of comparative neurology	2007	70
19332123	12803	Müller A	Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF.	Molecular and cellular neurosciences	2009	46
19906980	12803	Leibinger M	Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor.	The Journal of neuroscience 	2009	65
7923378	12912	Bourtchuladze R	Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein.	Cell	1994	320
10706216	12912	Kogan JH	Long-term memory underlying hippocampus-dependent social recognition in mice.	Hippocampus	2000	93
11099418	12912	Brazelton TR	From marrow to brain: expression of neuronal phenotypes in adult mice.	Science	2000	232
11889468	12912	Kida S	CREB required for the stability of new and reactivated fear memories.	Nature neuroscience	2002	158
11893339	12912	Barco A	Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture.	Cell	2002	124
11967539	12912	Mantamadiotis T	Disruption of CREB function in brain leads to neurodegeneration.	Nature genetics	2002	163
11978843	12912	Nakagawa S	Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein.	The Journal of neuroscience 	2002	104
11988175	12912	Pittenger C	Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory.	Neuron	2002	123
12165570	12912	Barrot M	CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.	Proceedings of the National Academy of Sciences of the United States of America	2002	148
12486182	12912	Newton SS	Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect.	The Journal of neuroscience 	2002	83
14566342	12912	McClung CA	Regulation of gene expression and cocaine reward by CREB and DeltaFosB.	Nature neuroscience	2003	202
15880109	12912	Ramanan N	SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability.	Nature neuroscience	2005	70
16380431	12912	Levine AA	CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum.	Proceedings of the National Academy of Sciences of the United States of America	2005	84
16427017	12912	Riccio A	A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons.	Molecular cell	2006	63
17018277	12912	Cui L	Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.	Cell	2006	297
17329213	12912	Putignano E	Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity.	Neuron	2007	56
17446403	12912	Han JH	Neuronal competition and selection during memory formation.	Science	2007	147
18511691	12912	Chahrour M	MeCP2, a key contributor to neurological disease, activates and represses transcription.	Science	2008	557
18596919	12912	Trinchese F	Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease.	The Journal of clinical investigation	2008	72
19160506	12912	Eckel-Mahan KL	Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence.	Nature neuroscience	2008	99
19447090	12912	Renthal W	Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins.	Neuron	2009	125
19535594	12912	Wilkinson MB	Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models.	The Journal of neuroscience 	2009	80
19557767	12912	Nudelman AS	Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo.	Hippocampus	2010	109
19657021	12912	Liu MT	5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice.	The Journal of neuroscience 	2009	81
19783993	12912	Zhou Y	CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala.	Nature neuroscience	2009	104
20307261	12912	Remenyi J	Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins.	The Biochemical journal	2010	69
21149712	12912	Caccamo A	CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2010	57
21220102	12912	Sasaki T	SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB.	Neuron	2011	38
21319221	12912	Azim K	GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo.	Glia	2011	50
21677163	12912	Suzuki A	Upregulation of CREB-mediated transcription enhances both short- and long-term memory.	The Journal of neuroscience 	2011	53
22179316	12912	Jeong H	Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.	Nature medicine	2011	87
22578505	12912	Martel MA	The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults.	Neuron	2012	42
24088811	12912	Cruz FC	New technologies for examining the role of neuronal ensembles in drug addiction and fear.	Nature reviews. Neuroscience	2013	47
24793238	12912	Villeda SA	Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.	Nature medicine	2014	104
24912150	12912	Czajkowski R	Encoding and storage of spatial information in the retrosplenial cortex.	Proceedings of the National Academy of Sciences of the United States of America	2014	20
25047355	12912	Chen Z	Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain.	Nature communications	2014	33
26184083	12912	Stilling RM	Microbes &amp;amp; neurodevelopment--Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala.	Brain, behavior, and immunity	2015	21
8637571	12918	Qu D	A role for melanin-concentrating hormone in the central regulation of feeding behaviour.	Nature	1996	181
10612706	12918	Koob GF	A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.	Brain research	1999	101
15077108	12918	Qi Y	Adiponectin acts in the brain to decrease body weight.	Nature medicine	2004	132
17551018	12918	Kang JE	Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity.	Proceedings of the National Academy of Sciences of the United States of America	2007	56
18308824	12918	Wanat MJ	Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih.	The Journal of physiology	2008	94
18566122	12918	Rice CJ	A novel mouse model for acute and long-lasting consequences of early life stress.	Endocrinology	2008	77
18768700	12918	Mueller BR	Sex-specific programming of offspring emotionality after stress early in pregnancy.	The Journal of neuroscience 	2008	236
18853426	12918	Justice NJ	Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system.	The Journal of comparative neurology	2008	55
20589909	12918	Fu W	Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain.	The Journal of comparative neurology	2010	42
20615973	12918	Chen Y	Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling.	Proceedings of the National Academy of Sciences of the United States of America	2010	49
21976528	12918	Carroll JC	Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.	The Journal of neuroscience 	2011	47
22171026	12918	Sarkar J	Neurosteroidogenesis is required for the physiological response to stress: role of neurosteroid-sensitive GABAA receptors.	The Journal of neuroscience 	2011	63
22399763	12918	Lowery-Gionta EG	Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice.	The Journal of neuroscience 	2012	48
22508464	12918	Bangasser DA	Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression.	Molecular psychiatry	2013	27
22992525	12918	Lemos JC	Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.	Nature	2012	53
22992651	12918	Gafford GM	Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction.	Proceedings of the National Academy of Sciences of the United States of America	2012	31
23325234	12918	Silberman Y	A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis.	The Journal of neuroscience 	2013	29
23773726	12918	Park AJ	Altered colonic function and microbiota profile in a mouse model of chronic depression.	Neurogastroenterology and motility 	2013	33
25157144	12918	Shah BP	MC4R-expressing glutamatergic neurons in the paraventricular hypothalamus regulate feeding and are synaptically connected to the parabrachial nucleus.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
27556938	12918	Marcinkiewcz CA	Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala.	Nature	2016	12
10805752	13051	Jung S	Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.	Molecular and cellular biology	2000	590
16732273	13051	Cardona AE	Control of microglial neurotoxicity by the fractalkine receptor.	Nature neuroscience	2006	399
17551020	13051	Clark AK	Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain.	Proceedings of the National Academy of Sciences of the United States of America	2007	100
17652758	13051	Tuo J	Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration.	Investigative ophthalmology and visual science	2007	92
17909628	13051	Combadière C	CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.	The Journal of clinical investigation	2007	169
18575457	13051	Dénes A	Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse.	Journal of cerebral blood flow and metabolism 	2008	99
20305648	13051	Fuhrmann M	Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.	Nature neuroscience	2010	151
20570721	13051	Wynne AM	Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge.	Brain, behavior, and immunity	2010	62
20864679	13051	Lee S	CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.	The American journal of pathology	2010	121
20920788	13051	Bhaskar K	Regulation of tau pathology by the microglial fractalkine receptor.	Neuron	2010	122
21159979	13051	Liu Z	CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.	The Journal of neuroscience 	2010	88
21167054	13051	Corona AW	Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide.	Journal of neuroinflammation	2010	49
21771791	13051	Cho SH	CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2011	69
22072675	13051	Rogers JT	CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.	The Journal of neuroscience 	2011	109
22072684	13051	Cipriani R	CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents.	The Journal of neuroscience 	2011	47
22573666	13051	Vukovic J	Microglia modulate hippocampal neural precursor activity in response to exercise and aging.	The Journal of neuroscience 	2012	46
23100431	13051	Hoshiko M	Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex.	The Journal of neuroscience 	2012	45
23424002	13051	Pong WW	Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.	Annals of neurology	2013	30
23440897	13051	Fumagalli S	CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice.	Glia	2013	32
23525041	13051	Ueno M	Layer V cortical neurons require microglial support for survival during postnatal development.	Nature neuroscience	2013	95
24468477	13051	Evans TA	High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury.	Experimental neurology	2014	39
24487234	13051	Zhan Y	Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior.	Nature neuroscience	2014	132
24490760	13051	Tang Z	CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke.	Journal of neuroinflammation	2014	28
24920619	13051	Peng B	Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa.	The Journal of neuroscience 	2014	27
25159150	13051	Squarzoni P	Microglia modulate wiring of the embryonic forebrain.	Cell reports	2014	45
25630253	13051	Condello C	Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques.	Nature communications	2015	28
25833819	13051	Maphis N	Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.	Brain 	2015	29
25902482	13051	Cronk JC	Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli.	Immunity	2015	24
25987130	13051	Feng X	Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.	Oncotarget	2015	15
9338784	13131	Sheldon M	Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice.	Nature	1997	123
9338785	13131	Howell BW	Neuronal position in the developing brain is regulated by mouse disabled-1.	Nature	1997	141
10380922	13131	Trommsdorff M	Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.	Cell	1999	289
10827173	13131	Gotthardt M	Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction.	The Journal of biological chemistry	2000	107
12526739	13131	Arnaud L	Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development.	Current biology 	2003	88
12526740	13131	Bock HH	Reelin activates SRC family tyrosine kinases in neurons.	Current biology 	2003	103
14715136	13131	Niu S	Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway.	Neuron	2004	99
18957219	13131	Hashimoto-Torii K	Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex.	Neuron	2008	66
20620871	13131	Yano M	Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling.	Neuron	2010	51
21460838	13131	Sentürk A	Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration.	Nature	2011	47
9482784	13162	Jones SR	Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.	The Journal of neuroscience 	1998	127
9520487	13162	Jones SR	Profound neuronal plasticity in response to inactivation of the dopamine transporter.	Proceedings of the National Academy of Sciences of the United States of America	1998	134
9888856	13162	Gainetdinov RR	Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.	Science	1999	135
11222668	13162	Wisor JP	Dopaminergic role in stimulant-induced wakefulness.	The Journal of neuroscience 	2001	129
11320258	13162	Sora I	Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.	Proceedings of the National Academy of Sciences of the United States of America	2001	94
11784783	13162	Morón JA	Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.	The Journal of neuroscience 	2002	127
12376616	13162	Dauer W	Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.	Proceedings of the National Academy of Sciences of the United States of America	2002	148
12379867	13162	Ourednik J	Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.	Nature biotechnology	2002	94
14561867	13162	Peciña S	Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards.	The Journal of neuroscience 	2003	103
16754872	13162	Chen R	Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.	Proceedings of the National Academy of Sciences of the United States of America	2006	98
16865686	13162	Bäckman CM	Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus.	Genesis	2006	82
17380124	13162	Lee FJ	Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.	The EMBO journal	2007	61
20685869	13162	Vucetic Z	Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes.	Endocrinology	2010	115
22712725	13162	Mebel DM	Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake.	The European journal of neuroscience	2012	31
25447236	13162	Masoud ST	Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.	Neurobiology of disease	2015	15
26139373	13162	Banerjee A	An Interglomerular Circuit Gates Glomerular Output and Implements Gain Control in the Mouse Olfactory Bulb.	Neuron	2015	25
10879536	13193	Magavi SS	Induction of neurogenesis in the neocortex of adult mice.	Nature	2000	184
12466205	13193	Kempermann G	Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice.	Development	2003	243
12882410	13193	Jin K	Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice.	Aging cell	2003	96
16699506	13193	Koizumi H	Doublecortin maintains bipolar shape and nuclear translocation during migration in the adult forebrain.	Nature neuroscience	2006	66
16914687	13193	Ganat YM	Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo.	The Journal of neuroscience 	2006	66
18455269	13193	Ben Abdallah NM	Early age-related changes in adult hippocampal neurogenesis in C57 mice.	Neurobiology of aging	2010	64
19095802	13193	Inta D	Neurogenesis and widespread forebrain migration of distinct GABAergic neurons from the postnatal subventricular zone.	Proceedings of the National Academy of Sciences of the United States of America	2008	72
20385829	13193	Jin K	Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	66
21228099	13193	Gaughwin P	Stage-specific modulation of cortical neuronal development by Mmu-miR-134.	Cerebral cortex	2011	44
21804544	13193	Lu Z	Phagocytic activity of neuronal progenitors regulates adult neurogenesis.	Nature cell biology	2011	45
9278515	13385	Irie M	Binding of neuroligins to PSD-95.	Science	1997	140
9853749	13385	Migaud M	Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein.	Nature	1998	261
12427827	13385	Komiyama NH	SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor.	The Journal of neuroscience 	2002	83
14980210	13385	Yao WD	Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity.	Neuron	2004	115
15470155	13385	Liu XB	Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development.	The Journal of neuroscience 	2004	104
16242627	13385	Almeida CG	Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.	Neurobiology of disease	2005	122
17148601	13385	Béïque JC	Synapse-specific regulation of AMPA receptor function by PSD-95.	Proceedings of the National Academy of Sciences of the United States of America	2006	125
18410515	13385	Lugli G	Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain.	Journal of neurochemistry	2008	97
18936077	13385	Carlisle HJ	Opposing effects of PSD-93 and PSD-95 on long-term potentiation and spike timing-dependent plasticity.	The Journal of physiology	2008	53
19104036	13385	Elias GM	Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
19145227	13385	Ricobaraza A	Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model.	Neuropsychopharmacology 	2009	94
19455133	13385	Fernández E	Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins.	Molecular systems biology	2009	77
19474308	13385	Stöhr H	TMEM16B, a novel protein with calcium-dependent chloride channel activity, associates with a presynaptic protein complex in photoreceptor terminals.	The Journal of neuroscience 	2009	75
19640847	13385	Schütt J	Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities.	The Journal of biological chemistry	2009	48
20655099	13385	Ittner LM	Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.	Cell	2010	385
20952458	13385	Feyder M	Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome.	The American journal of psychiatry	2010	49
21203469	13385	Head BP	Loss of caveolin-1 accelerates neurodegeneration and aging.	PloS one	2010	46
21282636	13385	Diaz Heijtz R	Normal gut microbiota modulates brain development and behavior.	Proceedings of the National Academy of Sciences of the United States of America	2011	345
21745643	13385	Ho GP	S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95.	Neuron	2011	51
22246437	13385	Zheng S	PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2.	Nature neuroscience	2012	57
23197725	13385	Chabrier MA	Soluble aβ promotes wild-type tau pathology in vivo.	The Journal of neuroscience 	2012	32
23201973	13385	Nithianantharajah J	Synaptic scaffold evolution generated components of vertebrate cognitive complexity.	Nature neuroscience	2013	60
23260144	13385	Tsai NP	Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.	Cell	2012	70
23858442	13385	Parihar VK	Cranial irradiation compromises neuronal architecture in the hippocampus.	Proceedings of the National Academy of Sciences of the United States of America	2013	34
24446074	13385	Parihar VK	Persistent changes in neuronal structure and synaptic plasticity caused by proton irradiation.	Brain structure and function	2015	24
24501349	13385	Cane M	The relationship between PSD-95 clustering and spine stability in vivo.	The Journal of neuroscience 	2014	26
25144834	13385	Isshiki M	Enhanced synapse remodelling as a common phenotype in mouse models of autism.	Nature communications	2014	21
10220457	13488	Bach ME	Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway.	Proceedings of the National Academy of Sciences of the United States of America	1999	116
11089973	13488	Usiello A	Distinct functions of the two isoforms of dopamine D2 receptors.	Nature	2000	141
15056714	13488	Zhang L	Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors.	The Journal of neuroscience 	2004	74
15078556	13488	Valjent E	Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.	The European journal of neuroscience	2004	124
15163680	13488	Thomas DM	Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.	The Journal of pharmacology and experimental therapeutics	2004	95
16492766	13488	Lee KW	Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens.	Proceedings of the National Academy of Sciences of the United States of America	2006	138
17194762	13488	Rashid AJ	D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.	Proceedings of the National Academy of Sciences of the United States of America	2007	135
17408758	13488	Surmeier DJ	D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.	Trends in neurosciences	2007	315
18234896	13488	Ade KK	Differential tonic GABA conductances in striatal medium spiny neurons.	The Journal of neuroscience 	2008	58
18279319	13488	Cepeda C	Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.	The European journal of neuroscience	2008	61
18337395	13488	Shuen JA	Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia.	The Journal of neuroscience 	2008	98
18509028	13488	Bertran-Gonzalez J	Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol.	The Journal of neuroscience 	2008	195
18760699	13488	Wang H	FMRP acts as a key messenger for dopamine modulation in the forebrain.	Neuron	2008	75
18987196	13488	Day M	Differential excitability and modulation of striatal medium spiny neuron dendrites.	The Journal of neuroscience 	2008	77
19187092	13488	Santini E	L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice.	Journal of neurochemistry	2009	55
19274089	13488	Matamales M	Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice.	PloS one	2009	81
19520364	13488	Darmopil S	Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.	Biological psychiatry	2009	54
19765834	13488	Valjent E	Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice.	Trends in neurosciences	2009	78
20613723	13488	Kravitz AV	Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.	Nature	2010	428
20956312	13488	Navarro G	Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine.	Proceedings of the National Academy of Sciences of the United States of America	2010	45
21055728	13488	Pascoli V	Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation.	Biological psychiatry	2011	40
21273402	13488	André VM	Differential electrophysiological changes in striatal output neurons in Huntington's disease.	The Journal of neuroscience 	2011	45
22158102	13488	Pascoli V	Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour.	Nature	2011	99
22544310	13488	Kravitz AV	Distinct roles for direct and indirect pathway striatal neurons in reinforcement.	Nature neuroscience	2012	202
22802650	13488	Yawata S	Pathway-specific control of reward learning and its flexibility via selective dopamine receptors in the nucleus accumbens.	Proceedings of the National Academy of Sciences of the United States of America	2012	35
22902719	13488	Tai LH	Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value.	Nature neuroscience	2012	77
23769604	13488	Suárez LM	L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.	Biological psychiatry	2014	29
24794428	13488	Portmann T	Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome.	Cell reports	2014	28
24797632	13488	Bronson SL	Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment.	Endocrinology	2014	30
24848058	13488	Pascoli V	Contrasting forms of cocaine-evoked plasticity control components of relapse.	Nature	2014	56
25657248	13488	Creed M	Addiction therapy. Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology.	Science	2015	33
26586182	13488	Pascoli V	Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.	Neuron	2015	18
26946430	13488	Renteria R	Selective alterations of NMDAR function and plasticity in D1 and D2 medium spiny neurons in the nucleus accumbens shell following chronic intermittent ethanol exposure.	Neuropharmacology	2017	8
15207238	13489	Beckstead MJ	Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons.	Neuron	2004	106
15721235	13489	Goldberg MS	Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.	Neuron	2005	137
16675398	13489	Wang Z	Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.	Neuron	2006	149
17634367	13489	Drew MR	Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing.	The Journal of neuroscience 	2007	68
18495884	13489	Taverna S	Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease.	The Journal of neuroscience 	2008	95
18716204	13489	Qu WM	Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil.	The Journal of neuroscience 	2008	58
18945889	13489	Gertler TS	Dichotomous anatomical properties of adult striatal medium spiny neurons.	The Journal of neuroscience 	2008	120
19244517	13489	Joshi PR	Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.	The Journal of neuroscience 	2009	55
19270687	13489	Durieux PF	D2R striatopallidal neurons inhibit both locomotor and drug reward processes.	Nature neuroscience	2009	87
19667187	13489	Tong Y	R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	97
21048118	13489	Doig NM	Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatum.	The Journal of neuroscience 	2010	46
21209197	13489	Kramer PF	Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice.	The Journal of neuroscience 	2011	38
21289195	13489	Tozzi A	The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.	The Journal of neuroscience 	2011	35
21743470	13489	Bello EP	Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors.	Nature neuroscience	2011	88
22492051	13489	Gee S	Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex.	The Journal of neuroscience 	2012	42
22745501	13489	Anzalone A	Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.	The Journal of neuroscience 	2012	45
23100428	13489	Hnasko TS	Ventral tegmental area glutamate neurons: electrophysiological properties and projections.	The Journal of neuroscience 	2012	60
24259563	13489	Lobo MK	ΔFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli.	The Journal of neuroscience 	2013	54
25343991	13489	Beccano-Kelly DA	LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.	Human molecular genetics	2015	18
26840481	13489	Zhu Y	A thalamic input to the nucleus accumbens mediates opiate dependence.	Nature	2016	17
11299042	13798	Srinivas S	Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.	BMC developmental biology	2001	1117
12736208	13798	Chi CL	The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum.	Development	2003	83
16525473	13798	Gosgnach S	V1 spinal neurons regulate the speed of vertebrate locomotor outputs.	Nature	2006	117
9348186	13982	Couse JF	Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.	Endocrinology	1997	128
10368776	13982	Couse JF	Estrogen receptor null mice: what have we learned and where will they lead us?	Endocrine reviews	1999	352
11172057	13982	Dubal DB	Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.	Proceedings of the National Academy of Sciences of the United States of America	2001	140
12351713	13982	Toran-Allerand CD	ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury.	The Journal of neuroscience 	2002	129
12624116	13982	Couse JF	Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta.	Molecular endocrinology	2003	79
12697714	13982	Mitra SW	Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha.	Endocrinology	2003	186
12878732	13982	Vegeto E	Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol.	Proceedings of the National Academy of Sciences of the United States of America	2003	79
15101093	13982	Merchenthaler I	Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses.	The Journal of comparative neurology	2004	78
16803960	13982	Musatov S	RNAi-mediated silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors.	Proceedings of the National Academy of Sciences of the United States of America	2006	63
17046690	13982	Wintermantel TM	Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility.	Neuron	2006	180
17284595	13982	Musatov S	Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2007	136
17470805	13982	Glidewell-Kenney C	Nonclassical estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive axis.	Proceedings of the National Academy of Sciences of the United States of America	2007	57
17604108	13982	Herbison AE	Estrogen positive feedback to gonadotropin-releasing hormone (GnRH) neurons in the rodent: the case for the rostral periventricular area of the third ventricle (RP3V).	Brain research reviews	2008	87
17936613	13982	Morissette M	Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.	The Journal of steroid biochemistry and molecular biology	2008	50
18297067	13982	Liu F	Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory.	Nature neuroscience	2008	141
18342349	13982	Qiu J	Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor.	Steroids	2008	60
19029819	13982	Tsai HW	Sex differences in histone modifications in the neonatal mouse brain.	Epigenetics	2009	61
19403828	13982	Chu Z	Differential regulation of gonadotropin-releasing hormone neuron activity and membrane properties by acutely applied estradiol: dependence on dose and estrogen receptor subtype.	The Journal of neuroscience 	2009	54
19625529	13982	Gottsch ML	Regulation of Kiss1 and dynorphin gene expression in the murine brain by classical and nonclassical estrogen receptor pathways.	The Journal of neuroscience 	2009	62
19966177	13982	Westberry JM	Epigenetic regulation of estrogen receptor alpha gene expression in the mouse cortex during early postnatal development.	Endocrinology	2010	45
20506473	13982	Mitterling KL	Cellular and subcellular localization of estrogen and progestin receptor immunoreactivities in the mouse hippocampus.	The Journal of comparative neurology	2010	48
20881113	13982	Kuo J	Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes.	The Journal of neuroscience 	2010	53
21149719	13982	Mayer C	Timing and completion of puberty in female mice depend on estrogen receptor alpha-signaling in kisspeptin neurons.	Proceedings of the National Academy of Sciences of the United States of America	2010	69
21555578	13982	Spence RD	Neuroprotection mediated through estrogen receptor-alpha in astrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2011	52
21982706	13982	Xu Y	Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction.	Cell metabolism	2011	126
22133892	13982	Spencer-Segal JL	Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation.	Neuroscience	2012	31
22209870	13982	Spence RD	Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.	Frontiers in neuroendocrinology	2012	38
23407940	13982	Frazão R	Shift in Kiss1 cell activity requires estrogen receptor α.	The Journal of neuroscience 	2013	26
23716699	13982	Kundakovic M	Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure.	Proceedings of the National Academy of Sciences of the United States of America	2013	92
23804112	13982	Spence RD	Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons.	The Journal of neuroscience 	2013	27
24048848	13982	Boulware MI	The memory-enhancing effects of hippocampal estrogen receptor activation involve metabotropic glutamate receptor signaling.	The Journal of neuroscience 	2013	33
24739975	13982	Lee H	Scalable control of mounting and attack by Esr1+ neurons in the ventromedial hypothalamus.	Nature	2014	49
25373903	13982	Morselli E	Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.	Cell reports	2014	29
11470906	14073	Cravatt BF	Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.	Proceedings of the National Academy of Sciences of the United States of America	2001	345
15157693	14073	Lichtman AH	Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.	Pain	2004	107
15247426	14073	Cravatt BF	Functional disassociation of the central and peripheral fatty acid amide signaling systems.	Proceedings of the National Academy of Sciences of the United States of America	2004	78
15579492	14073	Fegley D	Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.	The Journal of pharmacology and experimental therapeutics	2005	137
16501580	14073	Chang L	Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.	British journal of pharmacology	2006	63
16866345	14073	Saghatelian A	A FAAH-regulated class of N-acyl taurines that activates TRP ion channels.	Biochemistry	2006	61
17412883	14073	Russo R	The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.	The Journal of pharmacology and experimental therapeutics	2007	66
17675104	14073	Rademacher DJ	Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.	Neuropharmacology	2008	63
22776900	14073	Hill MN	Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure.	Molecular psychiatry	2013	39
25100669	14073	Lomazzo E	Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.	Neuropsychopharmacology 	2015	23
25731744	14073	Dincheva I	FAAH genetic variation enhances fronto-amygdala function in mouse and human.	Nature communications	2015	36
8033209	14265	-	Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.	Cell	1994	234
9030614	14265	Feng Y	Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes.	The Journal of neuroscience 	1997	128
9144249	14265	Comery TA	Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.	Proceedings of the National Academy of Sciences of the United States of America	1997	269
11301211	14265	Chen L	Fragile X mice develop sensory hyperreactivity to auditory stimuli.	Neuroscience	2001	97
11438589	14265	Nimchinsky EA	Abnormal development of dendritic spines in FMR1 knock-out mice.	The Journal of neuroscience 	2001	134
11860268	14265	Li J	Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.	Molecular and cellular neurosciences	2002	89
12032354	14265	Huber KM	Altered synaptic plasticity in a mouse model of fragile X mental retardation.	Proceedings of the National Academy of Sciences of the United States of America	2002	397
12052912	14265	O'Donnell WT	A decade of molecular studies of fragile X syndrome.	Annual review of neuroscience	2002	140
12700164	14265	Willemsen R	The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.	Human molecular genetics	2003	101
15475576	14265	Lu R	The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development.	Proceedings of the National Academy of Sciences of the United States of America	2004	106
15548614	14265	Weiler IJ	Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses.	Proceedings of the National Academy of Sciences of the United States of America	2004	72
15880753	14265	Galvez R	Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome.	American journal of medical genetics. Part A	2005	84
15901791	14265	Qin M	Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse.	The Journal of neuroscience 	2005	91
16076950	14265	Restivo L	Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
16093389	14265	Zhao MG	Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome.	The Journal of neuroscience 	2005	118
16135762	14265	Chuang SC	Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model.	The Journal of neuroscience 	2005	79
16452252	14265	Nosyreva ED	Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.	Journal of neurophysiology	2006	126
17287348	14265	Wilson BM	Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice.	Proceedings of the National Academy of Sciences of the United States of America	2007	56
17417632	14265	Zalfa F	A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability.	Nature neuroscience	2007	123
17442505	14265	Entezam A	Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model.	Gene	2007	86
17507556	14265	Muddashetty RS	Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.	The Journal of neuroscience 	2007	171
17521574	14265	Meredith RM	Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1.	Neuron	2007	62
17592139	14265	Hayashi ML	Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice.	Proceedings of the National Academy of Sciences of the United States of America	2007	95
17881561	14265	Nakamoto M	Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.	Proceedings of the National Academy of Sciences of the United States of America	2007	91
17913902	14265	Lauterborn JC	Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome.	The Journal of neuroscience 	2007	99
18093519	14265	Dölen G	Correction of fragile X syndrome in mice.	Neuron	2007	342
18474609	14265	Narayanan U	S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.	The Journal of biological chemistry	2008	83
18480274	14265	Bureau I	Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice.	The Journal of neuroscience 	2008	75
18539120	14265	Dictenberg JB	A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome.	Developmental cell	2008	146
18571098	14265	de Vrij FM	Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.	Neurobiology of disease	2008	134
18784272	14265	Gibson JR	Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.	Journal of neurophysiology	2008	136
18829439	14265	Liao L	Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	58
18835858	14265	Bilousova TV	Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.	Journal of medical genetics	2009	135
19014369	14265	Brouwer JR	CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome.	Journal of neurochemistry	2008	60
19166269	14265	Bechara EG	A novel function for fragile X mental retardation protein in translational activation.	PLoS biology	2009	50
19377084	14265	Hashem V	Ectopic expression of CGG containing mRNA is neurotoxic in mammals.	Human molecular genetics	2009	52
19846466	14265	Chen Y	Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration.	Human molecular genetics	2010	72
20071534	14265	Sharma A	Dysregulation of mTOR signaling in fragile X syndrome.	The Journal of neuroscience 	2010	175
20159450	14265	Edbauer D	Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132.	Neuron	2010	238
20159451	14265	Harlow EG	Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice.	Neuron	2010	73
20386739	14265	Luo Y	Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells.	PLoS genetics	2010	78
20434996	14265	Pfeiffer BE	Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2.	Neuron	2010	51
20497624	14265	Liu ZH	Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.	The international journal of neuropsychopharmacology	2011	55
20534533	14265	Suvrathan A	Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2010	56
20534828	14265	Cruz-Martín A	Delayed stabilization of dendritic spines in fragile X mice.	The Journal of neuroscience 	2010	84
20660275	14265	Olmos-Serrano JL	Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	92
20713728	14265	Kao DI	Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein.	Proceedings of the National Academy of Sciences of the United States of America	2010	44
20720104	14265	Chen LY	Physiological activation of synaptic Rac&amp;gt;PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	48
20861447	14265	Pan F	Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
20935171	14265	Cunningham CL	Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development.	Human molecular genetics	2011	35
21084617	14265	Osterweil EK	Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	118
21159962	14265	Soden ME	Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid.	The Journal of neuroscience 	2010	46
21220020	14265	Qin M	A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis.	Neurobiology of disease	2011	44
21262808	14265	Krueger DD	Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
21490210	14265	Gross C	Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2.	The Journal of neuroscience 	2011	46
21516088	14265	Guo W	Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning.	Nature medicine	2011	62
21784246	14265	Darnell JC	FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.	Cell	2011	483
21795546	14265	Deng PY	Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome.	The Journal of neuroscience 	2011	51
21856714	14265	Testa-Silva G	Hyperconnectivity and slow synapses during early development of medial prefrontal cortex in a mouse model for mental retardation and autism.	Cerebral cortex	2012	34
21934270	14265	Paluszkiewicz SM	Fragile X syndrome: the GABAergic system and circuit dysfunction.	Developmental neuroscience	2011	36
21976507	14265	Hays SA	Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry.	The Journal of neuroscience 	2011	51
22009360	14265	Hagerman R	Fragile X syndrome and targeted treatment trials.	Results and problems in cell differentiation	2012	39
22048960	14265	Guo W	Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.	Human molecular genetics	2012	42
22099464	14265	Lee HY	Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein.	Neuron	2011	53
22113615	14265	Auerbach BD	Mutations causing syndromic autism define an axis of synaptic pathophysiology.	Nature	2011	181
22267161	14265	Ronesi JA	Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.	Nature neuroscience	2012	63
22405502	14265	Goebel-Goody SM	Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.	Genes, brain, and behavior	2012	35
22466801	14265	Cao Z	Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone.	Human molecular genetics	2012	37
22500629	14265	Michalon A	Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.	Neuron	2012	132
22522472	14265	He CX	The trouble with spines in fragile X syndrome: density, maturity and plasticity.	Neuroscience	2013	38
22539853	14265	Niere F	Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.	The Journal of neuroscience 	2012	44
22993295	14265	Henderson C	Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.	Science translational medicine	2012	63
23235829	14265	Ascano M Jr	FMRP targets distinct mRNA sequence elements to regulate protein expression.	Nature	2012	149
23458504	14265	Rotschafer S	Altered auditory processing in a mouse model of fragile X syndrome.	Brain research	2013	25
23509247	14265	Dolan BM	Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486.	Proceedings of the National Academy of Sciences of the United States of America	2013	30
23727819	14265	Gonçalves JT	Circuit level defects in the developing neocortex of Fragile X mice.	Nature neuroscience	2013	57
24227732	14265	Janusz A	The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.	The Journal of neuroscience 	2013	29
24463622	14265	Ludwig AL	CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.	Human molecular genetics	2014	24
24813610	14265	Alpatov R	A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response.	Cell	2014	24
25383903	14265	Zhang Y	Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-/y) mice.	Nature neuroscience	2014	25
25921527	14265	Gross C	Selective role of the catalytic PI3K subunit p110β in impaired higher order cognition in fragile X syndrome.	Cell reports	2015	18
27293187	14265	Orefice LL	Peripheral Mechanosensory Neuron Dysfunction Underlies Tactile and Behavioral Deficits in Mouse Models of ASDs.	Cell	2016	13
1465144	14281	Wang ZQ	Bone and haematopoietic defects in mice lacking c-fos.	Nature	1992	136
10869852	14281	Honore P	Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.	Neuroscience	2000	104
12399951	14281	Wersinger SR	Vasopressin V1b receptor knockout reduces aggressive behavior in male mice.	Molecular psychiatry	2002	85
12481140	14281	Ruby NF	Role of melanopsin in circadian responses to light.	Science	2002	122
15269256	14281	Barth AL	Alteration of neuronal firing properties after in vivo experience in a FosGFP transgenic mouse.	The Journal of neuroscience 	2004	71
17482371	14281	Frenois F	Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior.	Psychoneuroendocrinology	2007	90
17537966	14281	Herry C	Processing of temporal unpredictability in human and animal amygdala.	The Journal of neuroscience 	2007	108
17761885	14281	Reijmers LG	Localization of a stable neural correlate of associative memory.	Science	2007	139
18195361	14281	Kelz MB	An essential role for orexins in emergence from general anesthesia.	Proceedings of the National Academy of Sciences of the United States of America	2008	74
18513320	14281	Chandramohan Y	The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway.	The European journal of neuroscience	2008	57
18601687	14281	Kovács KJ	Measurement of immediate-early gene activation- c-fos and beyond.	Journal of neuroendocrinology	2008	97
19176321	14281	Shimizu H	Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism.	Endocrinology	2009	54
19187265	14281	Kang N	A direct main olfactory bulb projection to the 'vomeronasal' amygdala in female mice selectively responds to volatile pheromones from males.	The European journal of neuroscience	2009	59
19717450	14281	Ma L	Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.	Proceedings of the National Academy of Sciences of the United States of America	2009	71
22099463	14281	Karnani MM	Activation of central orexin/hypocretin neurons by dietary amino acids.	Neuron	2011	36
22290116	14281	Stafford JM	Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction.	Biological psychiatry	2012	47
22662127	14281	Labrousse VF	Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice.	PloS one	2012	32
23035095	14281	Kron M	Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment.	The Journal of neuroscience 	2012	37
23764283	14281	Guenthner CJ	Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations.	Neuron	2013	36
24183705	14281	Trouche S	Fear extinction causes target-specific remodeling of perisomatic inhibitory synapses.	Neuron	2013	29
24411733	14281	Baldan LC	Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.	Neuron	2014	46
25194674	14281	Lieu T	The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.	Gastroenterology	2014	25
25558063	14281	Kim Y	Mapping social behavior-induced brain activation at cellular resolution in the mouse.	Cell reports	2015	26
12084936	14405	Crestani F	Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.	Proceedings of the National Academy of Sciences of the United States of America	2002	137
15017002	14405	Fagiolini M	Specific GABAA circuits for visual cortical plasticity.	Science	2004	124
15456836	14405	Peng Z	Altered expression of the delta subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy.	The Journal of neuroscience 	2004	111
16354909	14405	Belelli D	Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics.	The Journal of neuroscience 	2005	81
16525058	14405	Ford CP	Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.	The Journal of neuroscience 	2006	133
17322876	14405	Fernandez F	Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.	Nature neuroscience	2007	150
18762200	14405	Wafford KA	Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus.	Neuropharmacology	2009	49
21693554	14405	Braudeau J	Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice.	Journal of psychopharmacology	2011	40
23447605	14405	Martínez-Cué C	Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome.	The Journal of neuroscience 	2013	29
23550792	14405	Iancu OD	Selection for drinking in the dark alters brain gene coexpression networks.	Alcoholism, clinical and experimental research	2013	28
23995582	14405	Wilcox MV	Repeated binge-like ethanol drinking alters ethanol drinking patterns and depresses striatal GABAergic transmission.	Neuropsychopharmacology 	2014	23
24366261	14405	Maccione A	Following the ontogeny of retinal waves: pan-retinal recordings of population dynamics in the neonatal mouse.	The Journal of physiology	2014	28
25143620	14405	Goforth PB	Leptin acts via lateral hypothalamic area neurotensin neurons to inhibit orexin neurons by multiple GABA-independent mechanisms.	The Journal of neuroscience 	2014	27
10461223	14406	Crestani F	Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues.	Nature neuroscience	1999	114
15895085	14406	Maguire JL	Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.	Nature neuroscience	2005	191
16157276	14406	Tozuka Y	GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells.	Neuron	2005	169
16467523	14406	Liang J	Chronic intermittent ethanol-induced switch of ethanol actions from extrasynaptic to synaptic hippocampal GABAA receptors.	The Journal of neuroscience 	2006	78
17023503	14406	Mortensen M	Extrasynaptic alphabeta subunit GABAA receptors on rat hippocampal pyramidal neurons.	The Journal of physiology	2006	62
17329412	14406	Maguire J	Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress.	The Journal of neuroscience 	2007	78
17409249	14406	Earnheart JC	GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states.	The Journal of neuroscience 	2007	55
17626213	14406	Zhang N	Altered localization of GABA(A) receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy.	The Journal of neuroscience 	2007	75
20023655	14406	Mann EO	Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneurons.	Nature neuroscience	2010	72
20579975	14406	Shen Q	gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.	Biological psychiatry	2010	44
24503855	14406	Glykys J	Local impermeant anions establish the neuronal chloride concentration.	Science	2014	41
9023877	14432	Benowitz LI	GAP-43: an intrinsic determinant of neuronal development and plasticity.	Trends in neurosciences	1997	174
10729333	14432	Frey D	Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.	The Journal of neuroscience 	2000	150
10871285	14432	Laux T	GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism.	The Journal of cell biology	2000	151
12151536	14432	Dergham P	Rho signaling pathway targeted to promote spinal cord repair.	The Journal of neuroscience 	2002	130
20932918	14432	Lerch JP	Maze training in mice induces MRI-detectable brain shape changes specific to the type of learning.	NeuroImage	2011	56
21903256	14432	Li N	The promotion of neurite sprouting and outgrowth of mouse hippocampal cells in culture by graphene substrates.	Biomaterials	2011	36
8657306	14573	Sánchez MP	Renal agenesis and the absence of enteric neurons in mice lacking GDNF.	Nature	1996	201
8657307	14573	Pichel JG	Defects in enteric innervation and kidney development in mice lacking GDNF.	Nature	1996	193
8657308	14573	Moore MW	Renal and neuronal abnormalities in mice lacking GDNF.	Nature	1996	197
10414978	14573	Stucky CL	Isolectin B(4)-positive and -negative nociceptors are functionally distinct.	The Journal of neuroscience 	1999	122
11988777	14573	Airaksinen MS	The GDNF family: signalling, biological functions and therapeutic value.	Nature reviews. Neuroscience	2002	304
17720696	14573	Ai X	SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation.	Development	2007	65
18536709	14573	Pascual A	Absolute requirement of GDNF for adult catecholaminergic neuron survival.	Nature neuroscience	2008	73
21200028	14573	Bespalov MM	Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin.	The Journal of cell biology	2011	37
21262472	14573	Uchida S	Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events.	Neuron	2011	85
21375602	14573	Lau YS	Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration.	The European journal of neuroscience	2011	41
21775597	14573	Malin S	TRPV1 and TRPA1 function and modulation are target tissue dependent.	The Journal of neuroscience 	2011	38
26156989	14573	Uesaka T	Neuronal Differentiation in Schwann Cell Lineage Underlies Postnatal Neurogenesis in the Enteric Nervous System.	The Journal of neuroscience 	2015	16
9568712	14580	Bush TG	Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice.	Cell	1998	127
10399936	14580	Bush TG	Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice.	Neuron	1999	221
10783170	14580	Marino S	Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.	Genes and development	2000	202
11059815	14580	Eng LF	Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).	Neurochemical research	2000	194
11169793	14580	Nolte C	GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.	Glia	2001	135
11606625	14580	Lim GP	The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.	The Journal of neuroscience 	2001	222
12684469	14580	Imura T	The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses GFAP.	The Journal of neuroscience 	2003	81
12837622	14580	Filippov V	Subpopulation of nestin-expressing progenitor cells in the adult murine hippocampus shows electrophysiological and morphological characteristics of astrocytes.	Molecular and cellular neurosciences	2003	92
14702088	14580	Shi Y	Expression and function of orphan nuclear receptor TLX in adult neural stem cells.	Nature	2004	133
14730584	14580	Mignone JL	Neural stem and progenitor cells in nestin-GFP transgenic mice.	The Journal of comparative neurology	2004	193
14973255	14580	Maslov AY	Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice.	The Journal of neuroscience 	2004	142
15019942	14580	Woodruff RH	Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.	Molecular and cellular neurosciences	2004	84
15131433	14580	Ohtori S	TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord.	Spine	2004	85
15163694	14580	Wilhelmsson U	Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration.	The Journal of neuroscience 	2004	83
15240551	14580	Ferri AL	Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain.	Development	2004	173
15494728	14580	Garcia AD	GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain.	Nature neuroscience	2004	264
15998793	14580	Brambilla R	Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury.	The Journal of experimental medicine	2005	125
16116450	14580	Liu X	Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors.	Nature neuroscience	2005	117
16672668	14580	Brahmachari S	Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide.	The Journal of neuroscience 	2006	81
17205123	14580	Gelain F	Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures.	PloS one	2006	76
18003841	14580	Lagace DC	Dynamic contribution of nestin-expressing stem cells to adult neurogenesis.	The Journal of neuroscience 	2007	152
18367594	14580	Oberheim NA	Loss of astrocytic domain organization in the epileptic brain.	The Journal of neuroscience 	2008	73
19293246	14580	Hsuchou H	Obesity induces functional astrocytic leptin receptors in hypothalamus.	Brain 	2009	57
19562764	14580	Sun D	The morphology and spatial arrangement of astrocytes in the optic nerve head of the mouse.	The Journal of comparative neurology	2009	47
21372007	14580	Park SW	A selective inhibitor of drp1, mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina.	Investigative ophthalmology and visual science	2011	37
21451035	14580	Orellana JA	Amyloid β-induced death in neurons involves glial and neuronal hemichannels.	The Journal of neuroscience 	2011	71
22583833	14580	Gallego BI	IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma.	Journal of neuroinflammation	2012	40
22593063	14580	Shook BA	Spatiotemporal changes to the subventricular zone stem cell pool through aging.	The Journal of neuroscience 	2012	35
22912745	14580	Kamphuis W	GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease.	PloS one	2012	41
23047490	14580	Buckman LB	Regional astrogliosis in the mouse hypothalamus in response to obesity.	The Journal of comparative neurology	2013	30
23935246	14580	Biesmans S	Systemic immune activation leads to neuroinflammation and sickness behavior in mice.	Mediators of inflammation	2013	29
24033454	14580	Kane CJ	Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice.	Alcoholism, clinical and experimental research	2014	29
24357067	14580	Brambilla R	Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.	Glia	2014	26
24982137	14580	Stöhr J	Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	40
25043249	14580	Liu Z	Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke.	Glia	2014	22
26000486	14580	Luo Y	Single-cell transcriptome analyses reveal signals to activate dormant neural stem cells.	Cell	2015	32
26109658	14580	Liu Y	Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo.	The Journal of neuroscience 	2015	18
27518562	14580	García-Cáceres C	Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability.	Cell	2016	15
11516403	14617	Deans MR	Synchronous activity of inhibitory networks in neocortex requires electrical synapses containing connexin36.	Neuron	2001	152
11516404	14617	Hormuzdi SG	Impaired electrical signaling disrupts gamma frequency oscillations in connexin 36-deficient mice.	Neuron	2001	140
11826128	14617	Landisman CE	Electrical synapses in the thalamic reticular nucleus.	The Journal of neuroscience 	2002	105
12441058	14617	Deans MR	Connexin36 is essential for transmission of rod-mediated visual signals in the mammalian retina.	Neuron	2002	128
18498740	14617	Van Der Giessen RS	Role of olivary electrical coupling in cerebellar motor learning.	Neuron	2008	67
11095744	14685	Calvert PD	Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunit.	Proceedings of the National Academy of Sciences of the United States of America	2000	135
12154183	14685	Woodruff ML	Measurement of cytoplasmic calcium concentration in the rods of wild-type and transducin knock-out mice.	The Journal of physiology	2002	92
18171936	14685	Umino Y	Speed, spatial, and temporal tuning of rod and cone vision in mouse.	The Journal of neuroscience 	2008	75
20844144	14685	Naarendorp F	Dark light, rod saturation, and the absolute and incremental sensitivity of mouse cone vision.	The Journal of neuroscience 	2010	48
21613480	14685	Wang YV	Spectral and temporal sensitivity of cone-mediated responses in mouse retinal ganglion cells.	The Journal of neuroscience 	2011	51
22522934	14685	Pearson RA	Restoration of vision after transplantation of photoreceptors.	Nature	2012	117
23248312	14685	Barber AC	Repair of the degenerate retina by photoreceptor transplantation.	Proceedings of the National Academy of Sciences of the United States of America	2013	71
25728926	14685	Gunkel M	Higher-order architecture of rhodopsin in intact photoreceptors and its implication for phototransduction kinetics.	Structure	2015	21
2196069	14714	Mellon PL	Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis.	Neuron	1990	179
2645530	14714	Schwanzel-Fukuda M	Origin of luteinizing hormone-releasing hormone neurons.	Nature	1989	151
16230634	14714	Christian CA	Diurnal and estradiol-dependent changes in gonadotropin-releasing hormone neuron firing activity.	Proceedings of the National Academy of Sciences of the United States of America	2005	67
16290037	14714	Yoon H	Olfactory inputs to hypothalamic neurons controlling reproduction and fertility.	Cell	2005	106
17959774	14714	Pitteloud N	Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.	Proceedings of the National Academy of Sciences of the United States of America	2007	77
19321788	14714	Roseweir AK	Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation.	The Journal of neuroscience 	2009	90
19776272	14714	Navarro VM	Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse.	The Journal of neuroscience 	2009	151
20451543	14714	Bliss SP	GnRH signaling, the gonadotrope and endocrine control of fertility.	Frontiers in neuroendocrinology	2010	42
21518033	14714	Herbison AE	Depolarising and hyperpolarising actions of GABA(A) receptor activation on gonadotrophin-releasing hormone neurones: towards an emerging consensus.	Journal of neuroendocrinology	2011	38
21543621	14714	Forni PE	Neural crest and ectodermal cells intermix in the nasal placode to give rise to GnRH-1 neurons, sensory neurons, and olfactory ensheathing cells.	The Journal of neuroscience 	2011	40
25856430	14714	Yip SH	Conditional Viral Tract Tracing Delineates the Projections of the Distinct Kisspeptin Neuron Populations to Gonadotropin-Releasing Hormone (GnRH) Neurons in the Mouse.	Endocrinology	2015	15
7954803	14799	Aiba A	Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice.	Cell	1994	147
10364547	14799	Zamanillo D	Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning.	Science	1999	184
12195431	14799	Reisel D	Spatial memory dissociations in mice lacking GluR1.	Nature neuroscience	2002	86
12628184	14799	Lee HK	Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory.	Cell	2003	236
15140908	14799	Reichova I	Somatosensory corticothalamic projections: distinguishing drivers from modulators.	Journal of neurophysiology	2004	99
15695335	14799	Tang TS	Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2005	96
16582902	14799	Bellone C	Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression.	Nature neuroscience	2006	159
17114649	14799	Munton RP	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	Molecular and cellular proteomics 	2007	82
17296559	14799	Fuchs EC	Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior.	Neuron	2007	160
17446214	14799	Pace RW	Inspiratory bursts in the preBötzinger complex depend on a calcium-activated non-specific cation current linked to glutamate receptors in neonatal mice.	The Journal of physiology	2007	79
17684498	14799	Wiedholz LM	Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors.	Molecular psychiatry	2008	58
17923095	14799	Hu H	Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking.	Cell	2007	149
17972919	14799	Lu Y	Age-dependent requirement of AKAP150-anchored PKA and GluR2-lacking AMPA receptors in LTP.	The EMBO journal	2007	81
18292343	14799	Matsuo N	Spine-type-specific recruitment of newly synthesized AMPA receptors with learning.	Science	2008	101
18701074	14799	Engblom D	Glutamate receptors on dopamine neurons control the persistence of cocaine seeking.	Neuron	2008	78
19240035	14799	Gu Z	{beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution.	The Journal of biological chemistry	2009	53
19597494	14799	Mameli M	Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc.	Nature neuroscience	2009	126
19661377	14799	Grauer SM	Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia.	The Journal of pharmacology and experimental therapeutics	2009	46
19892736	14799	He K	Stabilization of Ca2+-permeable AMPA receptors at perisynaptic sites by GluR1-S845 phosphorylation.	Proceedings of the National Academy of Sciences of the United States of America	2009	79
19906877	14799	Lee HK	Specific roles of AMPA receptor subunit GluR1 (GluA1) phosphorylation sites in regulating synaptic plasticity in the CA1 region of hippocampus.	Journal of neurophysiology	2010	75
19925206	14799	Erickson MA	A single brief burst induces GluR1-dependent associative short-term potentiation: a potential mechanism for short-term memory.	Journal of cognitive neuroscience	2010	41
20392957	14799	Mozhui K	Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability.	The Journal of neuroscience 	2010	71
21482355	14799	Schonewille M	Reevaluating the role of LTD in cerebellar motor learning.	Neuron	2011	81
21483826	14799	Goel A	Phosphorylation of AMPA receptors is required for sensory deprivation-induced homeostatic synaptic plasticity.	PloS one	2011	38
21516102	14799	Kristensen AS	Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating.	Nature neuroscience	2011	66
21543593	14799	Asiedu MN	Spinal protein kinase M ζ underlies the maintenance mechanism of persistent nociceptive sensitization.	The Journal of neuroscience 	2011	45
21558424	14799	Wang X	Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.	Human molecular genetics	2011	120
22013185	14799	Lancaster E	Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.	Neurology	2011	47
24467847	14799	Lum EN	mGluR1 within the nucleus accumbens regulates alcohol intake in mice under limited-access conditions.	Neuropharmacology	2014	24
28154077	14799	Diering GH	Homer1a drives homeostatic scaling-down of excitatory synapses during sleep.	Science	2017	13
10499584	14800	Kelz MB	Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine.	Nature	1999	173
12805550	14800	Chung HJ	Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression.	Science	2003	98
16504942	14800	Clem RL	Pathway-specific trafficking of native AMPARs by in vivo experience.	Neuron	2006	93
16543133	14800	Steinberg JP	Targeted in vivo mutations of the AMPA receptor subunit GluR2 and its interacting protein PICK1 eliminate cerebellar long-term depression.	Neuron	2006	114
20159452	14800	Abraham NM	Synaptic inhibition in the olfactory bulb accelerates odor discrimination in mice.	Neuron	2010	70
20473292	14800	Vialou V	DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses.	Nature neuroscience	2010	146
21336270	14800	Mameli M	Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area.	Nature neuroscience	2011	52
21490215	14800	McCutcheon JE	Calcium-permeable AMPA receptors are present in nucleus accumbens synapses after prolonged withdrawal from cocaine self-administration but not experimenter-administered cocaine.	The Journal of neuroscience 	2011	67
21909089	14800	Rao-Ruiz P	Retrieval-specific endocytosis of GluA2-AMPARs underlies adaptive reconsolidation of contextual fear.	Nature neuroscience	2011	61
25401692	14800	Gascon E	Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia.	Nature medicine	2014	20
8980238	14810	Tsien JZ	The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory.	Cell	1996	353
9733192	14810	Frankland PW	The dorsal hippocampus is essential for context discrimination but not for contextual conditioning.	Behavioral neuroscience	1998	104
10700255	14810	Rampon C	Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice.	Nature neuroscience	2000	144
10862698	14810	Husi H	Proteomic analysis of NMDA receptor-adhesion protein signaling complexes.	Nature neuroscience	2000	265
10963597	14810	Iwasato T	Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex.	Nature	2000	123
16372012	14810	Salter MG	NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.	Nature	2005	150
16635246	14810	Collins MO	Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome.	Journal of neurochemistry	2006	145
17015831	14810	Dang MT	Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum.	Proceedings of the National Academy of Sciences of the United States of America	2006	85
17170137	14810	Kowal C	Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.	Proceedings of the National Academy of Sciences of the United States of America	2006	85
17188796	14810	Fan MM	N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.	Progress in neurobiology	2007	112
17313573	14810	Niewoehner B	Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus.	The European journal of neuroscience	2007	57
17556551	14810	McHugh TJ	Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network.	Science	2007	267
17625504	14810	Duffy S	D-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning.	Neuropsychopharmacology 	2008	57
17855598	14810	Corlew R	Developmental switch in the contribution of presynaptic and postsynaptic NMDA receptors to long-term depression.	The Journal of neuroscience 	2007	78
18701073	14810	Zweifel LS	Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors.	Neuron	2008	80
19015010	14810	Ehrlichman RS	N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.	Neuroscience	2009	54
19196972	14810	Kocerha J	MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction.	Proceedings of the National Academy of Sciences of the United States of America	2009	98
19503084	14810	Brennan AM	NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation.	Nature neuroscience	2009	148
19553918	14810	Kash TL	Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis.	Neuropsychopharmacology 	2009	55
19915563	14810	Belforte JE	Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.	Nature neuroscience	2010	248
20427654	14810	Kurup P	Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.	The Journal of neuroscience 	2010	74
21040854	14810	Korotkova T	NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory.	Neuron	2010	130
21190942	14810	Rauner C	Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses.	The Journal of biological chemistry	2011	69
21209199	14810	Rotaru DC	Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia.	The Journal of neuroscience 	2011	54
21468034	14810	Carlén M	A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior.	Molecular psychiatry	2012	137
21565394	14810	Bangash MA	Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism.	Cell	2011	46
21907762	14810	Raymond LA	Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.	Neuroscience	2011	55
22019731	14810	Kim JI	PI3Kγ is required for NMDA receptor-dependent long-term depression and behavioral flexibility.	Nature neuroscience	2011	40
22196339	14810	Wang LP	NMDA receptors in dopaminergic neurons are crucial for habit learning.	Neuron	2011	44
22308427	14810	Pontrello CG	Cofilin under control of β-arrestin-2 in NMDA-dependent dendritic spine plasticity, long-term depression (LTD), and learning.	Proceedings of the National Academy of Sciences of the United States of America	2012	35
22666364	14810	Kroener S	Chronic alcohol exposure alters behavioral and synaptic plasticity of the rodent prefrontal cortex.	PloS one	2012	63
22797694	14810	Bannerman DM	Dissecting spatial knowledge from spatial choice by hippocampal NMDA receptor deletion.	Nature neuroscience	2012	36
22806213	14810	Gandal MJ	GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.	Translational psychiatry	2012	49
22941108	14810	Holmes A	Chronic alcohol remodels prefrontal neurons and disrupts NMDAR-mediated fear extinction encoding.	Nature neuroscience	2012	75
23109148	14810	Kaindl AM	Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain.	Annals of neurology	2012	33
23271699	14810	Sluka KA	Regular physical activity prevents development of chronic pain and activation of central neurons.	Journal of applied physiology	2013	30
23348010	14810	Jiang Z	Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons.	Biological psychiatry	2013	27
23441094	14810	Saunders JA	Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes.	Autism research 	2013	26
23699525	14810	Tovar KR	Triheteromeric NMDA receptors at hippocampal synapses.	The Journal of neuroscience 	2013	45
24094148	14810	Balosso S	Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons.	Antioxidants and redox signaling	2014	22
24813892	14810	Dubal DB	Life extension factor klotho enhances cognition.	Cell reports	2014	32
24912493	14810	Stan AD	Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia.	Molecular psychiatry	2015	17
25140704	14810	Straub C	CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons.	PloS one	2014	22
25156700	14810	Tatard-Leitman VM	Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.	Biological psychiatry	2015	17
25174710	14810	Gambino F	Sensory-evoked LTP driven by dendritic plateau potentials in vivo.	Nature	2014	29
25490055	14810	Gasperini L	Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation.	Antioxidants and redox signaling	2015	18
26027926	14810	Duffney LJ	Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators.	Cell reports	2015	26
26875626	14810	Hackos DH	Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.	Neuron	2016	20
9630217	15165	Santoro B	Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain.	Cell	1998	148
10884310	15165	Santoro B	Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS.	The Journal of neuroscience 	2000	179
14651847	15165	Nolan MF	The hyperpolarization-activated HCN1 channel is important for motor learning and neuronal integration by cerebellar Purkinje cells.	Cell	2003	87
15550252	15165	Nolan MF	A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons.	Cell	2004	142
18003822	15165	Nolan MF	HCN1 channels control resting and active integrative properties of stellate cells from layer II of the entorhinal cortex.	The Journal of neuroscience 	2007	57
19158287	15165	Chen X	HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine.	The Journal of neuroscience 	2009	50
21358644	15165	Huang Z	Presynaptic HCN1 channels regulate Cav3.2 activity and neurotransmission at select cortical synapses.	Nature neuroscience	2011	51
21593326	15165	Lewis AS	Deletion of the hyperpolarization-activated cyclic nucleotide-gated channel auxiliary subunit TRIP8b impairs hippocampal Ih localization and function and promotes antidepressant behavior in mice.	The Journal of neuroscience 	2011	35
21795621	15165	Sheets PL	Corticospinal-specific HCN expression in mouse motor cortex: I(h)-dependent synaptic integration as a candidate microcircuit mechanism involved in motor control.	Journal of neurophysiology	2011	43
22100643	15165	Giocomo LM	Grid cells use HCN1 channels for spatial scaling.	Cell	2011	47
10481909	15171	Chemelli RM	Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.	Cell	1999	504
12495630	15171	Li Y	Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system.	Neuron	2002	100
12716916	15171	Georgescu D	Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.	The Journal of neuroscience 	2003	87
12797956	15171	Yamanaka A	Hypothalamic orexin neurons regulate arousal according to energy balance in mice.	Neuron	2003	185
12797957	15171	Willie JT	Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.	Neuron	2003	133
15745970	15171	Burdakov D	Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ.	The Journal of neuroscience 	2005	77
15848807	15171	Sakurai T	Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice.	Neuron	2005	107
16374809	15171	Yoshida K	Afferents to the orexin neurons of the rat brain.	The Journal of comparative neurology	2006	151
16407535	15171	Narita M	Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.	The Journal of neuroscience 	2006	135
17082459	15171	Conti B	Transgenic mice with a reduced core body temperature have an increased life span.	Science	2006	99
17910982	15171	Ohno K	Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.	Frontiers in neuroendocrinology	2008	52
17943086	15171	Adamantidis AR	Neural substrates of awakening probed with optogenetic control of hypocretin neurons.	Nature	2007	325
18354010	15171	Lutter M	Orexin signaling mediates the antidepressant-like effect of calorie restriction.	The Journal of neuroscience 	2008	53
18424001	15171	Takahashi K	Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.	Neuroscience	2008	65
19117547	15171	Funato H	Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity.	Cell metabolism	2009	68
19189786	15171	Scammell TE	A consensus definition of cataplexy in mouse models of narcolepsy.	Sleep	2009	50
19412176	15171	Hallmayer J	Narcolepsy is strongly associated with the T-cell receptor alpha locus.	Nature genetics	2009	110
19779148	15171	Kang JE	Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.	Science	2009	218
19945404	15171	Shiuchi T	Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system.	Cell metabolism	2009	50
20034618	15171	Perello M	Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner.	Biological psychiatry	2010	104
20039943	15171	España RA	The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system.	The European journal of neuroscience	2010	70
21368172	15171	Mochizuki T	Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	38
21525292	15171	Mieda M	Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep.	The Journal of neuroscience 	2011	50
21647372	15171	Sasaki K	Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice.	PloS one	2011	65
21775598	15171	Tsunematsu T	Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice.	The Journal of neuroscience 	2011	65
21788501	15171	Rolls A	Optogenetic disruption of sleep continuity impairs memory consolidation.	Proceedings of the National Academy of Sciences of the United States of America	2011	49
22956835	15171	Schöne C	Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ.	The Journal of neuroscience 	2012	42
24806676	15171	Tabuchi S	Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.	The Journal of neuroscience 	2014	26
25635459	15171	Jennings JH	Visualizing hypothalamic network dynamics for appetitive and consummatory behaviors.	Cell	2015	55
7618107	15194	Duyao MP	Inactivation of the mouse Huntington's disease gene homolog Hdh.	Science	1995	122
9267034	15194	Scherzinger E	Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.	Cell	1997	283
9949199	15194	Schilling G	Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.	Human molecular genetics	1999	184
10402204	15194	Hodgson JG	A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.	Neuron	1999	159
10699173	15194	Wheeler VC	Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.	Human molecular genetics	2000	113
10778856	15194	Yamamoto A	Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.	Cell	2000	218
10814708	15194	Luthi-Carter R	Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.	Human molecular genetics	2000	132
10942430	15194	Jana NR	Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.	Human molecular genetics	2000	91
11062468	15194	Dragatsis I	Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.	Nature genetics	2000	116
11152661	15194	Lin CH	Neurological abnormalities in a knock-in mouse model of Huntington's disease.	Human molecular genetics	2001	146
11821898	15194	Karpuj MV	Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.	Nature medicine	2002	81
11906693	15194	Zeron MM	Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.	Neuron	2002	114
12089530	15194	Panov AV	Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.	Nature neuroscience	2002	206
12165554	15194	Luthi-Carter R	Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.	Human molecular genetics	2002	85
12223539	15194	Wellington CL	Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2002	83
12812983	15194	Slow EJ	Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.	Human molecular genetics	2003	207
12926013	15194	Menalled LB	Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.	The Journal of comparative neurology	2003	134
14561870	15194	Ferrante RJ	Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.	The Journal of neuroscience 	2003	167
15882643	15194	Gu X	Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.	Neuron	2005	84
15983033	15194	Milakovic T	Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin.	The Journal of biological chemistry	2005	69
15996546	15194	Bae BI	p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.	Neuron	2005	118
16076956	15194	Slow EJ	Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.	Proceedings of the National Academy of Sciences of the United States of America	2005	75
16127709	15194	Stack EC	Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.	The Journal of comparative neurology	2005	79
16251441	15194	Valenza M	Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.	The Journal of neuroscience 	2005	68
16365166	15194	Shin JY	Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.	The Journal of cell biology	2005	110
16699508	15194	Yanai A	Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function.	Nature neuroscience	2006	92
16777606	15194	Graham RK	Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.	Cell	2006	204
17352931	15194	Woodman B	The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.	Brain research bulletin	2007	69
17519223	15194	Kuhn A	Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.	Human molecular genetics	2007	125
17652581	15194	Tang TS	Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2007	63
17913701	15194	Settembre C	A block of autophagy in lysosomal storage disorders.	Human molecular genetics	2008	144
17940007	15194	DiFiglia M	Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.	Proceedings of the National Academy of Sciences of the United States of America	2007	125
18362179	15194	Wang J	Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.	The Journal of cell biology	2008	53
18398004	15194	McBride JL	Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi.	Proceedings of the National Academy of Sciences of the United States of America	2008	206
18805465	15194	Hickey MA	Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.	Neuroscience	2008	73
18984744	15194	Martin B	Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.	Diabetes	2009	60
19052220	15194	Tydlacka S	Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.	The Journal of neuroscience 	2008	55
19525941	15194	Morfini GA	Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.	Nature neuroscience	2009	83
19825844	15194	Sathasivam K	Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.	Human molecular genetics	2010	65
19915593	15194	Okamoto S	Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.	Nature medicine	2009	119
20018729	15194	Bradford J	Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
20086007	15194	Landles C	Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.	The Journal of biological chemistry	2010	94
20145253	15194	Bradford J	Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.	The Journal of biological chemistry	2010	44
20190273	15194	Rose C	Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.	Human molecular genetics	2010	46
20220138	15194	Legleiter J	Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.	The Journal of biological chemistry	2010	63
20357106	15194	Li X	Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.	The Journal of neuroscience 	2010	51
20494921	15194	Faideau M	In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.	Human molecular genetics	2010	56
20696378	15194	Godin JD	Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis.	Neuron	2010	71
22726834	15194	Kordasiewicz HB	Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.	Neuron	2012	137
22794259	15194	Shirasaki DI	Network organization of the huntingtin proteomic interactome in mammalian brain.	Neuron	2012	47
22939619	15194	Yu D	Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression.	Cell	2012	77
23284626	15194	Menalled LB	Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.	PloS one	2012	57
23284644	15194	Heikkinen T	Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.	PloS one	2012	44
23341618	15194	Sathasivam K	Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.	Proceedings of the National Academy of Sciences of the United States of America	2013	91
23372043	15194	Hsiao HY	A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.	Human molecular genetics	2013	34
23872847	15194	Vashishtha M	Targeting H3K4 trimethylation in Huntington disease.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
24302884	15194	Mielcarek M	HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.	PLoS biology	2013	36
24784230	15194	Wang N	Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.	Nature medicine	2014	23
25038828	15194	Fernández-Nogales M	Huntington's disease is a four-repeat tauopathy with tau nuclear rods.	Nature medicine	2014	34
25556834	15194	Lee JH	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	Neuron	2015	16
26708003	15194	Choudhury SR	Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.	Molecular therapy 	2016	10
26900923	15194	Langfelder P	Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.	Nature neuroscience	2016	25
26951659	15194	Wang G	Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis.	Proceedings of the National Academy of Sciences of the United States of America	2016	10
9331358	15550	Lüscher C	G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons.	Neuron	1997	185
9826725	15550	Ramboz S	Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.	Proceedings of the National Academy of Sciences of the United States of America	1998	138
9844013	15550	Heisler LK	Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.	Proceedings of the National Academy of Sciences of the United States of America	1998	120
16979141	15550	Lanzenberger RR	Reduced serotonin-1A receptor binding in social anxiety disorder.	Biological psychiatry	2007	58
17429410	15550	Holick KA	Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor.	Neuropsychopharmacology 	2008	102
19423077	15550	Akimova E	The serotonin-1A receptor in anxiety disorders.	Biological psychiatry	2009	55
20152112	15550	Richardson-Jones JW	5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants.	Neuron	2010	106
20818386	15550	Liu C	Pet-1 is required across different stages of life to regulate serotonergic function.	Nature neuroscience	2010	60
21070242	15550	Gould GG	Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior.	Journal of neurochemistry	2011	41
21508226	15550	Richardson-Jones JW	Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety.	The Journal of neuroscience 	2011	55
11487658	15567	Chen JJ	Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.	The Journal of neuroscience 	2001	87
14625138	15567	Lira A	Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice.	Biological psychiatry	2003	94
15087484	15567	Murphy DL	Serotonin transporter: gene, genetic disorders, and pharmacogenetics.	Molecular interventions	2004	79
15514160	15567	Ansorge MS	Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice.	Science	2004	197
15589347	15567	Mathews TA	Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.	Journal of neuroscience methods	2004	74
16452991	15567	Zhu CB	The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters.	Neuropsychopharmacology 	2006	90
17151281	15567	Zhao ZQ	Lmx1b is required for maintenance of central serotonergic neurons and mice lacking central serotonergic system exhibit normal locomotor activity.	The Journal of neuroscience 	2006	81
17234600	15567	Wellman CL	Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice.	The Journal of neuroscience 	2007	116
18209729	15567	Murphy DL	Targeting the murine serotonin transporter: insights into human neurobiology.	Nature reviews. Neuroscience	2008	116
19208814	15567	Page DT	Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.	Proceedings of the National Academy of Sciences of the United States of America	2009	49
19698744	15567	Kalueff AV	Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes.	Neuroscience and biobehavioral reviews	2010	40
19963284	15567	Homberg JR	New perspectives on the neurodevelopmental effects of SSRIs.	Trends in pharmacological sciences	2010	53
20827273	15567	Zhu CB	Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.	Neuropsychopharmacology 	2010	49
20847275	15567	Baudry A	miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants.	Science	2010	101
21177701	15567	White K	The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.	Cardiovascular research	2011	37
21677183	15567	Li Z	Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons.	The Journal of neuroscience 	2011	73
23305936	15567	Couch Y	Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia.	Brain, behavior, and immunity	2013	27
26577932	15567	Muller CL	The serotonin system in autism spectrum disorder: From biomarker to animal models.	Neuroscience	2016	19
27111230	15567	Margolis KG	Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.	The Journal of clinical investigation	2016	12
8717038	16846	Ahima RS	Role of leptin in the neuroendocrine response to fasting.	Nature	1996	383
8782827	16846	Vaisse C	Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.	Nature genetics	1996	193
8787671	16846	Schwartz MW	Identification of targets of leptin action in rat hypothalamus.	The Journal of clinical investigation	1996	163
9218503	16846	Haynes WG	Receptor-mediated regional sympathetic nerve activation by leptin.	The Journal of clinical investigation	1997	135
9311777	16846	Kamohara S	Acute stimulation of glucose metabolism in mice by leptin treatment.	Nature	1997	110
9392508	16846	Schwartz MW	Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus.	Diabetes	1997	118
10523015	16846	Ozata M	Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects.	The Journal of clinical endocrinology and metabolism	1999	125
10660043	16846	Ducy P	Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.	Cell	2000	354
11796516	16846	Majdic G	Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity.	Endocrinology	2002	87
11970899	16846	Cheng A	Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.	Developmental cell	2002	112
12419242	16846	Takeda S	Leptin regulates bone formation via the sympathetic nervous system.	Cell	2002	287
15064421	16846	Pinto S	Rapid rewiring of arcuate nucleus feeding circuits by leptin.	Science	2004	261
16293343	16846	Farr SA	Effects of leptin on memory processing.	Peptides	2006	92
16423694	16846	Dhillon H	Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis.	Neuron	2006	257
16503925	16846	Smith JT	KiSS-1 neurones are direct targets for leptin in the ob/ob mouse.	Journal of neuroendocrinology	2006	98
17600230	16846	Zhang F	Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia.	Stroke	2007	59
18256137	16846	Stratigopoulos G	Regulation of Fto/Ftm gene expression in mice and humans.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	94
19117545	16846	Ozcan L	Endoplasmic reticulum stress plays a central role in development of leptin resistance.	Cell metabolism	2009	224
19179437	16846	Quennell JH	Leptin indirectly regulates gonadotropin-releasing hormone neuronal function.	Endocrinology	2009	56
20107083	16846	Qiu J	Leptin excites proopiomelanocortin neurons via activation of TRPC channels.	The Journal of neuroscience 	2010	71
20308782	16846	Greco SJ	Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	56
20739548	16846	Louis GW	Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons.	The Journal of neuroscience 	2010	44
21183787	16846	Donato J Jr	Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons.	The Journal of clinical investigation	2011	66
21325051	16846	Quennell JH	Leptin deficiency and diet-induced obesity reduce hypothalamic kisspeptin expression in mice.	Endocrinology	2011	48
21427219	16846	Louis GW	Molecular mapping of the neural pathways linking leptin to the neuroendocrine reproductive axis.	Endocrinology	2011	35
21521746	16846	Yamada N	Impaired CNS leptin action is implicated in depression associated with obesity.	Endocrinology	2011	40
21633176	16846	Gautron L	Sixteen years and counting: an update on leptin in energy balance.	The Journal of clinical investigation	2011	112
21865462	16846	Enriori PJ	Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance.	The Journal of neuroscience 	2011	82
22081158	16846	Domingos AI	Leptin regulates the reward value of nutrient.	Nature neuroscience	2011	58
22201680	16846	McNay DE	Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice.	The Journal of clinical investigation	2012	72
23064363	16846	Fuente-Martín E	Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes.	The Journal of clinical investigation	2012	32
24011077	16846	Fujikawa T	Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin.	Cell metabolism	2013	32
24880214	16846	Kim JG	Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding.	Nature neuroscience	2014	43
25480301	16846	Simonds SE	Leptin mediates the increase in blood pressure associated with obesity.	Cell	2014	37
9192681	16847	Fei H	Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues.	Proceedings of the National Academy of Sciences of the United States of America	1997	114
11602618	16847	Cohen P	Selective deletion of leptin receptor in neurons leads to obesity.	The Journal of clinical investigation	2001	183
16054045	16847	Coppari R	The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity.	Cell metabolism	2005	154
16284652	16847	de Luca C	Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes.	The Journal of clinical investigation	2005	141
17195839	16847	Gao Q	Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals.	Nature medicine	2007	125
17726024	16847	Gong Y	The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms.	The Journal of biological chemistry	2007	55
18258679	16847	Bingham NC	Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome.	Endocrinology	2008	75
19279251	16847	Leshan RL	Direct innervation of GnRH neurons by metabolic- and sexual odorant-sensing leptin receptor neurons in the hypothalamic ventral premammillary nucleus.	The Journal of neuroscience 	2009	70
19350671	16847	Scott MM	Leptin targets in the mouse brain.	The Journal of comparative neurology	2009	152
20017211	16847	Caron E	Distribution of leptin-sensitive cells in the postnatal and adult mouse brain.	The Journal of comparative neurology	2010	47
20374961	16847	Hill JW	Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility.	Cell metabolism	2010	134
20410123	16847	Leshan RL	Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala.	The Journal of neuroscience 	2010	51
21289197	16847	Zhang Y	Leptin-receptor-expressing neurons in the dorsomedial hypothalamus and median preoptic area regulate sympathetic brown adipose tissue circuits.	The Journal of neuroscience 	2011	75
21311043	16847	Harlan SM	Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation.	Circulation research	2011	48
21422382	16847	do Carmo JM	Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons.	Hypertension	2011	37
21606595	16847	Scott MM	Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice.	The Journal of clinical investigation	2011	52
21636788	16847	Kim KW	Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus.	Proceedings of the National Academy of Sciences of the United States of America	2011	40
21907138	16847	Leinninger GM	Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance.	Cell metabolism	2011	83
22279209	16847	Bouret SG	Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits.	The Journal of neuroscience 	2012	37
22326958	16847	Berglund ED	Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice.	The Journal of clinical investigation	2012	97
22522563	16847	Leshan RL	Leptin action through hypothalamic nitric oxide synthase-1-expressing neurons controls energy balance.	Nature medicine	2012	43
24506870	16847	Balland E	Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain.	Cell metabolism	2014	47
25232147	16847	Allison MB	20 years of leptin: connecting leptin signaling to biological function.	The Journal of endocrinology	2014	22
26000480	16847	Liu J	Treatment of obesity with celastrol.	Cell	2015	29
8221886	17172	Guillemot F	Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons.	Cell	1993	205
10648228	17172	Farah MH	Generation of neurons by transient expression of neural bHLH proteins in mammalian cells.	Development	2000	130
11934853	17172	Cau E	Mash1 and Ngn1 control distinct steps of determination and differentiation in the olfactory sensory neuron lineage.	Development	2002	80
16715081	17172	Mizuguchi R	Ascl1 and Gsh1/2 control inhibitory and excitatory cell fate in spinal sensory interneurons.	Nature neuroscience	2006	65
17442807	17172	Parras CM	The proneural gene Mash1 specifies an early population of telencephalic oligodendrocytes.	The Journal of neuroscience 	2007	57
18587391	17172	Jessberger S	Directed differentiation of hippocampal stem/progenitor cells in the adult brain.	Nature neuroscience	2008	67
20107439	17172	Vierbuchen T	Direct conversion of fibroblasts to functional neurons by defined factors.	Nature	2010	761
21483754	17172	Kim EJ	Ascl1 (Mash1) defines cells with long-term neurogenic potential in subgranular and subventricular zones in adult mouse brain.	PloS one	2011	53
21617644	17172	Pang ZP	Induction of human neuronal cells by defined transcription factors.	Nature	2011	311
23637330	17172	Pollak J	ASCL1 reprograms mouse Muller glia into neurogenic retinal progenitors.	Development	2013	36
24924197	17172	Borromeo MD	A transcription factor network specifying inhibitory versus excitatory neurons in the dorsal spinal cord.	Development	2014	21
25254342	17172	Chanda S	Generation of induced neuronal cells by the single reprogramming factor ASCL1.	Stem cell reports	2014	46
27281220	17172	Treutlein B	Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq.	Nature	2016	21
7520367	17196	Lafaille JJ	High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice.	Cell	1994	131
8755567	17196	Cantorna MT	1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	1996	115
9616125	17196	Griffiths I	Axonal swellings and degeneration in mice lacking the major proteolipid of myelin.	Science	1998	152
12796723	17196	Chen Y	Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.	Journal of cerebral blood flow and metabolism 	2003	75
14702638	17196	Windrem MS	Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain.	Nature medicine	2004	111
16213163	17196	Tyszka JM	Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant.	NeuroImage	2006	62
18187343	17196	Sun SW	Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging.	NeuroImage	2008	67
22028197	17196	Yasuda A	Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.	Stem cells	2011	35
24281246	17196	Kohli N	Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.	Molecular therapy 	2014	26
8990120	17202	Fan W	Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.	Nature	1997	269
12904474	17202	Liu H	Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter.	The Journal of neuroscience 	2003	133
15034587	17202	Fan W	Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system.	Nature neuroscience	2004	76
16269339	17202	Balthasar N	Divergence of melanocortin pathways in the control of food intake and energy expenditure.	Cell	2005	335
17194736	17202	Voss-Andreae A	Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue.	Endocrinology	2007	59
21169216	17202	Ghamari-Langroudi M	Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin.	Proceedings of the National Academy of Sciences of the United States of America	2011	36
21284986	17202	Rossi J	Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis.	Cell metabolism	2011	158
22785313	17202	Lim BK	Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens.	Nature	2012	88
23159449	17202	Zechner JF	Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.	Gastroenterology	2013	27
23374353	17202	Sohn JW	Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons.	Cell	2013	64
24166765	17202	Gao Y	Hormones and diet, but not body weight, control hypothalamic microglial activity.	Glia	2014	34
25609168	17202	Peñagarikano O	Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism.	Science translational medicine	2015	43
11242117	17257	Guy J	A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.	Nature genetics	2001	439
11242118	17257	Chen RZ	Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.	Nature genetics	2001	392
11809720	17257	Shahbazian MD	Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation.	Human molecular genetics	2002	131
12160743	17257	Shahbazian M	Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.	Neuron	2002	256
12432090	17257	Tudor M	Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain.	Proceedings of the National Academy of Sciences of the United States of America	2002	100
15069197	17257	Luikenhuis S	Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	104
15351775	17257	Collins AL	Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.	Human molecular genetics	2004	158
15492925	17257	Weaving LS	Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.	American journal of human genetics	2004	70
15519245	17257	Kishi N	MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions.	Molecular and cellular neurosciences	2004	147
16087343	17257	Asaka Y	Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.	Neurobiology of disease	2006	114
16116096	17257	Dani VS	Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2005	225
16199017	17257	Gemelli T	Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.	Biological psychiatry	2006	70
16354910	17257	Viemari JC	Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.	The Journal of neuroscience 	2005	90
16467389	17257	Pelka GJ	Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice.	Brain 	2006	68
16581518	17257	Nelson ED	MeCP2-dependent transcriptional repression regulates excitatory neurotransmission.	Current biology 	2006	84
17289941	17257	Guy J	Reversal of neurological defects in a mouse model of Rett syndrome.	Science	2007	312
17296936	17257	Nan X	Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation.	Proceedings of the National Academy of Sciences of the United States of America	2007	70
17383101	17257	Stearns NA	Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.	Neuroscience	2007	67
17532643	17257	Smrt RD	Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons.	Neurobiology of disease	2007	85
17913925	17257	Ogier M	Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.	The Journal of neuroscience 	2007	83
17920015	17257	Chao HT	MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.	Neuron	2007	177
17988628	17257	Chahrour M	The story of Rett syndrome: from clinic to neurobiology.	Neuron	2007	378
18032561	17257	Medrihan L	Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.	Journal of neurophysiology	2008	87
18058824	17257	Zhang L	The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability.	Hippocampus	2008	52
18321864	17257	Samaco RC	A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.	Human molecular genetics	2008	76
18817733	17257	Fyffe SL	Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress.	Neuron	2008	84
19225110	17257	Tao J	Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function.	Proceedings of the National Academy of Sciences of the United States of America	2009	86
19234456	17257	Ballas N	Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.	Nature neuroscience	2009	158
19296534	17257	Belichenko PV	Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.	The Journal of comparative neurology	2009	81
19339616	17257	Adachi M	MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome.	The Journal of neuroscience 	2009	50
19369296	17257	Ben-Shachar S	Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus.	Human molecular genetics	2009	84
19386901	17257	Maezawa I	Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions.	The Journal of neuroscience 	2009	105
19741133	17257	Dani VS	Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome.	The Journal of neuroscience 	2009	51
19793977	17257	Taneja P	Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome.	The Journal of neuroscience 	2009	45
19812320	17257	Wood L	Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency.	The Journal of neuroscience 	2009	54
20007372	17257	Samaco RC	Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.	Proceedings of the National Academy of Sciences of the United States of America	2009	75
20010955	17257	Lusardi TA	Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex.	Journal of cerebral blood flow and metabolism 	2010	58
20159591	17257	Kernohan KD	ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain.	Developmental cell	2010	42
20200124	17257	Zhang ZW	MeCP2 is required for normal development of GABAergic circuits in the thalamus.	Journal of neurophysiology	2010	40
20392952	17257	Kline DD	Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice.	The Journal of neuroscience 	2010	63
20711186	17257	Deng JV	MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants.	Nature neuroscience	2010	73
21068835	17257	Chao HT	Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.	Nature	2010	304
21239731	17257	Calfa G	Experimental models of Rett syndrome based on Mecp2 dysfunction.	Experimental biology and medicine	2011	44
21307327	17257	Calfa G	Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging.	Journal of neurophysiology	2011	40
21476867	17257	Gray SJ	Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors.	Human gene therapy	2011	60
21482354	17257	Noutel J	Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice.	Neuron	2011	39
21636743	17257	McGraw CM	Adult neural function requires MeCP2.	Science	2011	79
21716289	17257	Lioy DT	A role for glia in the progression of Rett's syndrome.	Nature	2011	150
21765426	17257	Li H	Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory.	Nature neuroscience	2011	48
21966470	17257	Ananiev G	Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model.	PloS one	2011	66
22119903	17257	Goffin D	Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses.	Nature neuroscience	2011	54
22230884	17257	Farra N	Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.	Molecular psychiatry	2012	38
22525157	17257	Robinson L	Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.	Brain 	2012	33
22815516	17257	Nguyen MV	MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain.	The Journal of neuroscience 	2012	47
22891354	17257	Deogracias R	Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2012	58
23011033	17257	Gadalla KK	Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice.	Molecular therapy 	2013	27
23015442	17257	Blackman MP	A critical and cell-autonomous role for MeCP2 in synaptic scaling up.	The Journal of neuroscience 	2012	32
23452848	17257	Baker SA	An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders.	Cell	2013	48
23770565	17257	Lyst MJ	Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.	Nature neuroscience	2013	69
23770587	17257	Ebert DH	Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR.	Nature	2013	49
23966684	17257	Garg SK	Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.	The Journal of neuroscience 	2013	46
24336718	17257	Jiang M	Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome.	The Journal of neuroscience 	2013	35
24523563	17257	Zhang W	Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures.	The Journal of neuroscience 	2014	27
24958891	17257	Castro J	Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2014	46
25232122	17257	Sugino K	Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes.	The Journal of neuroscience 	2014	30
25297674	17257	He LJ	Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity.	Nature communications	2014	20
25762136	17257	Gabel HW	Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.	Nature	2015	87
26237041	17257	Lombardi LM	MECP2 disorders: from the clinic to mice and back.	The Journal of clinical investigation	2015	28
26261347	17257	Krishnan K	MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
26590342	17257	Ito-Ishida A	Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing Neurons in Mice Leads to Distinct Rett Syndrome-like Phenotypes.	Neuron	2015	17
26808898	17257	Liu Z	Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2.	Nature	2016	20
10704463	17441	Secor VH	Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis.	The Journal of experimental medicine	2000	104
12732654	17441	Bettelli E	Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.	The Journal of experimental medicine	2003	225
16955140	17441	Krishnamoorthy G	Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.	The Journal of clinical investigation	2006	70
16955141	17441	Bettelli E	Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.	The Journal of clinical investigation	2006	86
19487416	17441	Pöllinger B	Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.	The Journal of experimental medicine	2009	62
21354971	17441	Linker RA	Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.	Brain 	2011	148
21915101	17441	Zhuang X	Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.	Molecular therapy 	2011	145
22031325	17441	Berer K	Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.	Nature	2011	193
22610068	17441	Bai L	Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.	Nature neuroscience	2012	76
25175979	17441	Ben-Nun A	From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development.	Journal of autoimmunity	2014	25
26656646	17441	Traka M	Oligodendrocyte death results in immune-mediated CNS demyelination.	Nature neuroscience	2016	16
10932182	17762	Lewis J	Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.	Nature genetics	2000	274
11013246	17762	Götz J	Tau filament formation in transgenic mice expressing P301L tau.	The Journal of biological chemistry	2001	93
12859672	17762	Andorfer C	Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.	Journal of neurochemistry	2003	169
15930395	17762	Andorfer C	Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.	The Journal of neuroscience 	2005	155
17478722	17762	Roberson ED	Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.	Science	2007	489
18832465	17762	Ittner LM	Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia.	Proceedings of the National Academy of Sciences of the United States of America	2008	53
19443730	17762	Van Bergen NJ	Recharacterization of the RGC-5 retinal ganglion cell line.	Investigative ophthalmology and visual science	2009	63
20209626	17762	Demars M	Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.	Journal of neuroscience research	2010	63
21854751	17762	Kopeikina KJ	Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.	The American journal of pathology	2011	51
22286308	17762	Lei P	Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.	Nature medicine	2012	87
22519910	17762	Dayton RD	The advent of AAV9 expands applications for brain and spinal cord gene delivery.	Expert opinion on biological therapy	2012	33
23638068	17762	d'Abramo C	Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity.	PloS one	2013	35
24298146	17762	Kimura T	Microtubule-associated protein tau is essential for long-term depression in the hippocampus.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2014	32
27160897	17762	Vanderweyde T	Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity.	Cell reports	2016	11
8107803	17967	Cremer H	Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning.	Nature	1994	143
10594662	17967	Nait-Oumesmar B	Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination.	The European journal of neuroscience	1999	120
10884058	17967	Yamaguchi M	Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice.	Neuroreport	2000	100
16267048	17967	Weinhold B	Genetic ablation of polysialic acid causes severe neurodevelopmental defects rescued by deletion of the neural cell adhesion molecule.	The Journal of biological chemistry	2005	66
7926784	18015	Brannan CI	Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.	Genes and development	1994	133
10591652	18015	Cichowski K	Mouse models of tumor development in neurofibromatosis type 1.	Science	1999	113
10591653	18015	Vogel KS	Mouse tumor model for neurofibromatosis type 1.	Science	1999	98
10973261	18015	Reilly KM	Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.	Nature genetics	2000	94
11297510	18015	Zhu Y	Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.	Genes and development	2001	178
11793011	18015	Costa RM	Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.	Nature	2002	140
11988578	18015	Zhu Y	Neurofibromas in NF1: Schwann cell origin and role of tumor environment.	Science	2002	158
12077339	18015	Bajenaru ML	Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.	Molecular and cellular biology	2002	95
14695164	18015	Bajenaru ML	Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.	Cancer research	2003	94
15805275	18015	Dasgupta B	Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.	Cancer research	2005	79
16271875	18015	Li W	The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.	Current biology 	2005	101
17362838	18015	Ferner RE	Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.	The Lancet. Neurology	2007	64
17400655	18015	Daginakatte GC	Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.	Human molecular genetics	2007	69
18242513	18015	Joseph NM	The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.	Cancer cell	2008	52
18451155	18015	Kwon CH	Pten haploinsufficiency accelerates formation of high-grade astrocytomas.	Cancer research	2008	91
18984165	18015	Cui Y	Neurofibromin regulation of ERK signaling modulates GABA release and learning.	Cell	2008	118
20876733	18015	Lee DY	Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.	Genes and development	2010	47
21737130	18015	Liu C	Mosaic analysis with double markers reveals tumor cell of origin in glioma.	Cell	2011	158
23221341	18015	Jessen WJ	MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.	The Journal of clinical investigation	2013	66
1317267	18053	Lee KF	Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system.	Cell	1992	151
12422217	18053	Wang KC	P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.	Nature	2002	158
12860969	18053	Dubreuil CI	Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system.	The Journal of cell biology	2003	83
15647357	18053	Zheng B	Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2005	88
16025106	18053	Woo NH	Activation of p75NTR by proBDNF facilitates hippocampal long-term depression.	Nature neuroscience	2005	157
16251447	18053	Zagrebelsky M	The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons.	The Journal of neuroscience 	2005	79
17934455	18053	Jansen P	Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury.	Nature neuroscience	2007	87
18400893	18053	Sotthibundhu A	Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.	The Journal of neuroscience 	2008	57
18786358	18053	Lim YS	p75(NTR) mediates ephrin-A reverse signaling required for axon repulsion and mapping.	Neuron	2008	75
19710315	18053	Knowles JK	The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo.	The Journal of neuroscience 	2009	47
21102451	18053	Vaegter CB	Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling.	Nature neuroscience	2011	42
7505721	18125	Huang PL	Targeted disruption of the neuronal nitric oxide synthase gene.	Cell	1993	210
7522345	18125	Huang Z	Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.	Science	1994	200
8625413	18125	Brenman JE	Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains.	Cell	1996	285
11175752	18125	Jaffrey SR	Protein S-nitrosylation: a physiological signal for neuronal nitric oxide.	Nature cell biology	2001	375
15284347	18125	Heinke B	Physiological, neurochemical and morphological properties of a subgroup of GABAergic spinal lamina II neurones identified by expression of green fluorescent protein in mice.	The Journal of physiology	2004	79
18305236	18125	Gutsaeva DR	Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism.	The Journal of neuroscience 	2008	56
23801246	18125	Lin AL	Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2013	34
24305053	18125	Whiteus C	Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period.	Nature	2014	23
17631520	18145	Liao G	Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain.	The American journal of pathology	2007	59
20581737	18145	Ramirez CM	Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.	Pediatric research	2010	51
22048958	18145	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	30
24290752	18145	Sarkar S	Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease.	Cell reports	2013	44
26888431	18145	Alam MS	Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model.	Science translational medicine	2016	10
10888874	18429	Ferguson JN	Social amnesia in mice lacking the oxytocin gene.	Nature genetics	2000	205
11588199	18429	Ferguson JN	Oxytocin in the medial amygdala is essential for social recognition in the mouse.	The Journal of neuroscience 	2001	196
11950245	18429	Ferguson JN	The neuroendocrine basis of social recognition.	Frontiers in neuroendocrinology	2002	89
16418825	18429	Ring RH	Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications.	Psychopharmacology	2006	70
18451093	18429	Kublaoui BM	Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice.	Molecular endocrinology	2008	77
19228979	18429	Yoshida M	Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice.	The Journal of neuroscience 	2009	92
19247273	18429	Camerino C	Low sympathetic tone and obese phenotype in oxytocin-deficient mice.	Obesity	2009	50
19481567	18429	Ross HE	Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior.	Frontiers in neuroendocrinology	2009	152
19482070	18429	Ross HE	Characterization of the oxytocin system regulating affiliative behavior in female prairie voles.	Neuroscience	2009	75
21306704	18429	Sala M	Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	Biological psychiatry	2011	70
23028821	18429	Wu Z	An obligate role of oxytocin neurons in diet induced energy expenditure.	PloS one	2012	32
24190025	18429	Huang H	Chronic and acute intranasal oxytocin produce divergent social effects in mice.	Neuropsychopharmacology 	2014	31
24464043	18429	Zheng JJ	Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices.	Nature neuroscience	2014	28
24964815	18429	Zoicas I	Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum.	Neuropsychopharmacology 	2014	20
25599930	18429	Meziane H	An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.	Biological psychiatry	2015	19
25874674	18429	Marlin BJ	Oxytocin enables maternal behaviour by balancing cortical inhibition.	Nature	2015	53
16849425	18587	Komeima K	Antioxidants reduce cone cell death in a model of retinitis pigmentosa.	Proceedings of the National Academy of Sciences of the United States of America	2006	108
17111372	18587	Gargini C	Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study.	The Journal of comparative neurology	2007	134
17267005	18587	Chang B	Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene.	Vision research	2007	91
17520694	18587	Komeima K	Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.	Journal of cellular physiology	2007	70
18216234	18587	Stasheff SF	Emergence of sustained spontaneous hyperactivity and temporary preservation of OFF responses in ganglion cells of the retinal degeneration (rd1) mouse.	Journal of neurophysiology	2008	82
18432197	18587	Lagali PS	Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration.	Nature neuroscience	2008	149
18562624	18587	Margolis DJ	Functional stability of retinal ganglion cells after degeneration-induced changes in synaptic input.	The Journal of neuroscience 	2008	74
18639614	18587	Barhoum R	Functional and structural modifications during retinal degeneration in the rd10 mouse.	Neuroscience	2008	53
19109509	18587	Mazzoni F	Retinal ganglion cells survive and maintain normal dendritic morphology in a mouse model of inherited photoreceptor degeneration.	The Journal of neuroscience 	2008	65
20592196	18587	Thyagarajan S	Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells.	The Journal of neuroscience 	2010	41
21307264	18587	Menzler J	Network oscillations in rod-degenerated mouse retinas.	The Journal of neuroscience 	2011	41
21451038	18587	Borowska J	An intrinsic neural oscillator in the degenerating mouse retina.	The Journal of neuroscience 	2011	46
21610698	18587	Caporale N	LiGluR restores visual responses in rodent models of inherited blindness.	Molecular therapy 	2011	50
22908283	18587	Murakami Y	Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
22986110	18587	Yoshida N	Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa.	Ophthalmology	2013	34
24489706	18587	Margolis DJ	Network oscillations drive correlated spiking of ON and OFF ganglion cells in the rd1 mouse model of retinal degeneration.	PloS one	2014	24
25008417	18587	Choi H	Intrinsic bursting of AII amacrine cells underlies oscillations in the rd1 mouse retina.	Journal of neurophysiology	2014	25
25092770	18587	Cronin T	Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter.	EMBO molecular medicine	2014	26
25489083	18587	Gaub BM	Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	27
26139610	18587	Zhao L	Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration.	EMBO molecular medicine	2015	29
17634366	18823	Werner HB	Proteolipid protein is required for transport of sirtuin 2 into CNS myelin.	The Journal of neuroscience 	2007	57
10470087	18976	Yaswen L	Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.	Nature medicine	1999	182
11373681	18976	Cowley MA	Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus.	Nature	2001	472
15070780	18976	Challis BG	Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).	Proceedings of the National Academy of Sciences of the United States of America	2004	78
15207242	18976	Balthasar N	Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.	Neuron	2004	313
16172601	18976	Sternson SM	Topographic mapping of VMH --&amp;gt; arcuate nucleus microcircuits and their reorganization by fasting.	Nature neuroscience	2005	92
17728716	18976	Parton LE	Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity.	Nature	2007	191
19864580	18976	Hentges ST	Proopiomelanocortin expression in both GABA and glutamate neurons.	The Journal of neuroscience 	2009	56
20160350	18976	Banno R	PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice.	The Journal of clinical investigation	2010	71
20679202	18976	Horvath TL	Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity.	Proceedings of the National Academy of Sciences of the United States of America	2010	82
21659607	18976	Mineur YS	Nicotine decreases food intake through activation of POMC neurons.	Science	2011	91
22166984	18976	Padilla SL	Defining POMC neurons using transgenic reagents: impact of transient Pomc expression in diverse immature neuronal populations.	Endocrinology	2012	31
24506071	18976	Wu Y	Early-life stress reduces DNA methylation of the Pomc gene in male mice.	Endocrinology	2014	23
1373228	19122	Büeler H	Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.	Nature	1992	355
1977523	19122	Prusiner SB	Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.	Cell	1990	211
8100741	19122	Büeler H	Mice devoid of PrP are resistant to scrapie.	Cell	1993	438
8552188	19122	Brandner S	Normal host prion protein necessary for scrapie-induced neurotoxicity.	Nature	1996	167
8635458	19122	Fischer M	Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.	The EMBO journal	1996	279
8953038	19122	Telling GC	Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.	Science	1996	228
9414160	19122	Brown DR	The cellular prion protein binds copper in vivo.	Nature	1997	181
9452375	19122	Hegde RS	A transmembrane form of the prion protein in neurodegenerative disease.	Science	1998	146
9568713	19122	Shmerling D	Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.	Cell	1998	150
10525406	19122	Moore RC	Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel.	Journal of molecular biology	1999	114
11823413	19122	Mallucci GR	Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration.	The EMBO journal	2002	88
12086640	19122	Peretz D	A change in the conformation of prions accompanies the emergence of a new prion strain.	Neuron	2002	83
12379910	19122	Eikelenboom P	Neuroinflammation in Alzheimer's disease and prion disease.	Glia	2002	82
12386337	19122	Ma J	Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.	Science	2002	99
14522852	19122	Bruce ME	TSE strain variation.	British medical bulletin	2003	82
14593181	19122	Mallucci G	Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.	Science	2003	185
15286374	19122	Legname G	Synthetic mammalian prions.	Science	2004	286
15671162	19122	Legname G	Strain-specified characteristics of mouse synthetic prions.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
15933194	19122	Chesebro B	Anchorless prion protein results in infectious amyloid disease without clinical scrapie.	Science	2005	218
16239348	19122	Le Dur A	A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes.	Proceedings of the National Academy of Sciences of the United States of America	2005	77
16492732	19122	Steele AD	Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	77
16940522	19122	Tamgüney G	Transmission of elk and deer prions to transgenic mice.	Journal of virology	2006	63
17245436	19122	Baumann F	Lethal recessive myelin toxicity of prion protein lacking its central domain.	The EMBO journal	2007	85
17245437	19122	Li A	Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125.	The EMBO journal	2007	81
17270731	19122	Mallucci GR	Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.	Neuron	2007	77
17334982	19122	Vella LJ	Packaging of prions into exosomes is associated with a novel pathway of PrP processing.	The Journal of pathology	2007	110
17360589	19122	Piccardo P	Accumulation of prion protein in the brain that is not associated with transmissible disease.	Proceedings of the National Academy of Sciences of the United States of America	2007	72
18233951	19122	Aguzzi A	Molecular mechanisms of prion pathogenesis.	Annual review of pathology	2008	111
18443219	19122	Khosravani H	Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.	The Journal of cell biology	2008	80
18775309	19122	Castilla J	Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.	Cell	2008	76
18800058	19122	Castilla J	Cell-free propagation of prion strains.	The EMBO journal	2008	68
19198598	19122	Gousset K	Prions hijack tunnelling nanotubes for intercellular spread.	Nature cell biology	2009	155
19242475	19122	Laurén J	Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.	Nature	2009	403
19308092	19122	Hwang D	A systems approach to prion disease.	Molecular systems biology	2009	98
19741608	19122	Tamgüney G	Asymptomatic deer excrete infectious prions in faeces.	Nature	2009	74
20098419	19122	Bremer J	Axonal prion protein is required for peripheral myelin maintenance.	Nature neuroscience	2010	107
20107515	19122	Colby DW	Protease-sensitive synthetic prions.	PLoS pathogens	2010	80
20110469	19122	Wang F	Generating a prion with bacterially expressed recombinant prion protein.	Science	2010	257
20221436	19122	Chesebro B	Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.	PLoS pathogens	2010	51
20445063	19122	Gimbel DA	Memory impairment in transgenic Alzheimer mice requires cellular prion protein.	The Journal of neuroscience 	2010	135
20466881	19122	Angers RC	Prion strain mutation determined by prion protein conformational compatibility and primary structure.	Science	2010	62
20946660	19122	Chung E	Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.	BMC neuroscience	2010	60
22100763	19122	Kudo W	Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.	Human molecular genetics	2012	45
22586108	19122	Deleault NR	Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.	Proceedings of the National Academy of Sciences of the United States of America	2012	86
22820466	19122	Um JW	Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.	Nature neuroscience	2012	126
23072804	19122	Watt NT	Prion protein facilitates uptake of zinc into neuronal cells.	Nature communications	2012	33
23208281	19122	Ashe KH	Prions, prionoids and pathogenic proteins in Alzheimer disease.	Prion	2013	27
23362282	19122	Fluharty BR	An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo.	The Journal of biological chemistry	2013	37
23604588	19122	Wagner J	Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.	Acta neuropathologica	2013	36
25505180	19122	Guo BB	The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes.	The Journal of biological chemistry	2015	20
27501152	19122	Küffer A	The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.	Nature	2016	14
8878479	19164	Duff K	Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.	Nature	1996	246
8986743	19164	Citron M	Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.	Nature medicine	1997	178
9160754	19164	Shen J	Skeletal and CNS defects in Presenilin-1-deficient mice.	Cell	1997	193
9450754	19164	De Strooper B	Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.	Nature	1998	318
10518543	19164	Herreman A	Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.	Proceedings of the National Academy of Sciences of the United States of America	1999	112
10623648	19164	Gouras GK	Intraneuronal Abeta42 accumulation in human brain.	The American journal of pathology	2000	208
11279122	19164	Chishti MA	Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.	The Journal of biological chemistry	2001	221
11738035	19164	Feng R	Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces.	Neuron	2001	96
12805290	19164	Pigino G	Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport.	The Journal of neuroscience 	2003	99
13130141	19164	Krichevsky AM	A microRNA array reveals extensive regulation of microRNAs during brain development.	RNA	2003	300
14645205	19164	Jankowsky JL	Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.	Human molecular genetics	2004	295
14724250	19164	Stutzmann GE	Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability.	The Journal of neuroscience 	2004	74
15466394	19164	Casas C	Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.	The American journal of pathology	2004	111
15649704	19164	Malm TM	Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.	Neurobiology of disease	2005	91
15745965	19164	Lazarov O	Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited.	The Journal of neuroscience 	2005	75
15748777	19164	Patel NV	Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models.	Neurobiology of aging	2005	71
16687509	19164	Stutzmann GE	Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.	The Journal of neuroscience 	2006	106
16906128	19164	Radde R	Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.	EMBO reports	2006	145
16938404	19164	Arendash GW	Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.	Neuroscience	2006	66
17070803	19164	Zhang C	Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.	Experimental neurology	2007	62
17233641	19164	Reiserer RS	Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.	Genes, brain, and behavior	2007	66
18667150	19164	Kuchibhotla KV	Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks.	Neuron	2008	165
18698410	19164	Rodríguez JJ	Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease.	PloS one	2008	80
18760694	19164	Choi SH	Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation.	Neuron	2008	57
19710322	19164	Yan P	Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.	The Journal of neuroscience 	2009	77
19837759	19164	Choi SR	Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.	Journal of nuclear medicine 	2009	93
20332427	19164	Cheung KH	Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons.	Science signaling	2010	61
20541250	19164	Lee JH	Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.	Cell	2010	260
20573903	19164	Zhang H	Role of presenilins in neuronal calcium homeostasis.	The Journal of neuroscience 	2010	52
21215373	19164	Bai G	Presenilin-dependent receptor processing is required for axon guidance.	Cell	2011	38
21296668	19164	Nixon RA	Autophagy failure in Alzheimer's disease--locating the primary defect.	Neurobiology of disease	2011	109
22306812	19164	Mouton-Liger F	Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.	Biochimica et biophysica acta	2012	30
22393443	19164	Trushina E	Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease.	PloS one	2012	46
22457485	19164	Bero AW	Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brain.	The Journal of neuroscience 	2012	31
22836255	19164	Bachstetter AD	Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology.	The Journal of neuroscience 	2012	32
23152608	19164	Lauritzen I	The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.	The Journal of neuroscience 	2012	35
24602800	19164	Jiang T	Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease.	Pharmacological research	2014	21
24828079	19164	Sheline YI	An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice.	Science translational medicine	2014	33
25031402	19164	Xiao Q	Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.	The Journal of neuroscience 	2014	30
25741723	19164	Xia D	Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease.	Neuron	2015	38
25756590	19164	López-González I	Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.	Journal of neuropathology and experimental neurology	2015	18
26338325	19164	Xiao Q	Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.	The Journal of neuroscience 	2015	18
26888450	19164	Graham LC	Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer's disease.	Scientific reports	2016	10
12213962	19293	Galarreta M	Electrical and chemical synapses among parvalbumin fast-spiking GABAergic interneurons in adult mouse neocortex.	Proceedings of the National Academy of Sciences of the United States of America	2002	95
17234587	19293	Woodruff AR	Networks of parvalbumin-positive interneurons in the basolateral amygdala.	The Journal of neuroscience 	2007	61
18023140	19293	Meyer U	Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice.	Brain, behavior, and immunity	2008	113
18063801	19293	Behrens MM	Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase.	Science	2007	187
18245383	19293	Tan Z	Robust but delayed thalamocortical activation of dendritic-targeting inhibitory interneurons.	Proceedings of the National Academy of Sciences of the United States of America	2008	51
19396159	19293	Sohal VS	Parvalbumin neurons and gamma rhythms enhance cortical circuit performance.	Nature	2009	627
19890015	19293	Wirth EK	Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration.	FASEB journal 	2010	44
20826315	19293	Runyan CA	Response features of parvalbumin-expressing interneurons suggest precise roles for subtypes of inhibition in visual cortex.	Neuron	2010	81
20826316	19293	Kerlin AM	Broadly tuned response properties of diverse inhibitory neuron subtypes in mouse visual cortex.	Neuron	2010	159
21277876	19293	Nakazawa K	GABAergic interneuron origin of schizophrenia pathophysiology.	Neuropharmacology	2012	91
21278730	19293	Murray AJ	Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory.	Nature neuroscience	2011	73
21693785	19293	Inan M	Spatial and temporal bias in the mitotic origins of somatostatin- and parvalbumin-expressing interneuron subgroups and the chandelier subtype in the medial ganglionic eminence.	Cerebral cortex	2012	39
21765421	19293	Hofer SB	Differential connectivity and response dynamics of excitatory and inhibitory neurons in visual cortex.	Nature neuroscience	2011	114
22446878	19293	Royer S	Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition.	Nature neuroscience	2012	133
22541439	19293	Verret L	Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.	Cell	2012	171
23708967	19293	Kvitsiani D	Distinct behavioural and network correlates of two interneuron types in prefrontal cortex.	Nature	2013	95
23817549	19293	Pfeffer CK	Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons.	Nature neuroscience	2013	208
23872595	19293	Polack PO	Cellular mechanisms of brain state-dependent gain modulation in visual cortex.	Nature neuroscience	2013	102
23966693	19293	Moore AK	Parvalbumin-expressing inhibitory interneurons in auditory cortex are well-tuned for frequency.	The Journal of neuroscience 	2013	45
24212671	19293	Song J	Parvalbumin interneurons mediate neuronal circuitry-neurogenesis coupling in the adult hippocampus.	Nature neuroscience	2013	40
24239124	19293	Kato HK	Parvalbumin-expressing interneurons linearly control olfactory bulb output.	Neuron	2013	45
24239125	19293	Miyamichi K	Dissecting local circuits: parvalbumin interneurons underlie broad feedback control of olfactory bulb output.	Neuron	2013	57
24256726	19293	Courtin J	Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression.	Nature	2014	89
24336286	19293	Donato F	Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning.	Nature	2013	94
24425250	19293	Li LY	Differential Receptive Field Properties of Parvalbumin and Somatostatin Inhibitory Neurons in Mouse Auditory Cortex.	Cerebral cortex	2015	29
24501350	19293	Mastro KJ	Transgenic mouse lines subdivide external segment of the globus pallidus (GPe) neurons and reveal distinct GPe output pathways.	The Journal of neuroscience 	2014	22
24705183	19293	Buetfering C	Parvalbumin interneurons provide grid cell-driven recurrent inhibition in the medial entorhinal cortex.	Nature neuroscience	2014	24
24814341	19293	Wolff SB	Amygdala interneuron subtypes control fear learning through disinhibition.	Nature	2014	84
25164650	19293	Lee AT	A class of GABAergic neurons in the prefrontal cortex sends long-range projections to the nucleus accumbens and elicits acute avoidance behavior.	The Journal of neuroscience 	2014	27
25297094	19293	Li LY	A feedforward inhibitory circuit mediates lateral refinement of sensory representation in upper layer 2/3 of mouse primary auditory cortex.	The Journal of neuroscience 	2014	23
25505119	19293	Yekhlef L	Selective activation of parvalbumin- or somatostatin-expressing interneurons triggers epileptic seizurelike activity in mouse medial entorhinal cortex.	Journal of neurophysiology	2015	20
25543458	19293	Pala A	In vivo measurement of cell-type-specific synaptic connectivity and synaptic transmission in layer 2/3 mouse barrel cortex.	Neuron	2015	18
25609625	19293	Neske GT	Contributions of diverse excitatory and inhibitory neurons to recurrent network activity in cerebral cortex.	The Journal of neuroscience 	2015	30
25733878	19293	Kim T	Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations.	Proceedings of the National Academy of Sciences of the United States of America	2015	30
25756808	19293	Wöhr M	Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities.	Translational psychiatry	2015	22
25979090	19293	Ji XY	Thalamocortical Innervation Pattern in Mouse Auditory and Visual Cortex: Laminar and Cell-Type Specificity.	Cerebral cortex	2016	11
26113723	19293	Shang C	BRAIN CIRCUITS. A parvalbumin-positive excitatory visual pathway to trigger fear responses in mice.	Science	2015	17
26527000	19293	Petitjean H	Dorsal Horn Parvalbumin Neurons Are Gate-Keepers of Touch-Evoked Pain after Nerve Injury.	Cell reports	2015	17
26551544	19293	Woo SH	Piezo2 is the principal mechanotransduction channel for proprioception.	Nature neuroscience	2015	21
26771492	19293	Kim H	Prefrontal Parvalbumin Neurons in Control of Attention.	Cell	2016	28
26968763	19293	Xu M	Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming.	Neuroscience	2016	10
7715726	19699	D'Arcangelo G	A protein related to extracellular matrix proteins deleted in the mouse mutant reeler.	Nature	1995	295
7748558	19699	Ogawa M	The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons.	Neuron	1995	133
10939329	19699	Dulabon L	Reelin binds alpha3beta1 integrin and inhibits neuronal migration.	Neuron	2000	114
11239428	19699	Hevner RF	Tbr1 regulates differentiation of the preplate and layer 6.	Neuron	2001	204
11520926	19699	Rice DS	Role of the reelin signaling pathway in central nervous system development.	Annual review of neuroscience	2001	144
19515914	19699	Hoe HS	Interaction of reelin with amyloid precursor protein promotes neurite outgrowth.	The Journal of neuroscience 	2009	74
20357114	19699	Pujadas L	Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation.	The Journal of neuroscience 	2010	58
21852430	19699	Rogers JT	Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density.	Learning and memory	2011	40
23752244	19699	Iafrati J	Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway.	Molecular psychiatry	2014	34
24599114	19699	Pujadas L	Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.	Nature communications	2014	20
15314237	20264	Nassar MA	Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.	Proceedings of the National Academy of Sciences of the United States of America	2004	119
17568746	20264	Zimmermann K	Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures.	Nature	2007	98
17766042	20264	Cummins TR	The roles of sodium channels in nociception: Implications for mechanisms of pain.	Pain	2007	90
18669863	20264	Abrahamsen B	The cell and molecular basis of mechanical, cold, and inflammatory pain.	Science	2008	142
20702715	20264	Zhao J	Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds.	The Journal of neuroscience 	2010	43
21295407	20264	Gaveriaux-Ruff C	Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.	Pain	2011	42
22703890	20264	Shields SD	Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system.	Pain	2012	61
22723301	20264	Verkerk AO	Functional Nav1.8 channels in intracardiac neurons: the link between SCN10A and cardiac electrophysiology.	Circulation research	2012	35
23965627	20264	Chiu IM	Bacteria activate sensory neurons that modulate pain and inflammation.	Nature	2013	76
24259584	20264	Daou I	Remote optogenetic activation and sensitization of pain pathways in freely moving mice.	The Journal of neuroscience 	2013	35
24440715	20264	Minett MS	Pain without nociceptors? Nav1.7-independent pain mechanisms.	Cell reports	2014	29
24759321	20264	Riol-Blanco L	Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.	Nature	2014	40
9052802	20511	Bruijn LI	ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.	Neuron	1997	275
9180080	20511	Tanaka K	Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.	Science	1997	314
15635412	20511	Rothstein JD	Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.	Nature	2005	368
17581948	20511	Regan MR	Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS.	The Journal of neuroscience 	2007	111
18353560	20511	Miller BR	Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.	Neuroscience	2008	98
18805467	20511	Furness DN	A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2).	Neuroscience	2008	61
23364798	20511	Morel L	Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1.	The Journal of biological chemistry	2013	53
25834045	20511	Petr GT	Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.	The Journal of neuroscience 	2015	24
9275227	20595	Schrank B	Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.	Proceedings of the National Academy of Sciences of the United States of America	1997	181
10655541	20595	Monani UR	The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.	Human molecular genetics	2000	222
17895963	20595	Gabanella F	Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs.	PloS one	2007	123
18065780	20595	Murray LM	Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.	Human molecular genetics	2008	137
18178576	20595	Gavrilina TO	Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.	Human molecular genetics	2008	82
18485868	20595	Zhang Z	SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing.	Cell	2008	209
19074460	20595	Rose FF Jr	Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.	Human molecular genetics	2009	45
19228773	20595	Baughan TD	Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy.	Human molecular genetics	2009	51
20019802	20595	Bäumer D	Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.	PLoS genetics	2009	82
20234094	20595	Passini MA	CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.	The Journal of clinical investigation	2010	108
20624852	20595	Hua Y	Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.	Genes and development	2010	134
20639395	20595	Bevan AK	Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery.	Human molecular genetics	2010	77
20826664	20595	Park GH	Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.	The Journal of neuroscience 	2010	58
21118896	20595	Dominguez E	Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.	Human molecular genetics	2011	88
21979052	20595	Hua Y	Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.	Nature	2011	180
22071333	20595	Bowerman M	A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.	Neuromuscular disorders 	2012	38
22723710	20595	Martinez TL	Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.	The Journal of neuroscience 	2012	55
23263861	20595	Ackermann B	Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.	Human molecular genetics	2013	29
23295949	20595	Benkhelifa-Ziyyat S	Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.	Molecular therapy 	2013	33
23839956	20595	McGivern JV	Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production.	Glia	2013	29
24218366	20595	See K	SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.	Human molecular genetics	2014	25
24617515	20595	Passini MA	Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.	Human gene therapy	2014	21
10707987	20617	Abeliovich A	Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.	Neuron	2000	384
12111846	20617	Rockenstein E	Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.	Journal of neuroscience research	2002	138
12597857	20617	Sharon R	The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease.	Neuron	2003	102
15026254	20617	Song DD	Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.	Experimental neurology	2004	79
15953415	20617	Masliah E	Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.	Neuron	2005	163
16260631	20617	Ellis CE	Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein.	Molecular and cellular biology	2005	71
17108165	20617	Larsen KE	Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis.	The Journal of neuroscience 	2006	113
17456777	20617	Dufty BM	Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.	The American journal of pathology	2007	66
19628698	20617	Junn E	Repression of alpha-synuclein expression and toxicity by microRNA-7.	Proceedings of the National Academy of Sciences of the United States of America	2009	120
19667183	20617	Jang H	Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration.	Proceedings of the National Academy of Sciences of the United States of America	2009	74
19864570	20617	Spencer B	Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.	The Journal of neuroscience 	2009	162
20098733	20617	Pan-Montojo F	Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.	PloS one	2010	60
20106867	20617	Kuo YM	Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.	Human molecular genetics	2010	56
20118279	20617	Reynolds AD	Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.	Journal of immunology	2010	73
23205266	20617	Pan-Montojo F	Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.	Scientific reports	2012	49
24082145	20617	Janezic S	Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.	Proceedings of the National Academy of Sciences of the United States of America	2013	41
24931606	20617	Tran HT	Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration.	Cell reports	2014	41
25095794	20617	Masuda-Suzukake M	Pathological alpha-synuclein propagates through neural networks.	Acta neuropathologica communications	2014	35
25484190	20617	Poehler AM	Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.	Autophagy	2014	22
25732816	20617	Osterberg VR	Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism.	Cell reports	2015	26
26093169	20617	Paumier KL	Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.	Neurobiology of disease	2015	26
7605627	20655	Wong PC	An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.	Neuron	1995	276
8673102	20655	Reaume AG	Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury.	Nature genetics	1996	217
9547233	20655	Kong J	Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1.	The Journal of neuroscience 	1998	132
9633809	20655	Hall ED	Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.	Glia	1998	119
9743498	20655	Bruijn LI	Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.	Science	1998	232
12966034	20655	Wang J	Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.	Human molecular genetics	2003	98
14526083	20655	Clement AM	Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.	Science	2003	249
14534160	20655	Jonsson PA	Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.	Brain 	2004	76
14736504	20655	Fischer LR	Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.	Experimental neurology	2004	322
15034571	20655	Kieran D	Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.	Nature medicine	2004	95
15164063	20655	Azzouz M	VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.	Nature	2004	129
15568021	20655	Storkebaum E	Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.	Nature neuroscience	2005	103
15911875	20655	Kieran D	A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice.	The Journal of cell biology	2005	78
16082680	20655	Schaefer AM	A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.	The Journal of comparative neurology	2005	79
16330499	20655	Jonsson PA	Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.	Brain 	2006	93
16369483	20655	Urushitani M	Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.	Nature neuroscience	2006	115
16595634	20655	Kikuchi H	Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
16636274	20655	Furukawa Y	Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
16636275	20655	Deng HX	Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.	Proceedings of the National Academy of Sciences of the United States of America	2006	146
16847061	20655	Atkin JD	Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1.	The Journal of biological chemistry	2006	87
17043238	20655	Beers DR	Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2006	178
17496168	20655	Bordet T	Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.	The Journal of pharmacology and experimental therapeutics	2007	61
17584954	20655	Muller FL	Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.	American journal of physiology. Regulatory, integrative and comparative physiology	2007	74
17715066	20655	Zetterström P	Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.	Proceedings of the National Academy of Sciences of the United States of America	2007	66
17715356	20655	Ferraiuolo L	Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS.	The Journal of neuroscience 	2007	66
17725983	20655	De Vos KJ	Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.	Human molecular genetics	2007	123
17766128	20655	Hegedus J	Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.	Neurobiology of disease	2007	81
18305242	20655	Jaarsma D	Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice.	The Journal of neuroscience 	2008	70
18467368	20655	Hegedus J	Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis.	The Journal of physiology	2008	52
18492803	20655	Yamanaka K	Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	82
18519638	20655	Nishitoh H	ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.	Genes and development	2008	117
18640245	20655	Feng HL	Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.	Neuroscience	2008	51
19046573	20655	Dobrowolny G	Skeletal muscle is a primary target of SOD1G93A-mediated toxicity.	Cell metabolism	2008	121
19251638	20655	Lobsiger CS	Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	48
19272377	20655	Martin LJ	The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.	Experimental neurology	2009	65
19416874	20655	Karch CM	Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS.	Proceedings of the National Academy of Sciences of the United States of America	2009	67
19715760	20655	Shi P	Mitochondrial dysfunction in amyotrophic lateral sclerosis.	Biochimica et biophysica acta	2010	50
19731042	20655	Henkel JS	Microglia in ALS: the good, the bad, and the resting.	Journal of neuroimmune pharmacology 	2009	91
19779023	20655	Magrané J	Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.	Human molecular genetics	2009	47
20040516	20655	Jang YC	Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration.	FASEB journal 	2010	83
20345765	20655	Gros-Louis F	Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.	Journal of neurochemistry	2010	48
20797535	20655	Israelson A	Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.	Neuron	2010	74
20962037	20655	Wang L	Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.	Human molecular genetics	2011	41
21057983	20655	Dadon-Nachum M	The "dying-back" phenomenon of motor neurons in ALS.	Journal of molecular neuroscience 	2011	59
21059924	20655	Bilsland LG	Deficits in axonal transport precede ALS symptoms in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2010	77
21078990	20655	Li Q	ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import.	Proceedings of the National Academy of Sciences of the United States of America	2010	42
21349440	20655	Philips T	Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.	The Lancet. Neurology	2011	126
22072713	20655	Murakami K	SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.	The Journal of biological chemistry	2011	40
23542689	20655	Kang SH	Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis.	Nature neuroscience	2013	93
23602540	20655	Yang YM	A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.	Cell stem cell	2013	63
23687121	20655	Saccon RA	Is SOD1 loss of function involved in amyotrophic lateral sclerosis?	Brain 	2013	30
23850290	20655	Chiu IM	A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model.	Cell reports	2013	80
24094105	20655	Saxena S	Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.	Neuron	2013	40
24108104	20655	Wang H	Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.	Human molecular genetics	2014	22
24154542	20655	Magrané J	Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.	Human molecular genetics	2014	50
24378874	20655	Sakellariou GK	Neuron-specific expression of CuZnSOD prevents the loss of muscle mass and function that occurs in homozygous CuZnSOD-knockout mice.	FASEB journal 	2014	20
24591593	20655	Winkler EA	Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	32
25559081	20655	Filézac de L'Etang A	Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS.	Nature neuroscience	2015	22
26650262	20655	Ayers JI	Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.	Acta neuropathologica	2016	14
27507699	20655	van Zundert B	Silencing strategies for therapy of SOD1-mediated ALS.	Neuroscience letters	2017	5
9288101	22215	Albrecht U	Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.	Nature genetics	1997	120
9808466	22215	Jiang YH	Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.	Neuron	1998	199
17940072	22215	Dindot SV	The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.	Human molecular genetics	2008	113
19430469	22215	Yashiro K	Ube3a is required for experience-dependent maturation of the neocortex.	Nature neuroscience	2009	108
20212164	22215	Sato M	Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a.	Proceedings of the National Academy of Sciences of the United States of America	2010	48
20423730	22215	Gustin RM	Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.	Neurobiology of disease	2010	41
22131424	22215	Kaphzan H	Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome.	The Journal of neuroscience 	2011	41
22190039	22215	Huang HS	Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons.	Nature	2011	100
22493002	22215	Meng L	Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a.	Human molecular genetics	2012	39
22681684	22215	Wallace ML	Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects.	Neuron	2012	38
24254964	22215	Judson MC	Allelic specificity of Ube3a expression in the mouse brain during postnatal development.	The Journal of comparative neurology	2014	31
24385930	22215	Meng L	Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.	PLoS genetics	2013	25
24672001	22215	Pignatelli M	Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome.	The Journal of neuroscience 	2014	23
25866966	22215	Silva-Santos S	Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.	The Journal of clinical investigation	2015	17
27021170	22215	Judson MC	GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.	Neuron	2016	11
11224535	23821	Luo Y	Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.	Nature neuroscience	2001	211
11406613	23821	Roberds SL	BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.	Human molecular genetics	2001	135
14715132	23821	Ohno M	BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease.	Neuron	2004	136
15824102	23821	Wong HK	beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase.	The Journal of biological chemistry	2005	105
15987683	23821	Dominguez D	Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.	The Journal of biological chemistry	2005	94
16306400	23821	Velliquette RA	Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.	The Journal of neuroscience 	2005	65
17099708	23821	Hu X	Bace1 modulates myelination in the central and peripheral nervous system.	Nature neuroscience	2006	206
17258906	23821	Ohno M	BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.	Neurobiology of disease	2007	87
17409228	23821	Zhao J	Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.	The Journal of neuroscience 	2007	122
17616527	23821	McConlogue L	Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice.	The Journal of biological chemistry	2007	94
18413858	23821	Hu X	Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves.	FASEB journal 	2008	66
18650431	23821	Cole SL	The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology.	The Journal of biological chemistry	2008	58
18986979	23821	Boissonneault V	MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1.	The Journal of biological chemistry	2009	82
20092570	23821	Zhang XM	Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.	The European journal of neuroscience	2009	49
20592204	23821	Hu X	BACE1 deficiency causes altered neuronal activity and neurodegeneration.	The Journal of neuroscience 	2010	55
21423189	23821	Alvarez-Erviti L	Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.	Nature biotechnology	2011	436
21613482	23821	Winton MJ	Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.	The Journal of neuroscience 	2011	49
21933711	23821	Devi L	Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.	Neurobiology of disease	2012	40
22728825	23821	Kuhn PH	Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons.	The EMBO journal	2012	72
23745722	23821	Austin SA	Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology.	Journal of neurochemistry	2013	26
26124111	23821	Gowrishankar S	Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.	Proceedings of the National Academy of Sciences of the United States of America	2015	19
16786561	108071	Seeman P	Psychosis pathways converge via D2high dopamine receptors.	Synapse	2006	65
18377703	108071	Blednov YA	Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.	The international journal of neuropsychopharmacology	2008	50
18579080	108071	Petzold GC	Coupling of neural activity to blood flow in olfactory glomeruli is mediated by astrocytic pathways.	Neuron	2008	70
18923032	108071	Zhang Y	The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation.	The Journal of neuroscience 	2008	85
18952114	108071	Min WW	Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.	Neuropharmacology	2009	52
19546859	108071	Elia J	Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes.	Molecular psychiatry	2010	153
21310164	108071	Rammes G	Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.	Neuropharmacology	2011	35
22373400	108071	Byrnes KR	Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury.	Journal of neuroinflammation	2012	46
25581360	108071	Tian D	Contribution of mGluR5 to pathophysiology in a mouse model of human chromosome 16p11.2 microdeletion.	Nature neuroscience	2015	25
26667279	108071	Haas LT	Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.	Brain 	2016	11
7566151	109648	Stephens TW	The role of neuropeptide Y in the antiobesity action of the obese gene product.	Nature	1995	135
8603777	109648	Schwartz MW	Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.	Diabetes	1996	118
8632796	109648	Erickson JC	Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y.	Nature	1996	128
9742148	109648	Alcántara S	Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse.	The Journal of neuroscience 	1998	118
9872314	109648	Shimada M	Mice lacking melanin-concentrating hormone are hypophagic and lean.	Nature	1998	164
10934256	109648	Marin O	Origin and molecular specification of striatal interneurons.	The Journal of neuroscience 	2000	153
11840218	109648	Cone RD	The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis.	International journal of obesity and related metabolic disorders 	2001	91
12077332	109648	Qian S	Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice.	Molecular and cellular biology	2002	113
12821374	109648	Borges K	Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model.	Experimental neurology	2003	103
14962995	109648	Chen HY	Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.	Endocrinology	2004	127
15591135	109648	Takahashi KA	Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons.	Endocrinology	2005	78
16099943	109648	Bewick GA	Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype.	FASEB journal 	2005	72
16158063	109648	Gropp E	Agouti-related peptide-expressing neurons are mandatory for feeding.	Nature neuroscience	2005	186
17261674	109648	Fioramonti X	Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks?	Diabetes	2007	57
18668043	109648	Andrews ZB	UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals.	Nature	2008	190
18800067	109648	Wittmann W	Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.	Neuropsychopharmacology 	2009	60
19121517	109648	Mellios N	Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.	Biological psychiatry	2009	80
19357287	109648	van den Pol AN	Neuromedin B and gastrin-releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons.	The Journal of neuroscience 	2009	75
19950390	109648	Xu X	Immunochemical characterization of inhibitory mouse cortical neurons: three chemically distinct classes of inhibitory cells.	The Journal of comparative neurology	2010	123
20207832	109648	Backholer K	Kisspeptin cells in the ewe brain respond to leptin and communicate with neuropeptide Y and proopiomelanocortin cells.	Endocrinology	2010	43
20348924	109648	Padilla SL	Pomc-expressing progenitors give rise to antagonistic neuronal populations in hypothalamic feeding circuits.	Nature medicine	2010	76
20855609	109648	Fujikawa T	Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
21211531	109648	Wu Q	GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism.	European journal of pharmacology	2011	37
21912391	109648	Guilloux JP	Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression.	Molecular psychiatry	2012	68
22090502	109648	Ibáñez-Sandoval O	A novel functionally distinct subtype of striatal neuropeptide Y interneuron.	The Journal of neuroscience 	2011	39
25202980	109648	Secher A	The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.	The Journal of clinical investigation	2014	55
25751534	109648	Pleil KE	NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking.	Nature neuroscience	2015	29
24973918	109731	Jo S	GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease.	Nature medicine	2014	47
11394998	110616	Hara J	Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.	Neuron	2001	266
19036964	110616	Chen X	Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.	The Journal of neuroscience 	2008	58
21900579	110616	Shakkottai VG	Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3.	The Journal of neuroscience 	2011	48
17670789	110648	Ono Y	Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells.	Development	2007	74
19383789	110648	Friling S	Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
21725324	110648	Caiazzo M	Direct generation of functional dopaminergic neurons from mouse and human fibroblasts.	Nature	2011	287
21877920	110648	Sánchez-Danés A	Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.	Human gene therapy	2012	34
15665093	114229	Messager S	Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54.	Proceedings of the National Academy of Sciences of the United States of America	2005	215
16339030	114229	Han SK	Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty.	The Journal of neuroscience 	2005	233
17978050	114229	Dungan HM	The role of kisspeptin-GPR54 signaling in the tonic regulation and surge release of gonadotropin-releasing hormone/luteinizing hormone.	The Journal of neuroscience 	2007	65
18162521	114229	Pielecka-Fortuna J	Kisspeptin acts directly and indirectly to increase gonadotropin-releasing hormone neuron activity and its effects are modulated by estradiol.	Endocrinology	2008	99
18450966	114229	d'Anglemont de Tassigny X	Kisspeptin can stimulate gonadotropin-releasing hormone (GnRH) release by a direct action at GnRH nerve terminals.	Endocrinology	2008	62
18483150	114229	Liu X	Kisspeptin excites gonadotropin-releasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels.	Endocrinology	2008	68
18753370	114229	Clarkson J	Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation and the luteinizing hormone surge.	The Journal of neuroscience 	2008	132
19770291	114229	Oakley AE	Kisspeptin signaling in the brain.	Endocrine reviews	2009	165
19966188	114229	Herbison AE	Distribution and postnatal development of Gpr54 gene expression in mouse brain and gonadotropin-releasing hormone neurons.	Endocrinology	2010	58
21516099	114229	Mayer C	Female reproductive maturation in the absence of kisspeptin/GPR54 signaling.	Nature neuroscience	2011	50
24051579	114229	Kirilov M	Dependence of fertility on kisspeptin-Gpr54 signaling at the GnRH neuron.	Nature communications	2013	33
11826117	121021	Mallon BS	Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.	The Journal of neuroscience 	2002	103
12629179	121021	Matthias K	Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus.	The Journal of neuroscience 	2003	98
12682089	121021	Belachew S	Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons.	The Journal of cell biology	2003	131
18045844	121021	Zhu X	NG2 cells generate both oligodendrocytes and gray matter astrocytes.	Development	2008	202
18299565	121021	Buffo A	Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain.	Proceedings of the National Academy of Sciences of the United States of America	2008	175
19494148	121021	Guo F	Early postnatal proteolipid promoter-expressing progenitors produce multilineage cells in vivo.	The Journal of neuroscience 	2009	50
20043946	121021	Trotter J	NG2 cells: Properties, progeny and origin.	Brain research reviews	2010	64
20173746	121021	Etxeberria A	Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum.	Nature neuroscience	2010	51
20219994	121021	De Biase LM	Excitability and synaptic communication within the oligodendrocyte lineage.	The Journal of neuroscience 	2010	70
20569695	121021	Zawadzka M	CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination.	Cell stem cell	2010	113
20599895	121021	Huang FJ	Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.	Developmental biology	2010	49
20826667	121021	Guo F	Pyramidal neurons are generated from oligodendroglial progenitor cells in adult piriform cortex.	The Journal of neuroscience 	2010	59
21193743	121021	Chen J	White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke.	Stroke	2011	37
21266410	121021	Zhu X	Age-dependent fate and lineage restriction of single NG2 cells.	Development	2011	95
21907924	121021	Sugiarto S	Asymmetry-defective oligodendrocyte progenitors are glioma precursors.	Cancer cell	2011	69
22627280	121021	Zhu X	Olig2-dependent developmental fate switch of NG2 cells.	Development	2012	31
23624515	121021	Hughes EG	Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain.	Nature neuroscience	2013	100
25458895	121021	Heinrich C	Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex.	Stem cell reports	2014	42
25821912	121021	Zonouzi M	GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury.	Nature neuroscience	2015	18
15064766	140919	Cheng L	Tlx3 and Tlx1 are post-mitotic selector genes determining glutamatergic over GABAergic cell fates.	Nature neuroscience	2004	113
17488640	140919	Tong Q	Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia.	Cell metabolism	2007	128
19711410	140919	Lazarenko RM	Acid sensitivity and ultrastructure of the retrotrapezoid nucleus in Phox2b-EGFP transgenic mice.	The Journal of comparative neurology	2009	53
20081850	140919	Hägglund M	Activation of groups of excitatory neurons in the mammalian spinal cord or hindbrain evokes locomotion.	Nature neuroscience	2010	58
20554874	140919	Stuber GD	Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate.	The Journal of neuroscience 	2010	177
21040853	140919	Liu Y	VGLUT2-dependent glutamate release from nociceptors is required to sense pain and suppress itch.	Neuron	2010	83
23238719	140919	Kudo T	Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice.	The Journal of neuroscience 	2012	40
23407970	140919	Abbott SB	Selective optogenetic activation of rostral ventrolateral medullary catecholaminergic neurons produces cardiorespiratory stimulation in conscious mice.	The Journal of neuroscience 	2013	28
23637157	140919	Kaur S	Glutamatergic signaling from the parabrachial nucleus plays a critical role in hypercapnic arousal.	The Journal of neuroscience 	2013	30
24041961	140919	Akiyama T	Roles of glutamate, substance P, and gastrin-releasing peptide as spinal neurotransmitters of histaminergic and nonhistaminergic itch.	Pain	2014	23
24715505	140919	Taylor SR	GABAergic and glutamatergic efferents of the mouse ventral tegmental area.	The Journal of comparative neurology	2014	33
25242304	140919	Root DH	Single rodent mesohabenular axons release glutamate and GABA.	Nature neuroscience	2014	50
25319687	140919	Root DH	Role of glutamatergic projections from ventral tegmental area to lateral habenula in aversive conditioning.	The Journal of neuroscience 	2014	34
25572002	140919	Yamaguchi T	Glutamatergic and dopaminergic neurons in the mouse ventral tegmental area.	The European journal of neuroscience	2015	18
25596588	140919	Saba L	Altered Functionality, Morphology, and Vesicular Glutamate Transporter Expression of Cortical Motor Neurons from a Presymptomatic Mouse Model of Amyotrophic Lateral Sclerosis.	Cerebral cortex	2016	14
15362149	171382	Tominaga M	Thermosensation and pain.	Journal of neurobiology	2004	88
17344381	171382	Hjerling-Leffler J	Emergence of functional sensory subtypes as defined by transient receptor potential channel expression.	The Journal of neuroscience 	2007	64
17481392	171382	Colburn RW	Attenuated cold sensitivity in TRPM8 null mice.	Neuron	2007	207
17538622	171382	Bautista DM	The menthol receptor TRPM8 is the principal detector of environmental cold.	Nature	2007	290
18094254	171382	Takashima Y	Diversity in the neural circuitry of cold sensing revealed by genetic axonal labeling of transient receptor potential melastatin 8 neurons.	The Journal of neuroscience 	2007	69
18199758	171382	Dhaka A	Visualizing cold spots: TRPM8-expressing sensory neurons and their projections.	The Journal of neuroscience 	2008	92
18218683	171382	Nassenstein C	Expression and function of the ion channel TRPA1 in vagal afferent nerves innervating mouse lungs.	The Journal of physiology	2008	76
19279249	171382	Madrid R	Variable threshold of trigeminal cold-thermosensitive neurons is determined by a balance between TRPM8 and Kv1 potassium channels.	The Journal of neuroscience 	2009	47
20542379	171382	Knowlton WM	TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo.	Pain	2010	82
21076394	171382	Parra A	Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea.	Nature medicine	2010	56
21903934	171382	Willis DN	Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants.	FASEB journal 	2011	42
21984952	171382	Knowlton WM	Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice.	PloS one	2011	49
22323721	171382	Almeida MC	Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature.	The Journal of neuroscience 	2012	49
23407943	171382	Knowlton WM	A sensory-labeled line for cold: TRPM8-expressing sensory neurons define the cellular basis for cold, cold pain, and cooling-mediated analgesia.	The Journal of neuroscience 	2013	47
23410158	171382	Vandewauw I	Systematic and quantitative mRNA expression analysis of TRP channel genes at the single trigeminal and dorsal root ganglion level in mouse.	BMC neuroscience	2013	25
10764638	193034	Caterina MJ	Impaired nociception and pain sensation in mice lacking the capsaicin receptor.	Science	2000	702
10821274	193034	Davis JB	Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.	Nature	2000	348
11466438	193034	Vlaskovska M	P2X3 knock-out mice reveal a major sensory role for urothelially released ATP.	The Journal of neuroscience 	2001	95
12161756	193034	Birder LA	Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1.	Nature neuroscience	2002	161
15128843	193034	Dai Y	Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain.	The Journal of neuroscience 	2004	80
15254097	193034	Woodbury CJ	Nociceptors lacking TRPV1 and TRPV2 have normal heat responses.	The Journal of neuroscience 	2004	84
15788769	193034	Ghilardi JR	Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain.	The Journal of neuroscience 	2005	78
16327782	193034	Sharif Naeini R	An N-terminal variant of Trpv1 channel is required for osmosensory transduction.	Nature neuroscience	2006	62
16399694	193034	Jin X	Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha.	The Journal of neuroscience 	2006	114
17174891	193034	Razavi R	TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes.	Cell	2006	78
17251423	193034	Marsch R	Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice.	The Journal of neuroscience 	2007	63
17329430	193034	Shim WS	TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase.	The Journal of neuroscience 	2007	105
17626206	193034	Steiner AA	Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors.	The Journal of neuroscience 	2007	59
18204441	193034	Maccarrone M	Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.	Nature neuroscience	2008	89
18226966	193034	Lawson JJ	TRPV1 unlike TRPV2 is restricted to a subset of mechanically insensitive cutaneous nociceptors responding to heat.	The journal of pain 	2008	64
18341994	193034	Gibson HE	TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.	Neuron	2008	109
18463244	193034	Schnizler K	Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons.	The Journal of neuroscience 	2008	61
18499726	193034	Taylor-Clark TE	Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal.	The Journal of physiology	2008	60
18952924	193034	Sappington RM	TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure.	Investigative ophthalmology and visual science	2009	58
19171673	193034	Taylor-Clark TE	Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1.	Molecular pharmacology	2009	46
19893614	193034	Miyamoto T	TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice.	PloS one	2009	47
20231274	193034	Staruschenko A	Contribution of TRPV1-TRPA1 interaction to the single channel properties of the TRPA1 channel.	The Journal of biological chemistry	2010	59
21076424	193034	Grueter BA	Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens.	Nature neuroscience	2010	101
21139565	193034	Mishra SK	TRPV1-lineage neurons are required for thermal sensation.	The EMBO journal	2011	67
21451044	193034	Cavanaugh DJ	Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells.	The Journal of neuroscience 	2011	106
21562271	193034	Ryskamp DA	The polymodal ion channel transient receptor potential vanilloid 4 modulates calcium flux, spiking rate, and apoptosis of mouse retinal ganglion cells.	The Journal of neuroscience 	2011	41
21708890	193034	Hillery CA	Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.	Blood	2011	42
21752988	193034	Cavanaugh DJ	Restriction of transient receptor potential vanilloid-1 to the peptidergic subset of primary afferent neurons follows its developmental downregulation in nonpeptidergic neurons.	The Journal of neuroscience 	2011	55
21832173	193034	Park U	TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception.	The Journal of neuroscience 	2011	51
22016541	193034	Park CK	Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.	The Journal of neuroscience 	2011	62
22253477	193034	Serhan CN	Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain.	FASEB journal 	2012	79
22632722	193034	Kim YH	TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord.	Neuron	2012	39
23263443	193034	Han L	A subpopulation of nociceptors specifically linked to itch.	Nature neuroscience	2013	96
23685721	193034	Roberson DP	Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons.	Nature neuroscience	2013	32
24573275	193034	Ward NJ	Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection.	The Journal of neuroscience 	2014	25
24855942	193034	Riera CE	TRPV1 pain receptors regulate longevity and metabolism by neuropeptide signaling.	Cell	2014	23
25640077	193034	Weng HJ	Tmem100 Is a Regulator of TRPA1-TRPV1 Complex and Contributes to Persistent Pain.	Neuron	2015	24
25765068	193034	Chen R	Wireless magnetothermal deep brain stimulation.	Science	2015	37
9020854	212541	Humphries MM	Retinopathy induced in mice by targeted disruption of the rhodopsin gene.	Nature genetics	1997	172
9892703	212541	Lem J	Morphological, physiological, and biochemical changes in rhodopsin knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	1999	164
10097103	212541	Chen CK	Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase.	Proceedings of the National Academy of Sciences of the United States of America	1999	116
12663652	212541	Liang Y	Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes.	The Journal of biological chemistry	2003	174
15111110	212541	Fotiadis D	The G protein-coupled receptor rhodopsin in the native membrane.	FEBS letters	2004	82
15610977	212541	Wenzel A	Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration.	Progress in retinal and eye research	2005	171
16600853	212541	Bi A	Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration.	Neuron	2006	155
17389515	212541	Ruggeri M	In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography.	Investigative ophthalmology and visual science	2007	87
21224384	212541	Sakami S	Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations.	The Journal of biological chemistry	2011	61
23873086	212541	Gonzalez-Cordero A	Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina.	Nature biotechnology	2013	93
24997763	212541	Chuong AS	Noninvasive optical inhibition with a red-shifted microbial rhodopsin.	Nature neuroscience	2014	62
25270370	212541	Chiang WC	Robust Endoplasmic Reticulum-Associated Degradation of Rhodopsin Precedes Retinal Degeneration.	Molecular neurobiology	2015	21
26586188	212541	Gong Y	High-speed recording of neural spikes in awake mice and flies with a fluorescent voltage sensor.	Science	2015	44
20040602	230908	Sephton CF	TDP-43 is a developmentally regulated protein essential for early embryonic development.	The Journal of biological chemistry	2010	107
20198480	230908	Kraemer BC	Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.	Acta neuropathologica	2010	90
20660618	230908	Tsai KJ	Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.	The Journal of experimental medicine	2010	70
20736350	230908	Shan X	Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	99
21206091	230908	Igaz LM	Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.	The Journal of clinical investigation	2011	127
21358643	230908	Polymenidou M	Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.	Nature neuroscience	2011	293
21752789	230908	Swarup V	Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.	Brain 	2011	52
22084410	230908	Swarup V	Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways.	The Journal of experimental medicine	2011	54
22485182	230908	Valdez G	Shared resistance to aging and ALS in neuromuscular junctions of specific muscles.	PloS one	2012	49
23023293	230908	Lagier-Tourenne C	Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.	Nature neuroscience	2012	163
23449777	230908	Iguchi Y	Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.	Brain 	2013	28
24616503	230908	Yang C	Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2014	35
24974230	230908	Barmada SJ	Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.	Nature chemical biology	2014	56
25977373	230908	Chew J	Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits.	Science	2015	48
26044557	230908	Koppers M	C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits.	Annals of neurology	2015	38
26197969	230908	Walker AK	Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.	Acta neuropathologica	2015	18
15046718	277328	Bandell M	Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin.	Neuron	2004	407
15483558	277328	Corey DP	TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells.	Nature	2004	152
16564016	277328	Bautista DM	TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents.	Cell	2006	499
16630838	277328	Kwan KY	TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction.	Neuron	2006	360
17237762	277328	Macpherson LJ	Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.	Nature	2007	293
17588549	277328	Sawada Y	Cold sensitivity of recombinant TRPA1 channels.	Brain research	2007	56
17686976	277328	McNamara CR	TRPA1 mediates formalin-induced pain.	Proceedings of the National Academy of Sciences of the United States of America	2007	253
18031925	277328	Streng T	Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder.	European urology	2008	65
18322093	277328	Andersson DA	Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress.	The Journal of neuroscience 	2008	172
18398506	277328	Bessac BF	TRPA1 is a major oxidant sensor in murine airway sensory neurons.	The Journal of clinical investigation	2008	122
18568077	277328	Andrè E	Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents.	The Journal of clinical investigation	2008	107
18687886	277328	Materazzi S	Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1.	Proceedings of the National Academy of Sciences of the United States of America	2008	54
19144922	277328	Karashima Y	TRPA1 acts as a cold sensor in vitro and in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2009	151
19202543	277328	Hu H	Zinc activates damage-sensing TRPA1 ion channels.	Nature chemical biology	2009	60
19369549	277328	Kwan KY	TRPA1 modulates mechanotransduction in cutaneous sensory neurons.	The Journal of neuroscience 	2009	92
19383149	277328	Kerstein PC	Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors.	Molecular pain	2009	45
19419422	277328	Salas MM	TRPA1-mediated responses in trigeminal sensory neurons: interaction between TRPA1 and TRPV1.	The European journal of neuroscience	2009	56
19458046	277328	Caceres AI	A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma.	Proceedings of the National Academy of Sciences of the United States of America	2009	97
19632231	277328	Brierley SM	The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli.	Gastroenterology	2009	70
19749751	277328	Talavera K	Nicotine activates the chemosensory cation channel TRPA1.	Nature neuroscience	2009	54
20056530	277328	da Costa DS	The involvement of the transient receptor potential A1 (TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent inflammation.	Pain	2010	63
21068322	277328	del Camino D	TRPA1 contributes to cold hypersensitivity.	The Journal of neuroscience 	2010	71
21460831	277328	Wilson SR	TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch.	Nature neuroscience	2011	117
22927999	277328	Lennertz RC	TRPA1 mediates mechanical sensitization in nociceptors during inflammation.	PloS one	2012	38
23719797	277328	Wilson SR	The ion channel TRPA1 is required for chronic itch.	The Journal of neuroscience 	2013	31
23761909	277328	Shigetomi E	TRPA1 channels are regulators of astrocyte basal calcium levels and long-term potentiation via constitutive D-serine release.	The Journal of neuroscience 	2013	56
